STUDYID,USUBJID,AESEQ,TRTA,TRTAN,AEDECOD,AEBODSYS,AESEV,AESER,AEREL,AESTDTC,AEENDTC,ASTDT,AENDT,ASTDY,AENDY,AOCCFL,AOCCSFL,TRTEMFL,CQ01NAM,SAFFL
CLIN-2025-042,CLIN-2025-042-SITE01-0001,1,Treatment A,1,Diarrhea,Gastrointestinal disorders,MODERATE,N,VERY LIKELY,2025-05-15,2025-05-25,2025-05-15,2025-05-25,29,39.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0001,2,Treatment A,1,Fever,General disorders and administration site conditions,MODERATE,N,PROBABLE,2025-05-24,2025-05-26,2025-05-24,2025-05-26,38,40.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0001,3,Treatment A,1,Nausea,Gastrointestinal disorders,MILD,N,PROBABLE,2025-04-29,,2025-04-29,,13,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0001,4,Treatment A,1,Vomiting,Gastrointestinal disorders,MILD,N,PROBABLE,2025-04-19,2025-05-04,2025-04-19,2025-05-04,3,18.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0001,5,Treatment A,1,Abdominal pain,Gastrointestinal disorders,MILD,N,UNLIKELY,2025-05-24,2025-06-07,2025-05-24,2025-06-07,38,52.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0002,6,Placebo,3,Headache,Nervous system disorders,MODERATE,N,POSSIBLE,2025-06-08,2025-06-13,2025-06-08,2025-06-13,46,51.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0002,7,Placebo,3,Dizziness,Nervous system disorders,MODERATE,N,POSSIBLE,2025-05-15,2025-05-22,2025-05-15,2025-05-22,22,29.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0002,8,Placebo,3,Muscle pain,Musculoskeletal and connective tissue disorders,MODERATE,N,PROBABLE,2025-05-26,2025-06-03,2025-05-26,2025-06-03,33,41.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0002,9,Placebo,3,Muscle pain,Musculoskeletal and connective tissue disorders,MODERATE,Y,POSSIBLE,2025-05-09,2025-05-17,2025-05-09,2025-05-17,16,24.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0002,10,Placebo,3,Back pain,Musculoskeletal and connective tissue disorders,MILD,N,POSSIBLE,2025-05-14,,2025-05-14,,21,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0002,11,Placebo,3,Constipation,Gastrointestinal disorders,MILD,Y,PROBABLE,2025-04-25,2025-05-11,2025-04-25,2025-05-11,2,18.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0002,12,Placebo,3,Fatigue,General disorders and administration site conditions,MILD,N,POSSIBLE,2025-05-14,2025-05-20,2025-05-14,2025-05-20,21,27.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0002,13,Placebo,3,Constipation,Gastrointestinal disorders,MODERATE,N,UNLIKELY,2025-05-23,2025-06-05,2025-05-23,2025-06-05,30,43.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0003,14,Placebo,3,Pruritus,Skin and subcutaneous tissue disorders,MODERATE,N,POSSIBLE,2025-03-06,,2025-03-06,,14,,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0003,15,Placebo,3,Tachycardia,Cardiac disorders,MILD,N,POSSIBLE,2025-03-01,2025-03-20,2025-03-01,2025-03-20,9,28.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0003,16,Placebo,3,Cough,"Respiratory, thoracic and mediastinal disorders",SEVERE,N,PROBABLE,2025-04-01,2025-04-12,2025-04-01,2025-04-12,40,51.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0003,17,Placebo,3,Tachycardia,Cardiac disorders,MILD,N,UNLIKELY,2025-02-27,2025-03-14,2025-02-27,2025-03-14,7,22.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0004,18,Treatment A,1,Diarrhea,Gastrointestinal disorders,MILD,N,UNLIKELY,2025-04-29,2025-05-03,2025-04-29,2025-05-03,47,51.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0004,19,Treatment A,1,Pruritus,Skin and subcutaneous tissue disorders,MODERATE,N,POSSIBLE,2025-04-15,2025-05-03,2025-04-15,2025-05-03,33,51.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0004,20,Treatment A,1,Pruritus,Skin and subcutaneous tissue disorders,MILD,N,POSSIBLE,2025-04-30,2025-05-17,2025-04-30,2025-05-17,48,65.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0005,21,Treatment A,1,Back pain,Musculoskeletal and connective tissue disorders,MILD,N,PROBABLE,2025-03-21,2025-03-27,2025-03-21,2025-03-27,16,22.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0006,22,Treatment A,1,Dyspnea,"Respiratory, thoracic and mediastinal disorders",MILD,N,UNLIKELY,2025-07-06,2025-07-18,2025-07-06,2025-07-18,42,54.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0006,23,Treatment A,1,Nausea,Gastrointestinal disorders,MODERATE,N,POSSIBLE,2025-05-30,2025-06-02,2025-05-30,2025-06-02,5,8.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0006,24,Treatment A,1,Constipation,Gastrointestinal disorders,MODERATE,N,PROBABLE,2025-06-19,2025-07-05,2025-06-19,2025-07-05,25,41.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0007,25,Treatment B,2,Cough,"Respiratory, thoracic and mediastinal disorders",MILD,N,PROBABLE,2025-06-13,2025-06-20,2025-06-13,2025-06-20,40,47.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0007,26,Treatment B,2,Headache,Nervous system disorders,SEVERE,N,UNLIKELY,2025-05-31,2025-06-05,2025-05-31,2025-06-05,27,32.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0007,27,Treatment B,2,Tremor,Nervous system disorders,MILD,N,POSSIBLE,2025-06-07,2025-06-08,2025-06-07,2025-06-08,34,35.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0007,28,Treatment B,2,Pruritus,Skin and subcutaneous tissue disorders,MODERATE,Y,UNLIKELY,2025-05-20,,2025-05-20,,16,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0007,29,Treatment B,2,Abdominal pain,Gastrointestinal disorders,MILD,N,UNLIKELY,2025-06-12,2025-06-16,2025-06-12,2025-06-16,39,43.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0008,30,Treatment B,2,Cough,"Respiratory, thoracic and mediastinal disorders",MILD,N,UNLIKELY,2025-06-28,2025-07-03,2025-06-28,2025-07-03,32,37.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0008,31,Treatment B,2,Rash,Skin and subcutaneous tissue disorders,MILD,N,PROBABLE,2025-07-09,2025-07-24,2025-07-09,2025-07-24,43,58.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0008,32,Treatment B,2,Fatigue,General disorders and administration site conditions,MODERATE,N,UNLIKELY,2025-06-16,2025-07-05,2025-06-16,2025-07-05,20,39.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0008,33,Treatment B,2,Fatigue,General disorders and administration site conditions,MILD,N,UNLIKELY,2025-06-05,2025-06-21,2025-06-05,2025-06-21,9,25.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0008,34,Treatment B,2,Back pain,Musculoskeletal and connective tissue disorders,MODERATE,N,UNLIKELY,2025-05-31,2025-06-02,2025-05-31,2025-06-02,4,6.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0008,35,Treatment B,2,Insomnia,Nervous system disorders,MILD,N,POSSIBLE,2025-06-19,2025-07-06,2025-06-19,2025-07-06,23,40.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0009,36,Treatment B,2,Dyspnea,"Respiratory, thoracic and mediastinal disorders",MODERATE,N,POSSIBLE,2025-02-23,2025-03-06,2025-02-23,2025-03-06,27,38.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0011,37,Placebo,3,Tachycardia,Cardiac disorders,MODERATE,N,POSSIBLE,2025-05-09,,2025-05-09,,28,,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0011,38,Placebo,3,Cough,"Respiratory, thoracic and mediastinal disorders",SEVERE,N,POSSIBLE,2025-04-15,2025-04-30,2025-04-15,2025-04-30,4,19.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0012,39,Treatment A,1,Fever,General disorders and administration site conditions,MILD,N,PROBABLE,2025-03-08,2025-03-22,2025-03-08,2025-03-22,13,27.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE02-0012,40,Treatment A,1,Muscle pain,Musculoskeletal and connective tissue disorders,MILD,N,PROBABLE,2025-04-10,2025-04-29,2025-04-10,2025-04-29,46,65.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE03-0013,41,Treatment A,1,Dyspnea,"Respiratory, thoracic and mediastinal disorders",MODERATE,N,POSSIBLE,2025-04-23,2025-05-09,2025-04-23,2025-05-09,38,54.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0013,42,Treatment A,1,Cough,"Respiratory, thoracic and mediastinal disorders",MILD,N,PROBABLE,2025-04-21,2025-04-30,2025-04-21,2025-04-30,36,45.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0013,43,Treatment A,1,Headache,Nervous system disorders,MILD,N,PROBABLE,2025-03-23,,2025-03-23,,7,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0013,44,Treatment A,1,Hypertension,Vascular disorders,MILD,N,POSSIBLE,2025-04-09,2025-04-17,2025-04-09,2025-04-17,24,32.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0014,45,Treatment B,2,Diarrhea,Gastrointestinal disorders,MODERATE,N,PROBABLE,2025-02-11,2025-02-16,2025-02-11,2025-02-16,28,33.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0014,46,Treatment B,2,Dyspnea,"Respiratory, thoracic and mediastinal disorders",MILD,N,POSSIBLE,2025-02-12,2025-02-18,2025-02-12,2025-02-18,29,35.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0016,47,Treatment B,2,Tachycardia,Cardiac disorders,MODERATE,N,POSSIBLE,2025-07-02,2025-07-19,2025-07-02,2025-07-19,19,36.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0016,48,Treatment B,2,Pruritus,Skin and subcutaneous tissue disorders,MODERATE,N,PROBABLE,2025-07-18,2025-07-27,2025-07-18,2025-07-27,35,44.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0016,49,Treatment B,2,Headache,Nervous system disorders,MILD,N,PROBABLE,2025-07-26,2025-08-08,2025-07-26,2025-08-08,43,56.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0017,50,Treatment A,1,Vomiting,Gastrointestinal disorders,MILD,N,POSSIBLE,2025-05-11,2025-05-26,2025-05-11,2025-05-26,32,47.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0017,51,Treatment A,1,Dizziness,Nervous system disorders,MODERATE,N,POSSIBLE,2025-05-20,2025-05-25,2025-05-20,2025-05-25,41,46.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0017,52,Treatment A,1,Rash,Skin and subcutaneous tissue disorders,MODERATE,N,VERY LIKELY,2025-04-30,2025-05-09,2025-04-30,2025-05-09,21,30.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0018,53,Treatment B,2,Muscle pain,Musculoskeletal and connective tissue disorders,MILD,Y,UNLIKELY,2025-04-08,2025-04-20,2025-04-08,2025-04-20,10,22.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0019,54,Treatment A,1,Vomiting,Gastrointestinal disorders,MODERATE,N,VERY LIKELY,2025-01-19,2025-02-06,2025-01-19,2025-02-06,3,21.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE04-0019,55,Treatment A,1,Abdominal pain,Gastrointestinal disorders,MILD,N,POSSIBLE,2025-02-03,2025-02-06,2025-02-03,2025-02-06,18,21.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE05-0020,56,Treatment A,1,Tachycardia,Cardiac disorders,SEVERE,N,POSSIBLE,2025-04-30,,2025-04-30,,48,,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0020,57,Treatment A,1,Muscle pain,Musculoskeletal and connective tissue disorders,MODERATE,N,PROBABLE,2025-05-02,2025-05-21,2025-05-02,2025-05-21,50,69.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0020,58,Treatment A,1,Constipation,Gastrointestinal disorders,MILD,N,POSSIBLE,2025-04-01,,2025-04-01,,19,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0021,59,Treatment A,1,Diarrhea,Gastrointestinal disorders,MILD,Y,POSSIBLE,2025-03-23,2025-03-26,2025-03-23,2025-03-26,30,33.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0021,60,Treatment A,1,Pruritus,Skin and subcutaneous tissue disorders,MILD,N,PROBABLE,2025-04-01,,2025-04-01,,39,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0021,61,Treatment A,1,Tachycardia,Cardiac disorders,MILD,N,VERY LIKELY,2025-03-14,2025-03-18,2025-03-14,2025-03-18,21,25.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0022,62,Treatment B,2,Vomiting,Gastrointestinal disorders,MILD,N,POSSIBLE,2025-04-21,2025-04-30,2025-04-21,2025-04-30,45,54.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0022,63,Treatment B,2,Dyspnea,"Respiratory, thoracic and mediastinal disorders",MODERATE,N,PROBABLE,2025-04-12,,2025-04-12,,36,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0022,64,Treatment B,2,Cough,"Respiratory, thoracic and mediastinal disorders",MILD,N,UNLIKELY,2025-04-08,,2025-04-08,,32,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0022,65,Treatment B,2,Fever,General disorders and administration site conditions,SEVERE,N,POSSIBLE,2025-03-23,2025-04-05,2025-03-23,2025-04-05,16,29.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0022,66,Treatment B,2,Insomnia,Nervous system disorders,MODERATE,N,POSSIBLE,2025-04-11,2025-04-23,2025-04-11,2025-04-23,35,47.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0023,67,Treatment A,1,Vomiting,Gastrointestinal disorders,MILD,N,UNLIKELY,2025-06-15,2025-07-02,2025-06-15,2025-07-02,30,47.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE03-0023,68,Treatment A,1,Rash,Skin and subcutaneous tissue disorders,MODERATE,N,POSSIBLE,2025-05-31,2025-06-16,2025-05-31,2025-06-16,15,31.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE04-0024,69,Treatment A,1,Nausea,Gastrointestinal disorders,MILD,N,VERY LIKELY,2025-04-25,,2025-04-25,,5,,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE04-0024,70,Treatment A,1,Cough,"Respiratory, thoracic and mediastinal disorders",MILD,N,POSSIBLE,2025-06-01,,2025-06-01,,42,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE04-0024,71,Treatment A,1,Nausea,Gastrointestinal disorders,MILD,Y,PROBABLE,2025-05-20,2025-05-24,2025-05-20,2025-05-24,30,34.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE05-0025,72,Treatment B,2,Tremor,Nervous system disorders,MODERATE,N,UNLIKELY,2025-08-07,2025-08-20,2025-08-07,2025-08-20,42,55.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0025,73,Treatment B,2,Hypertension,Vascular disorders,MODERATE,N,POSSIBLE,2025-07-10,,2025-07-10,,14,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0025,74,Treatment B,2,Tachycardia,Cardiac disorders,MODERATE,N,PROBABLE,2025-07-27,2025-08-02,2025-07-27,2025-08-02,31,37.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0026,75,Treatment A,1,Muscle pain,Musculoskeletal and connective tissue disorders,MILD,N,UNLIKELY,2025-03-03,,2025-03-03,,10,,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0026,76,Treatment A,1,Diarrhea,Gastrointestinal disorders,MILD,N,POSSIBLE,2025-03-02,2025-03-13,2025-03-02,2025-03-13,9,20.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0026,77,Treatment A,1,Tachycardia,Cardiac disorders,MILD,N,POSSIBLE,2025-04-04,2025-04-19,2025-04-04,2025-04-19,42,57.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0026,78,Treatment A,1,Muscle pain,Musculoskeletal and connective tissue disorders,MODERATE,N,UNLIKELY,2025-03-16,2025-03-22,2025-03-16,2025-03-22,23,29.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0027,79,Treatment A,1,Cough,"Respiratory, thoracic and mediastinal disorders",MILD,N,POSSIBLE,2025-08-05,,2025-08-05,,45,,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0027,80,Treatment A,1,Pruritus,Skin and subcutaneous tissue disorders,MODERATE,N,PROBABLE,2025-07-09,,2025-07-09,,18,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0028,81,Treatment A,1,Dyspnea,"Respiratory, thoracic and mediastinal disorders",MODERATE,N,PROBABLE,2025-04-09,2025-04-15,2025-04-09,2025-04-15,38,44.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0028,82,Treatment A,1,Tachycardia,Cardiac disorders,MILD,N,POSSIBLE,2025-03-21,,2025-03-21,,19,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0028,83,Treatment A,1,Headache,Nervous system disorders,MODERATE,N,VERY LIKELY,2025-03-18,2025-03-19,2025-03-18,2025-03-19,16,17.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0028,84,Treatment A,1,Cough,"Respiratory, thoracic and mediastinal disorders",MODERATE,N,POSSIBLE,2025-03-26,2025-03-28,2025-03-26,2025-03-28,24,26.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0028,85,Treatment A,1,Headache,Nervous system disorders,MILD,N,PROBABLE,2025-04-13,2025-04-14,2025-04-13,2025-04-14,42,43.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0029,86,Treatment A,1,Headache,Nervous system disorders,SEVERE,N,PROBABLE,2025-06-20,2025-07-05,2025-06-20,2025-07-05,11,26.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0029,87,Treatment A,1,Dyspnea,"Respiratory, thoracic and mediastinal disorders",MILD,N,POSSIBLE,2025-07-26,2025-07-27,2025-07-26,2025-07-27,47,48.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0029,88,Treatment A,1,Pruritus,Skin and subcutaneous tissue disorders,MODERATE,N,POSSIBLE,2025-06-20,2025-06-21,2025-06-20,2025-06-21,11,12.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0029,89,Treatment A,1,Dyspnea,"Respiratory, thoracic and mediastinal disorders",SEVERE,Y,POSSIBLE,2025-07-04,2025-07-21,2025-07-04,2025-07-21,25,42.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0029,90,Treatment A,1,Hypertension,Vascular disorders,MILD,N,POSSIBLE,2025-07-28,2025-08-10,2025-07-28,2025-08-10,49,62.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0029,91,Treatment A,1,Dyspnea,"Respiratory, thoracic and mediastinal disorders",MODERATE,N,POSSIBLE,2025-06-28,2025-07-02,2025-06-28,2025-07-02,19,23.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0029,92,Treatment A,1,Hypertension,Vascular disorders,MILD,N,UNLIKELY,2025-06-30,2025-07-05,2025-06-30,2025-07-05,21,26.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0030,93,Placebo,3,Muscle pain,Musculoskeletal and connective tissue disorders,MODERATE,N,POSSIBLE,2025-07-25,2025-07-26,2025-07-25,2025-07-26,29,30.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0030,94,Placebo,3,Abdominal pain,Gastrointestinal disorders,MILD,N,PROBABLE,2025-08-15,2025-08-22,2025-08-15,2025-08-22,50,57.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0031,95,Placebo,3,Headache,Nervous system disorders,MILD,Y,POSSIBLE,2025-08-04,2025-08-20,2025-08-04,2025-08-20,50,66.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0031,96,Placebo,3,Vomiting,Gastrointestinal disorders,MILD,N,PROBABLE,2025-07-27,2025-07-31,2025-07-27,2025-07-31,42,46.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0032,97,Treatment B,2,Nausea,Gastrointestinal disorders,MILD,N,UNLIKELY,2025-04-01,2025-04-14,2025-04-01,2025-04-14,45,58.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE02-0032,98,Treatment B,2,Dyspnea,"Respiratory, thoracic and mediastinal disorders",MILD,N,VERY LIKELY,2025-04-05,2025-04-09,2025-04-05,2025-04-09,49,53.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE02-0032,99,Treatment B,2,Muscle pain,Musculoskeletal and connective tissue disorders,MILD,N,VERY LIKELY,2025-03-04,2025-03-23,2025-03-04,2025-03-23,17,36.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE02-0032,100,Treatment B,2,Constipation,Gastrointestinal disorders,MILD,N,VERY LIKELY,2025-02-23,2025-02-28,2025-02-23,2025-02-28,8,13.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE02-0032,101,Treatment B,2,Pruritus,Skin and subcutaneous tissue disorders,MILD,N,POSSIBLE,2025-03-03,2025-03-20,2025-03-03,2025-03-20,16,33.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE02-0032,102,Treatment B,2,Constipation,Gastrointestinal disorders,MODERATE,N,PROBABLE,2025-03-09,,2025-03-09,,22,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE03-0033,103,Placebo,3,Dyspnea,"Respiratory, thoracic and mediastinal disorders",MODERATE,N,POSSIBLE,2025-06-25,2025-07-05,2025-06-25,2025-07-05,18,28.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE03-0033,104,Placebo,3,Dizziness,Nervous system disorders,MODERATE,N,PROBABLE,2025-06-26,2025-07-07,2025-06-26,2025-07-07,19,30.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE03-0033,105,Placebo,3,Abdominal pain,Gastrointestinal disorders,MILD,N,POSSIBLE,2025-06-17,,2025-06-17,,10,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE03-0033,106,Placebo,3,Constipation,Gastrointestinal disorders,MILD,N,POSSIBLE,2025-07-14,2025-07-21,2025-07-14,2025-07-21,37,44.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE04-0034,107,Placebo,3,Tremor,Nervous system disorders,MILD,N,UNLIKELY,2025-03-12,2025-03-19,2025-03-12,2025-03-19,7,14.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0034,108,Placebo,3,Headache,Nervous system disorders,MILD,N,POSSIBLE,2025-03-24,2025-04-03,2025-03-24,2025-04-03,19,29.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0034,109,Placebo,3,Tremor,Nervous system disorders,MILD,N,UNLIKELY,2025-04-01,2025-04-08,2025-04-01,2025-04-08,27,34.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0034,110,Placebo,3,Constipation,Gastrointestinal disorders,MODERATE,N,POSSIBLE,2025-04-08,,2025-04-08,,34,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0034,111,Placebo,3,Hypertension,Vascular disorders,MILD,N,POSSIBLE,2025-04-21,,2025-04-21,,47,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0034,112,Placebo,3,Nausea,Gastrointestinal disorders,MODERATE,N,POSSIBLE,2025-04-01,2025-04-20,2025-04-01,2025-04-20,27,46.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0035,113,Treatment B,2,Abdominal pain,Gastrointestinal disorders,MILD,N,VERY LIKELY,2025-04-09,2025-04-22,2025-04-09,2025-04-22,25,38.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0035,114,Treatment B,2,Tachycardia,Cardiac disorders,MILD,N,POSSIBLE,2025-04-14,2025-05-02,2025-04-14,2025-05-02,30,48.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0036,115,Placebo,3,Rash,Skin and subcutaneous tissue disorders,SEVERE,N,PROBABLE,2025-05-18,2025-05-29,2025-05-18,2025-05-29,8,19.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0036,116,Placebo,3,Tremor,Nervous system disorders,MILD,N,POSSIBLE,2025-05-24,2025-05-27,2025-05-24,2025-05-27,14,17.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0037,117,Treatment B,2,Headache,Nervous system disorders,MILD,N,VERY LIKELY,2025-04-23,2025-05-10,2025-04-23,2025-05-10,5,22.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0037,118,Treatment B,2,Vomiting,Gastrointestinal disorders,MILD,N,VERY LIKELY,2025-05-29,,2025-05-29,,41,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0038,119,Treatment B,2,Rash,Skin and subcutaneous tissue disorders,MILD,N,VERY LIKELY,2025-03-21,,2025-03-21,,49,,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0039,120,Treatment A,1,Tremor,Nervous system disorders,MILD,N,PROBABLE,2025-03-25,2025-04-09,2025-03-25,2025-04-09,39,54.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0039,121,Treatment A,1,Diarrhea,Gastrointestinal disorders,MILD,N,POSSIBLE,2025-03-02,,2025-03-02,,16,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0039,122,Treatment A,1,Cough,"Respiratory, thoracic and mediastinal disorders",MILD,N,PROBABLE,2025-03-27,,2025-03-27,,41,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0039,123,Treatment A,1,Hypertension,Vascular disorders,SEVERE,N,PROBABLE,2025-03-30,2025-04-12,2025-03-30,2025-04-12,44,57.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0039,124,Treatment A,1,Hypertension,Vascular disorders,MILD,N,POSSIBLE,2025-03-02,2025-03-19,2025-03-02,2025-03-19,16,33.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0040,125,Treatment B,2,Fatigue,General disorders and administration site conditions,MODERATE,N,POSSIBLE,2025-04-13,2025-04-22,2025-04-13,2025-04-22,47,56.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0041,126,Treatment A,1,Fever,General disorders and administration site conditions,MODERATE,N,POSSIBLE,2025-07-16,2025-08-01,2025-07-16,2025-08-01,32,48.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE01-0041,127,Treatment A,1,Fever,General disorders and administration site conditions,MODERATE,N,POSSIBLE,2025-06-28,2025-07-16,2025-06-28,2025-07-16,14,32.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE01-0041,128,Treatment A,1,Hypertension,Vascular disorders,MILD,Y,VERY LIKELY,2025-08-03,,2025-08-03,,50,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE02-0042,129,Treatment B,2,Cough,"Respiratory, thoracic and mediastinal disorders",MILD,N,VERY LIKELY,2025-03-24,2025-03-28,2025-03-24,2025-03-28,38,42.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0043,130,Treatment B,2,Abdominal pain,Gastrointestinal disorders,MILD,N,POSSIBLE,2025-04-14,2025-04-24,2025-04-14,2025-04-24,5,15.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0043,131,Treatment B,2,Tremor,Nervous system disorders,MILD,N,UNLIKELY,2025-05-18,2025-06-04,2025-05-18,2025-06-04,39,56.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0043,132,Treatment B,2,Insomnia,Nervous system disorders,MODERATE,N,PROBABLE,2025-04-27,2025-05-01,2025-04-27,2025-05-01,18,22.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0044,133,Treatment B,2,Pruritus,Skin and subcutaneous tissue disorders,SEVERE,N,VERY LIKELY,2025-06-20,2025-07-06,2025-06-20,2025-07-06,50,66.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0044,134,Treatment B,2,Muscle pain,Musculoskeletal and connective tissue disorders,MILD,N,VERY LIKELY,2025-05-25,2025-05-31,2025-05-25,2025-05-31,24,30.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0045,135,Treatment B,2,Back pain,Musculoskeletal and connective tissue disorders,MILD,Y,UNLIKELY,2025-05-31,,2025-05-31,,39,,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0045,136,Treatment B,2,Diarrhea,Gastrointestinal disorders,MILD,N,PROBABLE,2025-05-06,2025-05-16,2025-05-06,2025-05-16,14,24.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0045,137,Treatment B,2,Tremor,Nervous system disorders,MODERATE,Y,POSSIBLE,2025-05-13,2025-05-20,2025-05-13,2025-05-20,21,28.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0045,138,Treatment B,2,Hypertension,Vascular disorders,MILD,N,UNLIKELY,2025-04-30,2025-05-04,2025-04-30,2025-05-04,8,12.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0045,139,Treatment B,2,Insomnia,Nervous system disorders,MILD,N,UNLIKELY,2025-04-27,2025-05-08,2025-04-27,2025-05-08,5,16.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0045,140,Treatment B,2,Fatigue,General disorders and administration site conditions,MILD,N,POSSIBLE,2025-05-16,2025-05-19,2025-05-16,2025-05-19,24,27.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0046,141,Treatment A,1,Dyspnea,"Respiratory, thoracic and mediastinal disorders",MILD,N,UNLIKELY,2025-05-31,2025-06-16,2025-05-31,2025-06-16,46,62.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0046,142,Treatment A,1,Muscle pain,Musculoskeletal and connective tissue disorders,MILD,N,POSSIBLE,2025-05-18,2025-05-20,2025-05-18,2025-05-20,33,35.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0046,143,Treatment A,1,Vomiting,Gastrointestinal disorders,MILD,N,VERY LIKELY,2025-05-22,,2025-05-22,,37,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0047,144,Treatment B,2,Abdominal pain,Gastrointestinal disorders,MILD,N,POSSIBLE,2025-05-25,,2025-05-25,,3,,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0047,145,Treatment B,2,Headache,Nervous system disorders,MILD,N,PROBABLE,2025-05-30,2025-06-06,2025-05-30,2025-06-06,8,15.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0047,146,Treatment B,2,Hypertension,Vascular disorders,MILD,N,PROBABLE,2025-05-25,2025-06-13,2025-05-25,2025-06-13,3,22.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0047,147,Treatment B,2,Vomiting,Gastrointestinal disorders,MILD,N,POSSIBLE,2025-06-26,2025-07-02,2025-06-26,2025-07-02,35,41.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0047,148,Treatment B,2,Hypertension,Vascular disorders,MILD,N,UNLIKELY,2025-06-29,2025-07-16,2025-06-29,2025-07-16,38,55.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0048,149,Treatment B,2,Vomiting,Gastrointestinal disorders,MILD,N,PROBABLE,2025-04-17,2025-04-23,2025-04-17,2025-04-23,25,31.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0048,150,Treatment B,2,Dizziness,Nervous system disorders,SEVERE,N,POSSIBLE,2025-04-17,2025-04-29,2025-04-17,2025-04-29,25,37.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0049,151,Treatment A,1,Muscle pain,Musculoskeletal and connective tissue disorders,MILD,N,POSSIBLE,2025-04-07,2025-04-20,2025-04-07,2025-04-20,15,28.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0050,152,Treatment B,2,Fatigue,General disorders and administration site conditions,MODERATE,N,PROBABLE,2025-03-29,2025-04-11,2025-03-29,2025-04-11,36,49.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0050,153,Treatment B,2,Abdominal pain,Gastrointestinal disorders,SEVERE,N,UNLIKELY,2025-03-07,2025-03-14,2025-03-07,2025-03-14,14,21.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0050,154,Treatment B,2,Tremor,Nervous system disorders,MODERATE,N,POSSIBLE,2025-04-05,,2025-04-05,,43,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0050,155,Treatment B,2,Nausea,Gastrointestinal disorders,MILD,N,POSSIBLE,2025-03-10,2025-03-24,2025-03-10,2025-03-24,17,31.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0051,156,Treatment B,2,Constipation,Gastrointestinal disorders,MODERATE,N,POSSIBLE,2025-04-30,2025-05-05,2025-04-30,2025-05-05,38,43.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0051,157,Treatment B,2,Tachycardia,Cardiac disorders,MILD,N,PROBABLE,2025-04-24,2025-04-30,2025-04-24,2025-04-30,32,38.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0051,158,Treatment B,2,Fatigue,General disorders and administration site conditions,MODERATE,N,POSSIBLE,2025-04-27,2025-05-04,2025-04-27,2025-05-04,35,42.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0051,159,Treatment B,2,Back pain,Musculoskeletal and connective tissue disorders,MODERATE,Y,PROBABLE,2025-04-13,2025-04-28,2025-04-13,2025-04-28,21,36.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0052,160,Treatment B,2,Cough,"Respiratory, thoracic and mediastinal disorders",MILD,N,UNLIKELY,2025-02-18,2025-03-01,2025-02-18,2025-03-01,32,43.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0052,161,Treatment B,2,Headache,Nervous system disorders,MODERATE,N,POSSIBLE,2025-02-25,2025-03-01,2025-02-25,2025-03-01,39,43.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0052,162,Treatment B,2,Pruritus,Skin and subcutaneous tissue disorders,MODERATE,N,POSSIBLE,2025-03-06,2025-03-17,2025-03-06,2025-03-17,48,59.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0052,163,Treatment B,2,Diarrhea,Gastrointestinal disorders,MILD,N,UNLIKELY,2025-02-07,,2025-02-07,,21,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0053,164,Treatment B,2,Dyspnea,"Respiratory, thoracic and mediastinal disorders",SEVERE,N,PROBABLE,2025-05-25,2025-05-31,2025-05-25,2025-05-31,48,54.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0053,165,Treatment B,2,Abdominal pain,Gastrointestinal disorders,MILD,N,UNLIKELY,2025-05-04,2025-05-19,2025-05-04,2025-05-19,27,42.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0053,166,Treatment B,2,Back pain,Musculoskeletal and connective tissue disorders,MILD,Y,PROBABLE,2025-04-24,2025-05-08,2025-04-24,2025-05-08,17,31.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0053,167,Treatment B,2,Pruritus,Skin and subcutaneous tissue disorders,MILD,N,POSSIBLE,2025-04-16,2025-04-24,2025-04-16,2025-04-24,9,17.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0053,168,Treatment B,2,Muscle pain,Musculoskeletal and connective tissue disorders,MODERATE,N,UNLIKELY,2025-05-09,2025-05-25,2025-05-09,2025-05-25,32,48.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0054,169,Treatment A,1,Cough,"Respiratory, thoracic and mediastinal disorders",MILD,N,POSSIBLE,2025-08-01,2025-08-14,2025-08-01,2025-08-14,39,52.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0054,170,Treatment A,1,Tachycardia,Cardiac disorders,MODERATE,N,PROBABLE,2025-08-12,2025-08-26,2025-08-12,2025-08-26,50,64.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0054,171,Treatment A,1,Nausea,Gastrointestinal disorders,MODERATE,N,POSSIBLE,2025-07-19,2025-07-25,2025-07-19,2025-07-25,26,32.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0054,172,Treatment A,1,Diarrhea,Gastrointestinal disorders,MILD,N,UNLIKELY,2025-06-26,,2025-06-26,,3,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0055,173,Treatment A,1,Insomnia,Nervous system disorders,MODERATE,N,UNLIKELY,2025-07-10,2025-07-20,2025-07-10,2025-07-20,48,58.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE05-0055,174,Treatment A,1,Fatigue,General disorders and administration site conditions,MILD,N,PROBABLE,2025-06-17,2025-06-19,2025-06-17,2025-06-19,25,27.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE05-0055,175,Treatment A,1,Pruritus,Skin and subcutaneous tissue disorders,MODERATE,N,VERY LIKELY,2025-05-25,2025-05-27,2025-05-25,2025-05-27,2,4.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE05-0055,176,Treatment A,1,Vomiting,Gastrointestinal disorders,MILD,N,POSSIBLE,2025-07-04,,2025-07-04,,42,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE01-0056,177,Treatment A,1,Vomiting,Gastrointestinal disorders,SEVERE,N,UNLIKELY,2025-06-10,2025-06-13,2025-06-10,2025-06-13,33,36.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0056,178,Treatment A,1,Cough,"Respiratory, thoracic and mediastinal disorders",MILD,N,POSSIBLE,2025-06-08,2025-06-27,2025-06-08,2025-06-27,31,50.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0057,179,Placebo,3,Dizziness,Nervous system disorders,MILD,N,POSSIBLE,2025-06-19,2025-06-23,2025-06-19,2025-06-23,37,41.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0057,180,Placebo,3,Abdominal pain,Gastrointestinal disorders,MILD,N,POSSIBLE,2025-06-22,2025-07-01,2025-06-22,2025-07-01,40,49.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0058,181,Treatment B,2,Cough,"Respiratory, thoracic and mediastinal disorders",MILD,N,PROBABLE,2025-06-08,2025-06-27,2025-06-08,2025-06-27,47,66.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0058,182,Treatment B,2,Insomnia,Nervous system disorders,MODERATE,N,PROBABLE,2025-05-12,2025-05-15,2025-05-12,2025-05-15,20,23.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0059,183,Placebo,3,Pruritus,Skin and subcutaneous tissue disorders,SEVERE,N,POSSIBLE,2025-03-09,2025-03-27,2025-03-09,2025-03-27,18,36.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0059,184,Placebo,3,Muscle pain,Musculoskeletal and connective tissue disorders,MILD,N,PROBABLE,2025-03-17,2025-04-03,2025-03-17,2025-04-03,26,43.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0060,185,Treatment B,2,Diarrhea,Gastrointestinal disorders,MILD,N,PROBABLE,2025-06-20,2025-06-24,2025-06-20,2025-06-24,46,50.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0060,186,Treatment B,2,Muscle pain,Musculoskeletal and connective tissue disorders,SEVERE,N,PROBABLE,2025-06-08,,2025-06-08,,34,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0060,187,Treatment B,2,Back pain,Musculoskeletal and connective tissue disorders,MILD,N,UNLIKELY,2025-05-15,,2025-05-15,,10,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0060,188,Treatment B,2,Insomnia,Nervous system disorders,MILD,N,POSSIBLE,2025-06-01,,2025-06-01,,27,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0061,189,Placebo,3,Insomnia,Nervous system disorders,MILD,N,POSSIBLE,2025-05-14,2025-05-24,2025-05-14,2025-05-24,45,55.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0061,190,Placebo,3,Abdominal pain,Gastrointestinal disorders,MODERATE,N,PROBABLE,2025-04-10,2025-04-13,2025-04-10,2025-04-13,11,14.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0062,191,Treatment A,1,Nausea,Gastrointestinal disorders,MODERATE,N,PROBABLE,2025-05-28,2025-06-15,2025-05-28,2025-06-15,12,30.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE02-0062,192,Treatment A,1,Pruritus,Skin and subcutaneous tissue disorders,MILD,N,UNLIKELY,2025-06-16,2025-06-27,2025-06-16,2025-06-27,31,42.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE02-0062,193,Treatment A,1,Fever,General disorders and administration site conditions,MODERATE,N,POSSIBLE,2025-05-25,2025-06-01,2025-05-25,2025-06-01,9,16.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE02-0062,194,Treatment A,1,Insomnia,Nervous system disorders,MILD,N,UNLIKELY,2025-06-19,2025-06-24,2025-06-19,2025-06-24,34,39.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE02-0062,195,Treatment A,1,Dyspnea,"Respiratory, thoracic and mediastinal disorders",MILD,N,PROBABLE,2025-06-12,2025-06-30,2025-06-12,2025-06-30,27,45.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE02-0062,196,Treatment A,1,Cough,"Respiratory, thoracic and mediastinal disorders",SEVERE,N,UNLIKELY,2025-05-30,,2025-05-30,,14,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE02-0062,197,Treatment A,1,Hypertension,Vascular disorders,MILD,N,POSSIBLE,2025-06-24,2025-06-30,2025-06-24,2025-06-30,39,45.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE03-0063,198,Placebo,3,Constipation,Gastrointestinal disorders,MODERATE,N,POSSIBLE,2025-07-25,2025-08-07,2025-07-25,2025-08-07,26,39.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0063,199,Placebo,3,Nausea,Gastrointestinal disorders,MILD,N,VERY LIKELY,2025-08-03,2025-08-20,2025-08-03,2025-08-20,35,52.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0063,200,Placebo,3,Tachycardia,Cardiac disorders,MILD,N,PROBABLE,2025-07-03,2025-07-08,2025-07-03,2025-07-08,4,9.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0063,201,Placebo,3,Headache,Nervous system disorders,MILD,N,UNLIKELY,2025-07-27,2025-08-12,2025-07-27,2025-08-12,28,44.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0063,202,Placebo,3,Fatigue,General disorders and administration site conditions,MODERATE,N,POSSIBLE,2025-07-22,2025-08-01,2025-07-22,2025-08-01,23,33.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0063,203,Placebo,3,Insomnia,Nervous system disorders,MILD,N,POSSIBLE,2025-08-12,2025-08-31,2025-08-12,2025-08-31,44,63.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0064,204,Treatment A,1,Fatigue,General disorders and administration site conditions,MODERATE,N,PROBABLE,2025-04-24,,2025-04-24,,27,,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0064,205,Treatment A,1,Diarrhea,Gastrointestinal disorders,MILD,N,UNLIKELY,2025-05-12,,2025-05-12,,45,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0064,206,Treatment A,1,Abdominal pain,Gastrointestinal disorders,MILD,N,POSSIBLE,2025-03-31,2025-04-17,2025-03-31,2025-04-17,3,20.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0064,207,Treatment A,1,Nausea,Gastrointestinal disorders,SEVERE,N,VERY LIKELY,2025-04-22,2025-04-24,2025-04-22,2025-04-24,25,27.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0065,208,Treatment A,1,Nausea,Gastrointestinal disorders,MILD,N,POSSIBLE,2025-07-09,2025-07-15,2025-07-09,2025-07-15,40,46.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0066,209,Placebo,3,Insomnia,Nervous system disorders,MODERATE,N,POSSIBLE,2025-04-13,2025-04-16,2025-04-13,2025-04-16,4,7.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0066,210,Placebo,3,Abdominal pain,Gastrointestinal disorders,MILD,N,UNLIKELY,2025-05-10,2025-05-15,2025-05-10,2025-05-15,31,36.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0066,211,Placebo,3,Constipation,Gastrointestinal disorders,MILD,N,PROBABLE,2025-05-13,2025-05-23,2025-05-13,2025-05-23,34,44.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0067,212,Treatment A,1,Cough,"Respiratory, thoracic and mediastinal disorders",MILD,N,PROBABLE,2025-08-08,2025-08-12,2025-08-08,2025-08-12,48,52.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0067,213,Treatment A,1,Dyspnea,"Respiratory, thoracic and mediastinal disorders",MILD,N,UNLIKELY,2025-06-27,2025-07-13,2025-06-27,2025-07-13,6,22.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0068,214,Treatment B,2,Muscle pain,Musculoskeletal and connective tissue disorders,MILD,N,POSSIBLE,2025-06-19,2025-07-08,2025-06-19,2025-07-08,16,35.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0068,215,Treatment B,2,Vomiting,Gastrointestinal disorders,MODERATE,N,PROBABLE,2025-06-17,2025-07-04,2025-06-17,2025-07-04,14,31.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0069,216,Treatment A,1,Cough,"Respiratory, thoracic and mediastinal disorders",MILD,N,UNLIKELY,2025-05-25,2025-06-02,2025-05-25,2025-06-02,27,35.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0069,217,Treatment A,1,Abdominal pain,Gastrointestinal disorders,MILD,N,POSSIBLE,2025-06-03,2025-06-05,2025-06-03,2025-06-05,36,38.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0069,218,Treatment A,1,Insomnia,Nervous system disorders,MODERATE,N,PROBABLE,2025-05-27,2025-06-02,2025-05-27,2025-06-02,29,35.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0069,219,Treatment A,1,Back pain,Musculoskeletal and connective tissue disorders,MILD,N,UNLIKELY,2025-06-02,2025-06-12,2025-06-02,2025-06-12,35,45.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0069,220,Treatment A,1,Dyspnea,"Respiratory, thoracic and mediastinal disorders",MILD,Y,POSSIBLE,2025-05-13,2025-05-31,2025-05-13,2025-05-31,15,33.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0069,221,Treatment A,1,Muscle pain,Musculoskeletal and connective tissue disorders,SEVERE,N,VERY LIKELY,2025-05-17,2025-06-05,2025-05-17,2025-06-05,19,38.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0069,222,Treatment A,1,Fatigue,General disorders and administration site conditions,SEVERE,N,PROBABLE,2025-06-11,2025-06-22,2025-06-11,2025-06-22,44,55.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0070,223,Placebo,3,Nausea,Gastrointestinal disorders,MILD,N,UNLIKELY,2025-07-19,2025-07-21,2025-07-19,2025-07-21,21,23.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0070,224,Placebo,3,Constipation,Gastrointestinal disorders,MILD,N,UNLIKELY,2025-07-28,,2025-07-28,,30,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0070,225,Placebo,3,Pruritus,Skin and subcutaneous tissue disorders,MILD,Y,PROBABLE,2025-08-12,2025-08-27,2025-08-12,2025-08-27,45,60.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0071,226,Treatment A,1,Abdominal pain,Gastrointestinal disorders,MILD,N,UNLIKELY,2025-05-06,2025-05-09,2025-05-06,2025-05-09,33,36.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0071,227,Treatment A,1,Rash,Skin and subcutaneous tissue disorders,MILD,Y,POSSIBLE,2025-04-25,2025-05-01,2025-04-25,2025-05-01,22,28.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0072,228,Treatment A,1,Nausea,Gastrointestinal disorders,MILD,N,POSSIBLE,2025-06-21,2025-06-27,2025-06-21,2025-06-27,16,22.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0072,229,Treatment A,1,Tachycardia,Cardiac disorders,MILD,N,UNLIKELY,2025-06-30,,2025-06-30,,25,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0072,230,Treatment A,1,Fever,General disorders and administration site conditions,MODERATE,N,PROBABLE,2025-06-17,2025-06-24,2025-06-17,2025-06-24,12,19.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0073,231,Treatment A,1,Tremor,Nervous system disorders,MILD,N,UNLIKELY,2025-02-23,2025-03-03,2025-02-23,2025-03-03,29,37.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0073,232,Treatment A,1,Dizziness,Nervous system disorders,SEVERE,N,UNLIKELY,2025-02-22,2025-02-27,2025-02-22,2025-02-27,28,33.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0073,233,Treatment A,1,Nausea,Gastrointestinal disorders,MODERATE,N,UNLIKELY,2025-02-02,,2025-02-02,,8,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0074,234,Treatment A,1,Vomiting,Gastrointestinal disorders,SEVERE,N,VERY LIKELY,2025-05-22,2025-05-30,2025-05-22,2025-05-30,39,47.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0075,235,Placebo,3,Insomnia,Nervous system disorders,MILD,N,PROBABLE,2025-08-05,2025-08-24,2025-08-05,2025-08-24,49,68.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE05-0075,236,Placebo,3,Vomiting,Gastrointestinal disorders,MILD,Y,POSSIBLE,2025-07-03,2025-07-18,2025-07-03,2025-07-18,16,31.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE05-0075,237,Placebo,3,Muscle pain,Musculoskeletal and connective tissue disorders,MODERATE,N,UNLIKELY,2025-07-21,,2025-07-21,,34,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE05-0075,238,Placebo,3,Abdominal pain,Gastrointestinal disorders,MILD,N,VERY LIKELY,2025-06-24,2025-06-25,2025-06-24,2025-06-25,7,8.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE01-0076,239,Treatment A,1,Headache,Nervous system disorders,MILD,N,UNLIKELY,2025-07-10,2025-07-19,2025-07-10,2025-07-19,44,53.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0076,240,Treatment A,1,Fatigue,General disorders and administration site conditions,MODERATE,N,VERY LIKELY,2025-06-04,2025-06-06,2025-06-04,2025-06-06,8,10.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0076,241,Treatment A,1,Muscle pain,Musculoskeletal and connective tissue disorders,MODERATE,N,PROBABLE,2025-06-19,2025-06-24,2025-06-19,2025-06-24,23,28.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0076,242,Treatment A,1,Constipation,Gastrointestinal disorders,MILD,N,VERY LIKELY,2025-07-01,2025-07-10,2025-07-01,2025-07-10,35,44.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0076,243,Treatment A,1,Headache,Nervous system disorders,MODERATE,N,UNLIKELY,2025-07-16,2025-07-29,2025-07-16,2025-07-29,50,63.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0076,244,Treatment A,1,Headache,Nervous system disorders,MILD,Y,PROBABLE,2025-06-17,2025-06-27,2025-06-17,2025-06-27,21,31.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0076,245,Treatment A,1,Dyspnea,"Respiratory, thoracic and mediastinal disorders",SEVERE,N,POSSIBLE,2025-07-16,2025-07-24,2025-07-16,2025-07-24,50,58.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0076,246,Treatment A,1,Headache,Nervous system disorders,SEVERE,N,PROBABLE,2025-06-01,,2025-06-01,,5,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0077,247,Treatment A,1,Pruritus,Skin and subcutaneous tissue disorders,MILD,N,UNLIKELY,2025-03-18,2025-04-03,2025-03-18,2025-04-03,34,50.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0078,248,Placebo,3,Abdominal pain,Gastrointestinal disorders,MILD,N,POSSIBLE,2025-02-11,2025-02-26,2025-02-11,2025-02-26,18,33.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0078,249,Placebo,3,Headache,Nervous system disorders,SEVERE,N,POSSIBLE,2025-02-14,2025-02-19,2025-02-14,2025-02-19,21,26.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0078,250,Placebo,3,Cough,"Respiratory, thoracic and mediastinal disorders",MILD,N,UNLIKELY,2025-03-09,2025-03-15,2025-03-09,2025-03-15,44,50.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0078,251,Placebo,3,Fatigue,General disorders and administration site conditions,MILD,N,PROBABLE,2025-03-11,2025-03-23,2025-03-11,2025-03-23,46,58.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0079,252,Treatment A,1,Tremor,Nervous system disorders,MILD,N,VERY LIKELY,2025-04-28,,2025-04-28,,50,,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0079,253,Treatment A,1,Constipation,Gastrointestinal disorders,MILD,N,UNLIKELY,2025-04-17,,2025-04-17,,39,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0080,254,Treatment B,2,Abdominal pain,Gastrointestinal disorders,SEVERE,N,VERY LIKELY,2025-05-09,2025-05-14,2025-05-09,2025-05-14,33,38.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0080,255,Treatment B,2,Hypertension,Vascular disorders,MODERATE,N,UNLIKELY,2025-04-23,2025-05-05,2025-04-23,2025-05-05,17,29.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0081,256,Treatment A,1,Rash,Skin and subcutaneous tissue disorders,MILD,N,PROBABLE,2025-02-10,2025-02-12,2025-02-10,2025-02-12,24,26.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0082,257,Treatment B,2,Abdominal pain,Gastrointestinal disorders,MILD,Y,PROBABLE,2025-06-15,2025-07-02,2025-06-15,2025-07-02,35,52.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE02-0082,258,Treatment B,2,Abdominal pain,Gastrointestinal disorders,MODERATE,N,PROBABLE,2025-06-25,2025-07-12,2025-06-25,2025-07-12,45,62.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE03-0083,259,Treatment B,2,Abdominal pain,Gastrointestinal disorders,MODERATE,N,PROBABLE,2025-04-02,2025-04-10,2025-04-02,2025-04-10,22,30.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0083,260,Treatment B,2,Cough,"Respiratory, thoracic and mediastinal disorders",MILD,N,POSSIBLE,2025-03-30,2025-03-31,2025-03-30,2025-03-31,19,20.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0083,261,Treatment B,2,Dyspnea,"Respiratory, thoracic and mediastinal disorders",MILD,N,UNLIKELY,2025-04-17,,2025-04-17,,37,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0083,262,Treatment B,2,Vomiting,Gastrointestinal disorders,SEVERE,N,UNLIKELY,2025-04-14,2025-04-27,2025-04-14,2025-04-27,34,47.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0083,263,Treatment B,2,Tachycardia,Cardiac disorders,SEVERE,N,PROBABLE,2025-04-23,2025-05-06,2025-04-23,2025-05-06,43,56.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0083,264,Treatment B,2,Nausea,Gastrointestinal disorders,SEVERE,N,POSSIBLE,2025-04-20,2025-05-03,2025-04-20,2025-05-03,40,53.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0083,265,Treatment B,2,Rash,Skin and subcutaneous tissue disorders,MODERATE,N,VERY LIKELY,2025-03-29,2025-04-04,2025-03-29,2025-04-04,18,24.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0083,266,Treatment B,2,Vomiting,Gastrointestinal disorders,MODERATE,N,POSSIBLE,2025-04-20,2025-05-07,2025-04-20,2025-05-07,40,57.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0084,267,Treatment A,1,Diarrhea,Gastrointestinal disorders,MODERATE,N,POSSIBLE,2025-03-11,2025-03-29,2025-03-11,2025-03-29,19,37.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0084,268,Treatment A,1,Insomnia,Nervous system disorders,MILD,N,POSSIBLE,2025-03-07,2025-03-09,2025-03-07,2025-03-09,15,17.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0084,269,Treatment A,1,Rash,Skin and subcutaneous tissue disorders,MILD,N,PROBABLE,2025-02-25,2025-03-04,2025-02-25,2025-03-04,5,12.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0084,270,Treatment A,1,Headache,Nervous system disorders,MILD,N,POSSIBLE,2025-03-07,2025-03-26,2025-03-07,2025-03-26,15,34.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0084,271,Treatment A,1,Headache,Nervous system disorders,MODERATE,Y,POSSIBLE,2025-02-23,2025-02-28,2025-02-23,2025-02-28,3,8.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0085,272,Placebo,3,Fever,General disorders and administration site conditions,MODERATE,N,POSSIBLE,2025-04-25,2025-05-12,2025-04-25,2025-05-12,50,67.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0085,273,Placebo,3,Pruritus,Skin and subcutaneous tissue disorders,MILD,N,VERY LIKELY,2025-04-10,,2025-04-10,,35,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0085,274,Placebo,3,Back pain,Musculoskeletal and connective tissue disorders,MILD,N,UNLIKELY,2025-04-13,2025-05-02,2025-04-13,2025-05-02,38,57.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0086,275,Treatment B,2,Diarrhea,Gastrointestinal disorders,MILD,N,PROBABLE,2025-06-12,,2025-06-12,,12,,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0086,276,Treatment B,2,Insomnia,Nervous system disorders,MILD,N,UNLIKELY,2025-06-25,2025-06-28,2025-06-25,2025-06-28,25,28.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0086,277,Treatment B,2,Pruritus,Skin and subcutaneous tissue disorders,MODERATE,Y,POSSIBLE,2025-07-02,,2025-07-02,,32,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0086,278,Treatment B,2,Fever,General disorders and administration site conditions,MILD,N,UNLIKELY,2025-06-08,2025-06-15,2025-06-08,2025-06-15,8,15.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0086,279,Treatment B,2,Diarrhea,Gastrointestinal disorders,MILD,N,POSSIBLE,2025-07-01,2025-07-05,2025-07-01,2025-07-05,31,35.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0086,280,Treatment B,2,Abdominal pain,Gastrointestinal disorders,MILD,N,PROBABLE,2025-06-23,2025-07-06,2025-06-23,2025-07-06,23,36.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0087,281,Placebo,3,Diarrhea,Gastrointestinal disorders,MODERATE,N,POSSIBLE,2025-04-23,2025-04-30,2025-04-23,2025-04-30,47,54.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0087,282,Placebo,3,Tremor,Nervous system disorders,MODERATE,N,PROBABLE,2025-04-05,2025-04-15,2025-04-05,2025-04-15,29,39.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0087,283,Placebo,3,Tachycardia,Cardiac disorders,MILD,N,POSSIBLE,2025-03-09,2025-03-18,2025-03-09,2025-03-18,2,11.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0088,284,Treatment A,1,Constipation,Gastrointestinal disorders,MILD,N,PROBABLE,2025-06-03,2025-06-22,2025-06-03,2025-06-22,46,65.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0088,285,Treatment A,1,Cough,"Respiratory, thoracic and mediastinal disorders",MILD,N,VERY LIKELY,2025-06-05,2025-06-22,2025-06-05,2025-06-22,48,65.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0088,286,Treatment A,1,Constipation,Gastrointestinal disorders,MODERATE,N,POSSIBLE,2025-05-22,2025-05-26,2025-05-22,2025-05-26,34,38.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0088,287,Treatment A,1,Rash,Skin and subcutaneous tissue disorders,MODERATE,N,POSSIBLE,2025-04-23,2025-05-12,2025-04-23,2025-05-12,5,24.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0089,288,Treatment A,1,Insomnia,Nervous system disorders,MILD,Y,UNLIKELY,2025-05-13,,2025-05-13,,24,,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE04-0089,289,Treatment A,1,Insomnia,Nervous system disorders,MILD,N,POSSIBLE,2025-06-08,,2025-06-08,,50,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE04-0089,290,Treatment A,1,Muscle pain,Musculoskeletal and connective tissue disorders,MILD,N,POSSIBLE,2025-05-26,,2025-05-26,,37,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE04-0089,291,Treatment A,1,Cough,"Respiratory, thoracic and mediastinal disorders",MODERATE,N,UNLIKELY,2025-05-12,2025-05-19,2025-05-12,2025-05-19,23,30.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE04-0089,292,Treatment A,1,Hypertension,Vascular disorders,MILD,N,POSSIBLE,2025-04-21,2025-04-23,2025-04-21,2025-04-23,2,4.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE04-0089,293,Treatment A,1,Muscle pain,Musculoskeletal and connective tissue disorders,MILD,N,POSSIBLE,2025-06-07,2025-06-23,2025-06-07,2025-06-23,49,65.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE04-0089,294,Treatment A,1,Fever,General disorders and administration site conditions,MILD,N,UNLIKELY,2025-06-08,2025-06-19,2025-06-08,2025-06-19,50,61.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE04-0089,295,Treatment A,1,Tremor,Nervous system disorders,MILD,N,PROBABLE,2025-05-22,2025-06-09,2025-05-22,2025-06-09,33,51.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE04-0089,296,Treatment A,1,Rash,Skin and subcutaneous tissue disorders,MILD,Y,PROBABLE,2025-04-26,2025-04-30,2025-04-26,2025-04-30,7,11.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE05-0090,297,Treatment A,1,Nausea,Gastrointestinal disorders,MILD,N,VERY LIKELY,2025-08-02,,2025-08-02,,31,,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0090,298,Treatment A,1,Fever,General disorders and administration site conditions,SEVERE,N,POSSIBLE,2025-08-16,2025-08-27,2025-08-16,2025-08-27,45,56.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0090,299,Treatment A,1,Hypertension,Vascular disorders,MODERATE,N,PROBABLE,2025-07-13,2025-07-19,2025-07-13,2025-07-19,11,17.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0090,300,Treatment A,1,Muscle pain,Musculoskeletal and connective tissue disorders,MILD,N,PROBABLE,2025-07-07,2025-07-18,2025-07-07,2025-07-18,5,16.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0090,301,Treatment A,1,Cough,"Respiratory, thoracic and mediastinal disorders",SEVERE,N,POSSIBLE,2025-08-02,,2025-08-02,,31,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0090,302,Treatment A,1,Tremor,Nervous system disorders,MILD,N,UNLIKELY,2025-08-13,,2025-08-13,,42,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0090,303,Treatment A,1,Fatigue,General disorders and administration site conditions,MILD,N,VERY LIKELY,2025-08-13,2025-08-21,2025-08-13,2025-08-21,42,50.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0091,304,Treatment A,1,Headache,Nervous system disorders,MILD,N,UNLIKELY,2025-05-13,2025-05-30,2025-05-13,2025-05-30,42,59.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0092,305,Treatment A,1,Fatigue,General disorders and administration site conditions,SEVERE,N,POSSIBLE,2025-04-01,2025-04-19,2025-04-01,2025-04-19,30,48.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0092,306,Treatment A,1,Tachycardia,Cardiac disorders,MILD,N,PROBABLE,2025-03-11,2025-03-25,2025-03-11,2025-03-25,9,23.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0093,307,Treatment A,1,Fatigue,General disorders and administration site conditions,MILD,N,VERY LIKELY,2025-04-18,2025-04-30,2025-04-18,2025-04-30,48,60.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0093,308,Treatment A,1,Cough,"Respiratory, thoracic and mediastinal disorders",MILD,N,PROBABLE,2025-04-19,2025-05-01,2025-04-19,2025-05-01,49,61.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0093,309,Treatment A,1,Insomnia,Nervous system disorders,MODERATE,N,UNLIKELY,2025-03-15,2025-04-03,2025-03-15,2025-04-03,14,33.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0093,310,Treatment A,1,Dyspnea,"Respiratory, thoracic and mediastinal disorders",MILD,N,POSSIBLE,2025-03-15,,2025-03-15,,14,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0094,311,Treatment A,1,Headache,Nervous system disorders,MODERATE,N,VERY LIKELY,2025-02-07,2025-02-18,2025-02-07,2025-02-18,18,29.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0094,312,Treatment A,1,Constipation,Gastrointestinal disorders,MILD,N,PROBABLE,2025-01-24,,2025-01-24,,4,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0095,313,Treatment A,1,Muscle pain,Musculoskeletal and connective tissue disorders,MILD,N,UNLIKELY,2025-03-23,2025-04-04,2025-03-23,2025-04-04,31,43.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0095,314,Treatment A,1,Pruritus,Skin and subcutaneous tissue disorders,MODERATE,N,PROBABLE,2025-03-22,2025-04-05,2025-03-22,2025-04-05,30,44.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0095,315,Treatment A,1,Insomnia,Nervous system disorders,MILD,N,POSSIBLE,2025-03-27,2025-04-11,2025-03-27,2025-04-11,35,50.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0095,316,Treatment A,1,Headache,Nervous system disorders,MODERATE,N,POSSIBLE,2025-03-15,,2025-03-15,,23,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0096,317,Placebo,3,Pruritus,Skin and subcutaneous tissue disorders,MILD,N,POSSIBLE,2025-05-29,2025-06-03,2025-05-29,2025-06-03,50,55.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0096,318,Placebo,3,Fatigue,General disorders and administration site conditions,MODERATE,N,PROBABLE,2025-04-19,2025-05-02,2025-04-19,2025-05-02,10,23.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0097,319,Treatment A,1,Dyspnea,"Respiratory, thoracic and mediastinal disorders",MODERATE,N,PROBABLE,2025-06-10,2025-06-21,2025-06-10,2025-06-21,39,50.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0098,320,Treatment A,1,Tachycardia,Cardiac disorders,MILD,N,POSSIBLE,2025-08-12,,2025-08-12,,42,,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0098,321,Treatment A,1,Abdominal pain,Gastrointestinal disorders,MILD,N,POSSIBLE,2025-08-19,2025-09-06,2025-08-19,2025-09-06,49,67.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0099,322,Treatment A,1,Headache,Nervous system disorders,MILD,N,POSSIBLE,2025-05-20,2025-06-07,2025-05-20,2025-06-07,18,36.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0099,323,Treatment A,1,Cough,"Respiratory, thoracic and mediastinal disorders",MILD,N,VERY LIKELY,2025-06-05,2025-06-17,2025-06-05,2025-06-17,34,46.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0099,324,Treatment A,1,Cough,"Respiratory, thoracic and mediastinal disorders",MODERATE,N,POSSIBLE,2025-05-17,,2025-05-17,,15,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0100,325,Treatment A,1,Dizziness,Nervous system disorders,MILD,N,UNLIKELY,2025-04-13,,2025-04-13,,15,,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0101,326,Placebo,3,Fever,General disorders and administration site conditions,MILD,N,PROBABLE,2025-02-02,2025-02-11,2025-02-02,2025-02-11,14,23.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0102,327,Treatment B,2,Tremor,Nervous system disorders,MODERATE,Y,VERY LIKELY,2025-07-06,,2025-07-06,,38,,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE02-0102,328,Treatment B,2,Tremor,Nervous system disorders,MILD,N,POSSIBLE,2025-06-19,2025-06-24,2025-06-19,2025-06-24,21,26.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE02-0102,329,Treatment B,2,Fatigue,General disorders and administration site conditions,MILD,N,PROBABLE,2025-07-12,2025-07-25,2025-07-12,2025-07-25,44,57.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE02-0102,330,Treatment B,2,Constipation,Gastrointestinal disorders,MODERATE,N,POSSIBLE,2025-07-13,2025-07-31,2025-07-13,2025-07-31,45,63.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE03-0103,331,Treatment B,2,Tremor,Nervous system disorders,MODERATE,N,UNLIKELY,2025-03-18,2025-03-20,2025-03-18,2025-03-20,44,46.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0103,332,Treatment B,2,Fatigue,General disorders and administration site conditions,MODERATE,N,UNLIKELY,2025-02-18,2025-02-20,2025-02-18,2025-02-20,16,18.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0103,333,Treatment B,2,Fever,General disorders and administration site conditions,MILD,N,POSSIBLE,2025-02-17,2025-03-07,2025-02-17,2025-03-07,15,33.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0103,334,Treatment B,2,Tachycardia,Cardiac disorders,MODERATE,N,POSSIBLE,2025-02-12,2025-02-25,2025-02-12,2025-02-25,10,23.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0104,335,Placebo,3,Back pain,Musculoskeletal and connective tissue disorders,MODERATE,N,POSSIBLE,2025-04-29,2025-05-03,2025-04-29,2025-05-03,29,33.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0104,336,Placebo,3,Tremor,Nervous system disorders,SEVERE,N,UNLIKELY,2025-04-26,,2025-04-26,,26,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0104,337,Placebo,3,Hypertension,Vascular disorders,MILD,N,UNLIKELY,2025-04-02,,2025-04-02,,2,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0104,338,Placebo,3,Hypertension,Vascular disorders,MILD,N,UNLIKELY,2025-04-20,2025-04-25,2025-04-20,2025-04-25,20,25.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0105,339,Treatment B,2,Vomiting,Gastrointestinal disorders,SEVERE,N,POSSIBLE,2025-06-25,2025-07-06,2025-06-25,2025-07-06,25,36.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE05-0105,340,Treatment B,2,Rash,Skin and subcutaneous tissue disorders,SEVERE,N,VERY LIKELY,2025-06-18,2025-06-27,2025-06-18,2025-06-27,18,27.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE01-0106,341,Treatment A,1,Vomiting,Gastrointestinal disorders,MILD,N,UNLIKELY,2025-06-16,2025-07-01,2025-06-16,2025-07-01,11,26.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0106,342,Treatment A,1,Nausea,Gastrointestinal disorders,MODERATE,Y,POSSIBLE,2025-06-30,2025-07-07,2025-06-30,2025-07-07,25,32.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0106,343,Treatment A,1,Fever,General disorders and administration site conditions,MILD,N,VERY LIKELY,2025-07-02,,2025-07-02,,27,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0106,344,Treatment A,1,Tremor,Nervous system disorders,MILD,Y,POSSIBLE,2025-06-23,2025-06-29,2025-06-23,2025-06-29,18,24.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0108,345,Treatment B,2,Hypertension,Vascular disorders,MILD,N,VERY LIKELY,2025-02-08,2025-02-24,2025-02-08,2025-02-24,15,31.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0108,346,Treatment B,2,Tremor,Nervous system disorders,MILD,Y,VERY LIKELY,2025-02-11,2025-02-24,2025-02-11,2025-02-24,18,31.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0109,347,Treatment A,1,Dyspnea,"Respiratory, thoracic and mediastinal disorders",MILD,N,POSSIBLE,2025-05-25,2025-05-26,2025-05-25,2025-05-26,49,50.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0109,348,Treatment A,1,Headache,Nervous system disorders,MILD,N,POSSIBLE,2025-05-09,2025-05-26,2025-05-09,2025-05-26,33,50.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0110,349,Treatment B,2,Hypertension,Vascular disorders,MODERATE,N,UNLIKELY,2025-01-31,2025-02-16,2025-01-31,2025-02-16,4,20.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0110,350,Treatment B,2,Pruritus,Skin and subcutaneous tissue disorders,MILD,N,POSSIBLE,2025-02-17,2025-03-06,2025-02-17,2025-03-06,21,38.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0110,351,Treatment B,2,Fever,General disorders and administration site conditions,MODERATE,N,PROBABLE,2025-02-27,2025-03-08,2025-02-27,2025-03-08,31,40.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0111,352,Treatment B,2,Muscle pain,Musculoskeletal and connective tissue disorders,MILD,Y,UNLIKELY,2025-06-29,2025-07-03,2025-06-29,2025-07-03,22,26.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0112,353,Treatment B,2,Fatigue,General disorders and administration site conditions,MODERATE,N,POSSIBLE,2025-05-02,2025-05-18,2025-05-02,2025-05-18,42,58.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0112,354,Treatment B,2,Cough,"Respiratory, thoracic and mediastinal disorders",MILD,N,UNLIKELY,2025-04-12,2025-04-13,2025-04-12,2025-04-13,22,23.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0112,355,Treatment B,2,Abdominal pain,Gastrointestinal disorders,MILD,N,POSSIBLE,2025-04-27,2025-05-13,2025-04-27,2025-05-13,37,53.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0113,356,Placebo,3,Back pain,Musculoskeletal and connective tissue disorders,MILD,N,POSSIBLE,2025-03-05,2025-03-13,2025-03-05,2025-03-13,18,26.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0113,357,Placebo,3,Hypertension,Vascular disorders,MILD,N,VERY LIKELY,2025-03-11,2025-03-18,2025-03-11,2025-03-18,24,31.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0113,358,Placebo,3,Cough,"Respiratory, thoracic and mediastinal disorders",MILD,N,PROBABLE,2025-04-03,2025-04-14,2025-04-03,2025-04-14,47,58.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0114,359,Treatment A,1,Abdominal pain,Gastrointestinal disorders,MILD,N,POSSIBLE,2025-04-13,,2025-04-13,,24,,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0115,360,Treatment B,2,Back pain,Musculoskeletal and connective tissue disorders,MILD,N,POSSIBLE,2025-03-14,2025-03-26,2025-03-14,2025-03-26,13,25.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0115,361,Treatment B,2,Tremor,Nervous system disorders,MILD,N,POSSIBLE,2025-04-11,2025-04-28,2025-04-11,2025-04-28,41,58.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0116,362,Treatment B,2,Tremor,Nervous system disorders,MILD,N,POSSIBLE,2025-07-29,,2025-07-29,,24,,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0117,363,Treatment B,2,Dizziness,Nervous system disorders,MODERATE,Y,PROBABLE,2025-03-11,2025-03-20,2025-03-11,2025-03-20,30,39.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0117,364,Treatment B,2,Dizziness,Nervous system disorders,MODERATE,N,POSSIBLE,2025-03-03,2025-03-12,2025-03-03,2025-03-12,22,31.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0118,365,Treatment A,1,Fatigue,General disorders and administration site conditions,SEVERE,N,PROBABLE,2025-05-02,2025-05-14,2025-05-02,2025-05-14,2,14.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0119,366,Treatment A,1,Headache,Nervous system disorders,MODERATE,Y,POSSIBLE,2025-05-31,,2025-05-31,,34,,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0119,367,Treatment A,1,Tremor,Nervous system disorders,MODERATE,N,UNLIKELY,2025-06-08,2025-06-21,2025-06-08,2025-06-21,42,55.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0119,368,Treatment A,1,Back pain,Musculoskeletal and connective tissue disorders,MODERATE,N,VERY LIKELY,2025-05-31,,2025-05-31,,34,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0119,369,Treatment A,1,Back pain,Musculoskeletal and connective tissue disorders,MILD,N,UNLIKELY,2025-05-21,2025-05-29,2025-05-21,2025-05-29,24,32.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0120,370,Treatment A,1,Headache,Nervous system disorders,MILD,N,VERY LIKELY,2025-04-20,,2025-04-20,,5,,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0120,371,Treatment A,1,Hypertension,Vascular disorders,MILD,N,PROBABLE,2025-05-17,2025-05-27,2025-05-17,2025-05-27,32,42.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0120,372,Treatment A,1,Tachycardia,Cardiac disorders,MODERATE,N,PROBABLE,2025-05-02,,2025-05-02,,17,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0120,373,Treatment A,1,Nausea,Gastrointestinal disorders,MILD,N,POSSIBLE,2025-04-23,,2025-04-23,,8,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0121,374,Placebo,3,Headache,Nervous system disorders,MODERATE,N,UNLIKELY,2025-06-16,2025-06-22,2025-06-16,2025-06-22,3,9.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0121,375,Placebo,3,Dizziness,Nervous system disorders,MODERATE,N,POSSIBLE,2025-07-14,2025-07-19,2025-07-14,2025-07-19,31,36.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0121,376,Placebo,3,Back pain,Musculoskeletal and connective tissue disorders,MILD,N,PROBABLE,2025-07-17,2025-07-24,2025-07-17,2025-07-24,34,41.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0121,377,Placebo,3,Headache,Nervous system disorders,MILD,N,PROBABLE,2025-07-15,2025-07-29,2025-07-15,2025-07-29,32,46.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0122,378,Treatment A,1,Pruritus,Skin and subcutaneous tissue disorders,MODERATE,N,POSSIBLE,2025-06-16,2025-07-03,2025-06-16,2025-07-03,17,34.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE02-0122,379,Treatment A,1,Abdominal pain,Gastrointestinal disorders,MILD,N,PROBABLE,2025-07-15,,2025-07-15,,46,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE02-0122,380,Treatment A,1,Rash,Skin and subcutaneous tissue disorders,MODERATE,N,PROBABLE,2025-06-16,2025-06-21,2025-06-16,2025-06-21,17,22.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE03-0123,381,Treatment A,1,Headache,Nervous system disorders,MILD,N,POSSIBLE,2025-03-27,2025-04-02,2025-03-27,2025-04-02,48,54.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0123,382,Treatment A,1,Cough,"Respiratory, thoracic and mediastinal disorders",MILD,N,POSSIBLE,2025-03-09,2025-03-18,2025-03-09,2025-03-18,30,39.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0124,383,Treatment A,1,Hypertension,Vascular disorders,MODERATE,N,POSSIBLE,2025-08-10,,2025-08-10,,30,,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0124,384,Treatment A,1,Fatigue,General disorders and administration site conditions,SEVERE,N,UNLIKELY,2025-08-04,2025-08-20,2025-08-04,2025-08-20,24,40.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0124,385,Treatment A,1,Insomnia,Nervous system disorders,MILD,N,POSSIBLE,2025-08-15,2025-08-17,2025-08-15,2025-08-17,35,37.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0124,386,Treatment A,1,Hypertension,Vascular disorders,MILD,N,PROBABLE,2025-08-03,2025-08-12,2025-08-03,2025-08-12,23,32.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0125,387,Treatment B,2,Rash,Skin and subcutaneous tissue disorders,MILD,N,UNLIKELY,2025-06-18,,2025-06-18,,6,,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0126,388,Treatment B,2,Constipation,Gastrointestinal disorders,SEVERE,N,PROBABLE,2025-02-27,2025-03-07,2025-02-27,2025-03-07,44,52.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0126,389,Treatment B,2,Fatigue,General disorders and administration site conditions,MILD,N,UNLIKELY,2025-01-18,2025-02-04,2025-01-18,2025-02-04,4,21.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0126,390,Treatment B,2,Diarrhea,Gastrointestinal disorders,MODERATE,Y,UNLIKELY,2025-02-24,2025-02-25,2025-02-24,2025-02-25,41,42.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0127,391,Treatment A,1,Headache,Nervous system disorders,MODERATE,N,PROBABLE,2025-06-26,2025-07-15,2025-06-26,2025-07-15,6,25.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0127,392,Treatment A,1,Insomnia,Nervous system disorders,MILD,N,UNLIKELY,2025-07-04,2025-07-06,2025-07-04,2025-07-06,14,16.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0127,393,Treatment A,1,Back pain,Musculoskeletal and connective tissue disorders,MILD,N,UNLIKELY,2025-07-04,,2025-07-04,,14,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0127,394,Treatment A,1,Constipation,Gastrointestinal disorders,MILD,N,POSSIBLE,2025-07-29,2025-08-06,2025-07-29,2025-08-06,39,47.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0128,395,Treatment B,2,Tachycardia,Cardiac disorders,MILD,N,UNLIKELY,2025-06-04,2025-06-22,2025-06-04,2025-06-22,29,47.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0128,396,Treatment B,2,Insomnia,Nervous system disorders,MILD,N,VERY LIKELY,2025-05-09,2025-05-13,2025-05-09,2025-05-13,3,7.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0128,397,Treatment B,2,Insomnia,Nervous system disorders,MILD,N,VERY LIKELY,2025-06-04,2025-06-19,2025-06-04,2025-06-19,29,44.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0128,398,Treatment B,2,Cough,"Respiratory, thoracic and mediastinal disorders",MILD,N,PROBABLE,2025-05-15,2025-06-03,2025-05-15,2025-06-03,9,28.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0129,399,Treatment A,1,Headache,Nervous system disorders,MILD,N,POSSIBLE,2025-04-08,,2025-04-08,,30,,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0129,400,Treatment A,1,Back pain,Musculoskeletal and connective tissue disorders,MILD,Y,PROBABLE,2025-03-20,2025-04-08,2025-03-20,2025-04-08,11,30.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0130,401,Placebo,3,Headache,Nervous system disorders,MODERATE,N,UNLIKELY,2025-02-19,2025-03-03,2025-02-19,2025-03-03,5,17.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0130,402,Placebo,3,Headache,Nervous system disorders,MODERATE,N,POSSIBLE,2025-03-03,2025-03-21,2025-03-03,2025-03-21,17,35.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0130,403,Placebo,3,Abdominal pain,Gastrointestinal disorders,MILD,N,PROBABLE,2025-03-14,2025-03-19,2025-03-14,2025-03-19,28,33.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0130,404,Placebo,3,Nausea,Gastrointestinal disorders,MODERATE,Y,POSSIBLE,2025-03-20,2025-03-23,2025-03-20,2025-03-23,34,37.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0131,405,Treatment A,1,Hypertension,Vascular disorders,MILD,N,POSSIBLE,2025-04-27,,2025-04-27,,32,,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0131,406,Treatment A,1,Muscle pain,Musculoskeletal and connective tissue disorders,MILD,N,UNLIKELY,2025-05-07,,2025-05-07,,42,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0131,407,Treatment A,1,Tachycardia,Cardiac disorders,MILD,N,POSSIBLE,2025-04-12,2025-04-20,2025-04-12,2025-04-20,17,25.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0131,408,Treatment A,1,Tachycardia,Cardiac disorders,MILD,N,PROBABLE,2025-05-09,2025-05-25,2025-05-09,2025-05-25,44,60.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0133,409,Treatment A,1,Hypertension,Vascular disorders,SEVERE,N,PROBABLE,2025-03-28,,2025-03-28,,19,,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0133,410,Treatment A,1,Fatigue,General disorders and administration site conditions,MILD,N,POSSIBLE,2025-03-27,2025-04-02,2025-03-27,2025-04-02,18,24.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0133,411,Treatment A,1,Diarrhea,Gastrointestinal disorders,MILD,N,POSSIBLE,2025-04-05,2025-04-20,2025-04-05,2025-04-20,27,42.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0134,412,Placebo,3,Insomnia,Nervous system disorders,MODERATE,N,PROBABLE,2025-03-11,2025-03-26,2025-03-11,2025-03-26,28,43.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0134,413,Placebo,3,Fatigue,General disorders and administration site conditions,MILD,N,POSSIBLE,2025-03-26,2025-04-11,2025-03-26,2025-04-11,43,59.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0134,414,Placebo,3,Fever,General disorders and administration site conditions,MODERATE,N,POSSIBLE,2025-02-28,2025-03-09,2025-02-28,2025-03-09,17,26.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0135,415,Treatment A,1,Diarrhea,Gastrointestinal disorders,MILD,N,POSSIBLE,2025-06-26,2025-07-14,2025-06-26,2025-07-14,34,52.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0135,416,Treatment A,1,Fever,General disorders and administration site conditions,MILD,N,POSSIBLE,2025-07-03,2025-07-04,2025-07-03,2025-07-04,41,42.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0136,417,Treatment B,2,Diarrhea,Gastrointestinal disorders,MILD,N,PROBABLE,2025-07-20,2025-08-01,2025-07-20,2025-08-01,16,28.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0136,418,Treatment B,2,Back pain,Musculoskeletal and connective tissue disorders,SEVERE,N,POSSIBLE,2025-08-04,2025-08-19,2025-08-04,2025-08-19,31,46.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0137,419,Placebo,3,Vomiting,Gastrointestinal disorders,MODERATE,N,PROBABLE,2025-05-18,,2025-05-18,,5,,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0137,420,Placebo,3,Rash,Skin and subcutaneous tissue disorders,MILD,N,VERY LIKELY,2025-06-10,2025-06-19,2025-06-10,2025-06-19,28,37.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0137,421,Placebo,3,Insomnia,Nervous system disorders,MILD,N,POSSIBLE,2025-06-25,2025-07-05,2025-06-25,2025-07-05,43,53.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0137,422,Placebo,3,Back pain,Musculoskeletal and connective tissue disorders,MILD,N,UNLIKELY,2025-06-12,,2025-06-12,,30,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0137,423,Placebo,3,Pruritus,Skin and subcutaneous tissue disorders,MILD,N,POSSIBLE,2025-05-16,,2025-05-16,,3,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0137,424,Placebo,3,Hypertension,Vascular disorders,MILD,N,POSSIBLE,2025-06-25,,2025-06-25,,43,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0137,425,Placebo,3,Nausea,Gastrointestinal disorders,MODERATE,Y,PROBABLE,2025-06-07,2025-06-15,2025-06-07,2025-06-15,25,33.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0137,426,Placebo,3,Nausea,Gastrointestinal disorders,MODERATE,N,POSSIBLE,2025-05-20,2025-05-30,2025-05-20,2025-05-30,7,17.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0138,427,Treatment B,2,Rash,Skin and subcutaneous tissue disorders,MILD,N,POSSIBLE,2025-02-28,2025-03-14,2025-02-28,2025-03-14,21,35.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0138,428,Treatment B,2,Fatigue,General disorders and administration site conditions,MILD,N,VERY LIKELY,2025-02-26,2025-03-16,2025-02-26,2025-03-16,19,37.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0139,429,Treatment A,1,Headache,Nervous system disorders,MODERATE,N,UNLIKELY,2025-02-20,2025-03-05,2025-02-20,2025-03-05,9,22.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0139,430,Treatment A,1,Headache,Nervous system disorders,MILD,N,VERY LIKELY,2025-02-18,2025-03-05,2025-02-18,2025-03-05,7,22.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0139,431,Treatment A,1,Rash,Skin and subcutaneous tissue disorders,MILD,N,POSSIBLE,2025-03-25,2025-03-26,2025-03-25,2025-03-26,42,43.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0139,432,Treatment A,1,Nausea,Gastrointestinal disorders,MILD,N,POSSIBLE,2025-03-07,2025-03-24,2025-03-07,2025-03-24,24,41.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0140,433,Treatment B,2,Cough,"Respiratory, thoracic and mediastinal disorders",MILD,N,POSSIBLE,2025-02-21,2025-02-24,2025-02-21,2025-02-24,5,8.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0140,434,Treatment B,2,Tremor,Nervous system disorders,MILD,N,POSSIBLE,2025-02-18,,2025-02-18,,2,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0140,435,Treatment B,2,Vomiting,Gastrointestinal disorders,MILD,N,PROBABLE,2025-02-27,2025-03-10,2025-02-27,2025-03-10,11,22.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0140,436,Treatment B,2,Tremor,Nervous system disorders,MILD,N,PROBABLE,2025-03-06,2025-03-22,2025-03-06,2025-03-22,18,34.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0140,437,Treatment B,2,Hypertension,Vascular disorders,MODERATE,N,UNLIKELY,2025-03-12,2025-03-16,2025-03-12,2025-03-16,24,28.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0140,438,Treatment B,2,Tachycardia,Cardiac disorders,MODERATE,N,POSSIBLE,2025-03-23,2025-03-27,2025-03-23,2025-03-27,35,39.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0141,439,Treatment A,1,Tremor,Nervous system disorders,MILD,N,VERY LIKELY,2025-04-16,2025-05-05,2025-04-16,2025-05-05,7,26.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0141,440,Treatment A,1,Hypertension,Vascular disorders,MILD,N,UNLIKELY,2025-04-14,2025-04-25,2025-04-14,2025-04-25,5,16.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0141,441,Treatment A,1,Muscle pain,Musculoskeletal and connective tissue disorders,MILD,N,POSSIBLE,2025-04-26,2025-05-03,2025-04-26,2025-05-03,17,24.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0141,442,Treatment A,1,Tachycardia,Cardiac disorders,SEVERE,N,PROBABLE,2025-05-15,2025-05-21,2025-05-15,2025-05-21,36,42.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0141,443,Treatment A,1,Headache,Nervous system disorders,MILD,N,VERY LIKELY,2025-04-18,2025-04-28,2025-04-18,2025-04-28,9,19.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0142,444,Placebo,3,Vomiting,Gastrointestinal disorders,SEVERE,N,UNLIKELY,2025-06-02,2025-06-20,2025-06-02,2025-06-20,18,36.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0143,445,Treatment A,1,Back pain,Musculoskeletal and connective tissue disorders,MODERATE,N,POSSIBLE,2025-03-20,2025-03-25,2025-03-20,2025-03-25,30,35.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0143,446,Treatment A,1,Muscle pain,Musculoskeletal and connective tissue disorders,MILD,Y,VERY LIKELY,2025-03-08,,2025-03-08,,18,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0144,447,Treatment A,1,Tachycardia,Cardiac disorders,MILD,N,PROBABLE,2025-04-25,2025-05-10,2025-04-25,2025-05-10,48,63.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0144,448,Treatment A,1,Headache,Nervous system disorders,MILD,N,PROBABLE,2025-04-04,2025-04-11,2025-04-04,2025-04-11,27,34.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0144,449,Treatment A,1,Rash,Skin and subcutaneous tissue disorders,MILD,Y,PROBABLE,2025-03-13,2025-03-28,2025-03-13,2025-03-28,5,20.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0144,450,Treatment A,1,Rash,Skin and subcutaneous tissue disorders,MILD,N,PROBABLE,2025-03-12,,2025-03-12,,4,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0146,451,Treatment A,1,Abdominal pain,Gastrointestinal disorders,MILD,N,PROBABLE,2025-08-04,2025-08-11,2025-08-04,2025-08-11,49,56.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0146,452,Treatment A,1,Muscle pain,Musculoskeletal and connective tissue disorders,MILD,N,PROBABLE,2025-06-28,2025-07-15,2025-06-28,2025-07-15,12,29.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0146,453,Treatment A,1,Insomnia,Nervous system disorders,MILD,N,UNLIKELY,2025-08-01,,2025-08-01,,46,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0146,454,Treatment A,1,Tachycardia,Cardiac disorders,MILD,N,UNLIKELY,2025-06-28,,2025-06-28,,12,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0146,455,Treatment A,1,Hypertension,Vascular disorders,MILD,N,PROBABLE,2025-07-23,,2025-07-23,,37,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0147,456,Treatment B,2,Tremor,Nervous system disorders,MILD,N,UNLIKELY,2025-07-13,2025-08-01,2025-07-13,2025-08-01,10,29.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0147,457,Treatment B,2,Cough,"Respiratory, thoracic and mediastinal disorders",MODERATE,N,POSSIBLE,2025-08-04,2025-08-07,2025-08-04,2025-08-07,32,35.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0148,458,Treatment A,1,Constipation,Gastrointestinal disorders,MILD,Y,PROBABLE,2025-05-01,2025-05-09,2025-05-01,2025-05-09,10,18.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0148,459,Treatment A,1,Vomiting,Gastrointestinal disorders,MODERATE,N,POSSIBLE,2025-06-08,2025-06-16,2025-06-08,2025-06-16,48,56.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0148,460,Treatment A,1,Pruritus,Skin and subcutaneous tissue disorders,MILD,N,UNLIKELY,2025-05-09,2025-05-10,2025-05-09,2025-05-10,18,19.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0148,461,Treatment A,1,Cough,"Respiratory, thoracic and mediastinal disorders",MODERATE,N,PROBABLE,2025-06-08,2025-06-17,2025-06-08,2025-06-17,48,57.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0149,462,Treatment A,1,Cough,"Respiratory, thoracic and mediastinal disorders",MILD,N,PROBABLE,2025-04-14,,2025-04-14,,17,,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0149,463,Treatment A,1,Vomiting,Gastrointestinal disorders,MILD,N,PROBABLE,2025-04-20,2025-04-30,2025-04-20,2025-04-30,23,33.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0149,464,Treatment A,1,Pruritus,Skin and subcutaneous tissue disorders,MILD,N,POSSIBLE,2025-04-25,2025-05-07,2025-04-25,2025-05-07,28,40.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0149,465,Treatment A,1,Dyspnea,"Respiratory, thoracic and mediastinal disorders",MILD,N,POSSIBLE,2025-04-28,2025-05-05,2025-04-28,2025-05-05,31,38.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0149,466,Treatment A,1,Back pain,Musculoskeletal and connective tissue disorders,SEVERE,N,PROBABLE,2025-04-04,2025-04-20,2025-04-04,2025-04-20,7,23.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0150,467,Treatment B,2,Vomiting,Gastrointestinal disorders,MILD,N,POSSIBLE,2025-06-18,2025-06-26,2025-06-18,2025-06-26,38,46.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0150,468,Treatment B,2,Pruritus,Skin and subcutaneous tissue disorders,MODERATE,N,POSSIBLE,2025-05-28,2025-06-01,2025-05-28,2025-06-01,17,21.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0150,469,Treatment B,2,Constipation,Gastrointestinal disorders,MILD,N,UNLIKELY,2025-05-17,2025-05-25,2025-05-17,2025-05-25,6,14.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0150,470,Treatment B,2,Muscle pain,Musculoskeletal and connective tissue disorders,MILD,Y,PROBABLE,2025-06-26,2025-07-09,2025-06-26,2025-07-09,46,59.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0150,471,Treatment B,2,Insomnia,Nervous system disorders,MILD,N,POSSIBLE,2025-06-09,2025-06-25,2025-06-09,2025-06-25,29,45.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0150,472,Treatment B,2,Hypertension,Vascular disorders,MODERATE,N,POSSIBLE,2025-05-19,2025-05-22,2025-05-19,2025-05-22,8,11.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0151,473,Treatment A,1,Muscle pain,Musculoskeletal and connective tissue disorders,MILD,N,UNLIKELY,2025-07-17,2025-07-29,2025-07-17,2025-07-29,31,43.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0151,474,Treatment A,1,Back pain,Musculoskeletal and connective tissue disorders,MODERATE,N,PROBABLE,2025-07-27,2025-08-09,2025-07-27,2025-08-09,41,54.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0151,475,Treatment A,1,Back pain,Musculoskeletal and connective tissue disorders,MILD,N,PROBABLE,2025-06-26,2025-07-10,2025-06-26,2025-07-10,10,24.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0151,476,Treatment A,1,Abdominal pain,Gastrointestinal disorders,MODERATE,N,VERY LIKELY,2025-07-23,,2025-07-23,,37,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0151,477,Treatment A,1,Dizziness,Nervous system disorders,MILD,N,VERY LIKELY,2025-07-11,2025-07-27,2025-07-11,2025-07-27,25,41.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0152,478,Treatment A,1,Dyspnea,"Respiratory, thoracic and mediastinal disorders",MODERATE,N,UNLIKELY,2025-07-30,2025-08-17,2025-07-30,2025-08-17,22,40.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0152,479,Treatment A,1,Fatigue,General disorders and administration site conditions,MILD,N,POSSIBLE,2025-07-29,2025-08-08,2025-07-29,2025-08-08,21,31.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0152,480,Treatment A,1,Cough,"Respiratory, thoracic and mediastinal disorders",MILD,N,PROBABLE,2025-07-17,2025-08-03,2025-07-17,2025-08-03,9,26.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0153,481,Placebo,3,Muscle pain,Musculoskeletal and connective tissue disorders,SEVERE,N,POSSIBLE,2025-07-04,,2025-07-04,,5,,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0153,482,Placebo,3,Pruritus,Skin and subcutaneous tissue disorders,MILD,N,PROBABLE,2025-08-09,2025-08-25,2025-08-09,2025-08-25,41,57.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0154,483,Treatment B,2,Muscle pain,Musculoskeletal and connective tissue disorders,MODERATE,Y,PROBABLE,2025-08-12,2025-08-21,2025-08-12,2025-08-21,43,52.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0154,484,Treatment B,2,Pruritus,Skin and subcutaneous tissue disorders,MILD,N,POSSIBLE,2025-08-13,,2025-08-13,,44,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0154,485,Treatment B,2,Insomnia,Nervous system disorders,MILD,N,VERY LIKELY,2025-07-31,2025-08-12,2025-07-31,2025-08-12,31,43.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0155,486,Treatment B,2,Hypertension,Vascular disorders,MILD,N,PROBABLE,2025-06-23,2025-07-02,2025-06-23,2025-07-02,20,29.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0156,487,Placebo,3,Dizziness,Nervous system disorders,SEVERE,N,VERY LIKELY,2025-02-20,2025-02-21,2025-02-20,2025-02-21,25,26.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0156,488,Placebo,3,Fatigue,General disorders and administration site conditions,MILD,N,VERY LIKELY,2025-03-15,2025-03-24,2025-03-15,2025-03-24,48,57.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0156,489,Placebo,3,Tremor,Nervous system disorders,MILD,N,VERY LIKELY,2025-02-16,2025-02-24,2025-02-16,2025-02-24,21,29.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0157,490,Treatment A,1,Pruritus,Skin and subcutaneous tissue disorders,MILD,N,PROBABLE,2025-03-12,2025-03-19,2025-03-12,2025-03-19,29,36.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0157,491,Treatment A,1,Constipation,Gastrointestinal disorders,MILD,N,UNLIKELY,2025-03-03,2025-03-14,2025-03-03,2025-03-14,20,31.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0157,492,Treatment A,1,Fatigue,General disorders and administration site conditions,MILD,N,PROBABLE,2025-03-03,2025-03-16,2025-03-03,2025-03-16,20,33.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0157,493,Treatment A,1,Insomnia,Nervous system disorders,MILD,N,PROBABLE,2025-04-02,2025-04-21,2025-04-02,2025-04-21,50,69.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0158,494,Treatment B,2,Dizziness,Nervous system disorders,MILD,N,VERY LIKELY,2025-07-12,,2025-07-12,,27,,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0158,495,Treatment B,2,Tachycardia,Cardiac disorders,SEVERE,Y,UNLIKELY,2025-06-24,,2025-06-24,,9,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0158,496,Treatment B,2,Tremor,Nervous system disorders,MILD,N,POSSIBLE,2025-08-02,2025-08-15,2025-08-02,2025-08-15,48,61.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0159,497,Treatment B,2,Tachycardia,Cardiac disorders,MODERATE,N,POSSIBLE,2025-05-18,2025-05-20,2025-05-18,2025-05-20,5,7.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0159,498,Treatment B,2,Tremor,Nervous system disorders,MODERATE,N,VERY LIKELY,2025-06-05,2025-06-14,2025-06-05,2025-06-14,23,32.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0159,499,Treatment B,2,Tremor,Nervous system disorders,MILD,N,POSSIBLE,2025-06-05,2025-06-16,2025-06-05,2025-06-16,23,34.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0160,500,Placebo,3,Tremor,Nervous system disorders,MODERATE,N,POSSIBLE,2025-04-04,,2025-04-04,,20,,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0160,501,Placebo,3,Nausea,Gastrointestinal disorders,MODERATE,N,PROBABLE,2025-04-16,2025-04-27,2025-04-16,2025-04-27,32,43.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0160,502,Placebo,3,Back pain,Musculoskeletal and connective tissue disorders,MODERATE,N,POSSIBLE,2025-04-12,2025-04-23,2025-04-12,2025-04-23,28,39.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0160,503,Placebo,3,Constipation,Gastrointestinal disorders,MILD,N,PROBABLE,2025-03-29,2025-04-02,2025-03-29,2025-04-02,14,18.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0161,504,Placebo,3,Fever,General disorders and administration site conditions,MODERATE,N,UNLIKELY,2025-02-13,,2025-02-13,,20,,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0162,505,Treatment A,1,Cough,"Respiratory, thoracic and mediastinal disorders",MILD,N,POSSIBLE,2025-06-12,2025-06-13,2025-06-12,2025-06-13,40,41.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE02-0162,506,Treatment A,1,Rash,Skin and subcutaneous tissue disorders,MILD,N,PROBABLE,2025-05-17,2025-05-23,2025-05-17,2025-05-23,14,20.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE03-0163,507,Placebo,3,Constipation,Gastrointestinal disorders,MILD,N,POSSIBLE,2025-05-28,2025-06-12,2025-05-28,2025-06-12,15,30.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0163,508,Placebo,3,Constipation,Gastrointestinal disorders,MILD,N,UNLIKELY,2025-06-06,,2025-06-06,,24,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0164,509,Treatment B,2,Nausea,Gastrointestinal disorders,MILD,N,PROBABLE,2025-06-06,2025-06-13,2025-06-06,2025-06-13,21,28.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0164,510,Treatment B,2,Hypertension,Vascular disorders,MODERATE,N,POSSIBLE,2025-07-02,2025-07-09,2025-07-02,2025-07-09,47,54.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0164,511,Treatment B,2,Cough,"Respiratory, thoracic and mediastinal disorders",MODERATE,N,POSSIBLE,2025-05-24,2025-05-31,2025-05-24,2025-05-31,8,15.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0165,512,Placebo,3,Diarrhea,Gastrointestinal disorders,SEVERE,N,POSSIBLE,2025-03-16,2025-03-17,2025-03-16,2025-03-17,49,50.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0165,513,Placebo,3,Tachycardia,Cardiac disorders,MODERATE,Y,VERY LIKELY,2025-02-08,2025-02-16,2025-02-08,2025-02-16,13,21.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0166,514,Treatment A,1,Back pain,Musculoskeletal and connective tissue disorders,MILD,Y,UNLIKELY,2025-05-04,,2025-05-04,,35,,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0167,515,Treatment A,1,Rash,Skin and subcutaneous tissue disorders,MILD,Y,VERY LIKELY,2025-07-06,,2025-07-06,,50,,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0167,516,Treatment A,1,Rash,Skin and subcutaneous tissue disorders,MODERATE,N,PROBABLE,2025-06-06,2025-06-20,2025-06-06,2025-06-20,20,34.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0168,517,Treatment A,1,Hypertension,Vascular disorders,MODERATE,N,UNLIKELY,2025-03-18,2025-04-02,2025-03-18,2025-04-02,36,51.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0168,518,Treatment A,1,Tremor,Nervous system disorders,MILD,N,VERY LIKELY,2025-03-30,,2025-03-30,,48,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0168,519,Treatment A,1,Fever,General disorders and administration site conditions,MILD,Y,POSSIBLE,2025-02-27,2025-03-01,2025-02-27,2025-03-01,17,19.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0168,520,Treatment A,1,Abdominal pain,Gastrointestinal disorders,MILD,N,UNLIKELY,2025-03-22,2025-04-04,2025-03-22,2025-04-04,40,53.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0169,521,Treatment B,2,Hypertension,Vascular disorders,MODERATE,N,POSSIBLE,2025-06-26,2025-07-04,2025-06-26,2025-07-04,49,57.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0171,522,Treatment A,1,Dyspnea,"Respiratory, thoracic and mediastinal disorders",SEVERE,N,POSSIBLE,2025-07-28,2025-08-02,2025-07-28,2025-08-02,26,31.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0172,523,Treatment A,1,Muscle pain,Musculoskeletal and connective tissue disorders,MODERATE,N,POSSIBLE,2025-02-12,2025-02-18,2025-02-12,2025-02-18,7,13.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE02-0172,524,Treatment A,1,Hypertension,Vascular disorders,MILD,N,POSSIBLE,2025-03-18,2025-03-21,2025-03-18,2025-03-21,41,44.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE02-0172,525,Treatment A,1,Muscle pain,Musculoskeletal and connective tissue disorders,MODERATE,N,PROBABLE,2025-02-28,2025-03-01,2025-02-28,2025-03-01,23,24.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE03-0173,526,Treatment A,1,Vomiting,Gastrointestinal disorders,MILD,N,POSSIBLE,2025-06-01,2025-06-16,2025-06-01,2025-06-16,39,54.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0173,527,Treatment A,1,Insomnia,Nervous system disorders,MILD,N,PROBABLE,2025-06-06,2025-06-17,2025-06-06,2025-06-17,44,55.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0174,528,Placebo,3,Headache,Nervous system disorders,MODERATE,N,PROBABLE,2025-03-13,2025-03-29,2025-03-13,2025-03-29,42,58.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0174,529,Placebo,3,Tremor,Nervous system disorders,MODERATE,N,VERY LIKELY,2025-02-11,2025-02-12,2025-02-11,2025-02-12,12,13.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0174,530,Placebo,3,Tachycardia,Cardiac disorders,MILD,N,VERY LIKELY,2025-02-04,2025-02-09,2025-02-04,2025-02-09,5,10.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0174,531,Placebo,3,Hypertension,Vascular disorders,MILD,N,POSSIBLE,2025-02-15,2025-02-24,2025-02-15,2025-02-24,16,25.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0175,532,Treatment B,2,Tachycardia,Cardiac disorders,SEVERE,Y,PROBABLE,2025-04-27,2025-05-07,2025-04-27,2025-05-07,34,44.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0175,533,Treatment B,2,Tachycardia,Cardiac disorders,MODERATE,N,UNLIKELY,2025-04-13,2025-04-19,2025-04-13,2025-04-19,20,26.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0175,534,Treatment B,2,Vomiting,Gastrointestinal disorders,MILD,N,POSSIBLE,2025-05-12,2025-05-22,2025-05-12,2025-05-22,49,59.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0176,535,Placebo,3,Tremor,Nervous system disorders,MILD,N,POSSIBLE,2025-02-06,2025-02-10,2025-02-06,2025-02-10,2,6.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE01-0176,536,Placebo,3,Nausea,Gastrointestinal disorders,MODERATE,N,PROBABLE,2025-02-13,2025-03-03,2025-02-13,2025-03-03,9,27.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE01-0176,537,Placebo,3,Diarrhea,Gastrointestinal disorders,MILD,N,PROBABLE,2025-02-28,2025-03-08,2025-02-28,2025-03-08,24,32.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE02-0177,538,Treatment A,1,Insomnia,Nervous system disorders,MILD,N,POSSIBLE,2025-03-01,2025-03-17,2025-03-01,2025-03-17,35,51.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0177,539,Treatment A,1,Abdominal pain,Gastrointestinal disorders,MILD,N,POSSIBLE,2025-02-18,2025-02-19,2025-02-18,2025-02-19,24,25.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0177,540,Treatment A,1,Fever,General disorders and administration site conditions,MILD,N,PROBABLE,2025-03-12,2025-03-30,2025-03-12,2025-03-30,46,64.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0178,541,Placebo,3,Dizziness,Nervous system disorders,MILD,N,UNLIKELY,2025-03-18,2025-04-04,2025-03-18,2025-04-04,35,52.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0178,542,Placebo,3,Back pain,Musculoskeletal and connective tissue disorders,MILD,N,VERY LIKELY,2025-02-13,2025-02-16,2025-02-13,2025-02-16,2,5.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0178,543,Placebo,3,Cough,"Respiratory, thoracic and mediastinal disorders",MODERATE,N,VERY LIKELY,2025-02-13,,2025-02-13,,2,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0179,544,Treatment A,1,Dyspnea,"Respiratory, thoracic and mediastinal disorders",MILD,N,POSSIBLE,2025-06-19,2025-07-07,2025-06-19,2025-07-07,18,36.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE04-0179,545,Treatment A,1,Cough,"Respiratory, thoracic and mediastinal disorders",MILD,N,UNLIKELY,2025-07-01,2025-07-07,2025-07-01,2025-07-07,30,36.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE04-0179,546,Treatment A,1,Fatigue,General disorders and administration site conditions,MILD,N,PROBABLE,2025-07-12,2025-07-14,2025-07-12,2025-07-14,41,43.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE04-0179,547,Treatment A,1,Tremor,Nervous system disorders,MILD,N,PROBABLE,2025-06-22,2025-06-27,2025-06-22,2025-06-27,21,26.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE04-0179,548,Treatment A,1,Nausea,Gastrointestinal disorders,MILD,N,VERY LIKELY,2025-06-11,,2025-06-11,,10,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE04-0179,549,Treatment A,1,Pruritus,Skin and subcutaneous tissue disorders,MILD,N,UNLIKELY,2025-06-10,2025-06-13,2025-06-10,2025-06-13,9,12.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE05-0180,550,Treatment A,1,Fatigue,General disorders and administration site conditions,MILD,N,PROBABLE,2025-02-13,2025-03-04,2025-02-13,2025-03-04,2,21.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0180,551,Treatment A,1,Back pain,Musculoskeletal and connective tissue disorders,MILD,N,UNLIKELY,2025-02-17,,2025-02-17,,6,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0180,552,Treatment A,1,Diarrhea,Gastrointestinal disorders,MODERATE,N,POSSIBLE,2025-03-11,,2025-03-11,,28,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0181,553,Treatment B,2,Muscle pain,Musculoskeletal and connective tissue disorders,MODERATE,N,POSSIBLE,2025-06-23,2025-06-26,2025-06-23,2025-06-26,4,7.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE01-0181,554,Treatment B,2,Tachycardia,Cardiac disorders,MILD,N,VERY LIKELY,2025-07-22,2025-08-01,2025-07-22,2025-08-01,33,43.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE01-0181,555,Treatment B,2,Fatigue,General disorders and administration site conditions,MILD,N,VERY LIKELY,2025-06-24,,2025-06-24,,5,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE02-0182,556,Placebo,3,Cough,"Respiratory, thoracic and mediastinal disorders",MODERATE,N,UNLIKELY,2025-04-19,2025-05-05,2025-04-19,2025-05-05,4,20.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0182,557,Placebo,3,Hypertension,Vascular disorders,MODERATE,N,POSSIBLE,2025-04-29,2025-05-13,2025-04-29,2025-05-13,14,28.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0182,558,Placebo,3,Rash,Skin and subcutaneous tissue disorders,MILD,N,PROBABLE,2025-05-07,2025-05-22,2025-05-07,2025-05-22,22,37.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0183,559,Treatment A,1,Fever,General disorders and administration site conditions,MILD,N,UNLIKELY,2025-05-28,2025-06-11,2025-05-28,2025-06-11,4,18.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0183,560,Treatment A,1,Hypertension,Vascular disorders,MODERATE,N,PROBABLE,2025-06-20,2025-07-07,2025-06-20,2025-07-07,27,44.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0183,561,Treatment A,1,Fever,General disorders and administration site conditions,MILD,N,PROBABLE,2025-06-30,,2025-06-30,,37,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0183,562,Treatment A,1,Dizziness,Nervous system disorders,MODERATE,N,PROBABLE,2025-06-23,,2025-06-23,,30,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0183,563,Treatment A,1,Hypertension,Vascular disorders,MILD,N,PROBABLE,2025-06-27,2025-07-09,2025-06-27,2025-07-09,34,46.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0184,564,Treatment B,2,Constipation,Gastrointestinal disorders,MILD,N,PROBABLE,2025-03-10,2025-03-15,2025-03-10,2025-03-15,38,43.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0185,565,Treatment A,1,Dyspnea,"Respiratory, thoracic and mediastinal disorders",MODERATE,N,PROBABLE,2025-04-25,,2025-04-25,,9,,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0185,566,Treatment A,1,Fatigue,General disorders and administration site conditions,MILD,N,POSSIBLE,2025-05-14,,2025-05-14,,28,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0185,567,Treatment A,1,Fever,General disorders and administration site conditions,MODERATE,N,UNLIKELY,2025-06-03,2025-06-09,2025-06-03,2025-06-09,48,54.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0185,568,Treatment A,1,Nausea,Gastrointestinal disorders,MILD,N,VERY LIKELY,2025-04-23,2025-05-09,2025-04-23,2025-05-09,7,23.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0186,569,Treatment A,1,Constipation,Gastrointestinal disorders,MILD,N,PROBABLE,2025-03-16,,2025-03-16,,2,,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0186,570,Treatment A,1,Dyspnea,"Respiratory, thoracic and mediastinal disorders",MILD,N,UNLIKELY,2025-04-26,2025-05-11,2025-04-26,2025-05-11,43,58.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0186,571,Treatment A,1,Nausea,Gastrointestinal disorders,MILD,N,PROBABLE,2025-03-29,2025-04-11,2025-03-29,2025-04-11,15,28.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0186,572,Treatment A,1,Abdominal pain,Gastrointestinal disorders,MILD,N,POSSIBLE,2025-03-23,2025-04-09,2025-03-23,2025-04-09,9,26.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0186,573,Treatment A,1,Tachycardia,Cardiac disorders,SEVERE,N,UNLIKELY,2025-04-11,,2025-04-11,,28,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0187,574,Treatment B,2,Rash,Skin and subcutaneous tissue disorders,MILD,N,PROBABLE,2025-06-20,2025-07-06,2025-06-20,2025-07-06,32,48.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0187,575,Treatment B,2,Tachycardia,Cardiac disorders,MILD,N,POSSIBLE,2025-07-01,2025-07-18,2025-07-01,2025-07-18,43,60.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0188,576,Treatment A,1,Dyspnea,"Respiratory, thoracic and mediastinal disorders",MILD,N,PROBABLE,2025-07-12,2025-07-18,2025-07-12,2025-07-18,50,56.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0188,577,Treatment A,1,Back pain,Musculoskeletal and connective tissue disorders,SEVERE,N,VERY LIKELY,2025-05-31,,2025-05-31,,8,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0188,578,Treatment A,1,Cough,"Respiratory, thoracic and mediastinal disorders",MODERATE,N,PROBABLE,2025-06-13,2025-06-26,2025-06-13,2025-06-26,21,34.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0189,579,Treatment A,1,Cough,"Respiratory, thoracic and mediastinal disorders",MILD,N,UNLIKELY,2025-05-04,2025-05-22,2025-05-04,2025-05-22,47,65.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0189,580,Treatment A,1,Muscle pain,Musculoskeletal and connective tissue disorders,MODERATE,N,POSSIBLE,2025-04-24,2025-05-11,2025-04-24,2025-05-11,37,54.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0189,581,Treatment A,1,Headache,Nervous system disorders,MILD,N,PROBABLE,2025-04-19,,2025-04-19,,32,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0190,582,Treatment B,2,Headache,Nervous system disorders,MILD,N,UNLIKELY,2025-07-07,2025-07-10,2025-07-07,2025-07-10,39,42.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0190,583,Treatment B,2,Tremor,Nervous system disorders,MODERATE,N,UNLIKELY,2025-06-08,2025-06-12,2025-06-08,2025-06-12,10,14.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0190,584,Treatment B,2,Fever,General disorders and administration site conditions,MILD,N,POSSIBLE,2025-06-04,2025-06-12,2025-06-04,2025-06-12,6,14.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0190,585,Treatment B,2,Rash,Skin and subcutaneous tissue disorders,SEVERE,N,POSSIBLE,2025-06-17,2025-07-05,2025-06-17,2025-07-05,19,37.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0190,586,Treatment B,2,Headache,Nervous system disorders,MILD,Y,POSSIBLE,2025-07-07,2025-07-24,2025-07-07,2025-07-24,39,56.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0190,587,Treatment B,2,Pruritus,Skin and subcutaneous tissue disorders,MILD,N,POSSIBLE,2025-06-19,2025-07-04,2025-06-19,2025-07-04,21,36.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0191,588,Placebo,3,Back pain,Musculoskeletal and connective tissue disorders,SEVERE,N,VERY LIKELY,2025-07-05,,2025-07-05,,13,,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0191,589,Placebo,3,Back pain,Musculoskeletal and connective tissue disorders,MODERATE,N,PROBABLE,2025-07-22,2025-08-07,2025-07-22,2025-08-07,30,46.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0192,590,Treatment A,1,Abdominal pain,Gastrointestinal disorders,MILD,N,POSSIBLE,2025-02-03,2025-02-06,2025-02-03,2025-02-06,19,22.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0192,591,Treatment A,1,Hypertension,Vascular disorders,SEVERE,N,UNLIKELY,2025-02-15,2025-03-02,2025-02-15,2025-03-02,31,46.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0193,592,Treatment A,1,Dizziness,Nervous system disorders,MILD,N,UNLIKELY,2025-07-23,2025-08-08,2025-07-23,2025-08-08,41,57.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0193,593,Treatment A,1,Tremor,Nervous system disorders,MILD,N,POSSIBLE,2025-07-01,2025-07-10,2025-07-01,2025-07-10,19,28.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0193,594,Treatment A,1,Pruritus,Skin and subcutaneous tissue disorders,MILD,N,UNLIKELY,2025-07-04,2025-07-12,2025-07-04,2025-07-12,22,30.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0193,595,Treatment A,1,Back pain,Musculoskeletal and connective tissue disorders,MILD,N,POSSIBLE,2025-06-23,2025-07-03,2025-06-23,2025-07-03,11,21.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0193,596,Treatment A,1,Pruritus,Skin and subcutaneous tissue disorders,SEVERE,N,POSSIBLE,2025-06-26,2025-07-11,2025-06-26,2025-07-11,14,29.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0194,597,Treatment A,1,Pruritus,Skin and subcutaneous tissue disorders,SEVERE,N,PROBABLE,2025-03-31,2025-04-15,2025-03-31,2025-04-15,28,43.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0194,598,Treatment A,1,Tachycardia,Cardiac disorders,SEVERE,N,PROBABLE,2025-04-21,2025-04-25,2025-04-21,2025-04-25,49,53.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0194,599,Treatment A,1,Back pain,Musculoskeletal and connective tissue disorders,MILD,N,PROBABLE,2025-04-13,2025-04-16,2025-04-13,2025-04-16,41,44.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0194,600,Treatment A,1,Diarrhea,Gastrointestinal disorders,MODERATE,N,POSSIBLE,2025-03-17,2025-03-29,2025-03-17,2025-03-29,14,26.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0195,601,Placebo,3,Fatigue,General disorders and administration site conditions,SEVERE,N,POSSIBLE,2025-06-15,2025-06-25,2025-06-15,2025-06-25,50,60.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0195,602,Placebo,3,Fever,General disorders and administration site conditions,MILD,N,VERY LIKELY,2025-05-21,2025-05-30,2025-05-21,2025-05-30,25,34.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0196,603,Placebo,3,Dyspnea,"Respiratory, thoracic and mediastinal disorders",MILD,N,PROBABLE,2025-02-04,2025-02-17,2025-02-04,2025-02-17,15,28.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0196,604,Placebo,3,Tachycardia,Cardiac disorders,MODERATE,N,POSSIBLE,2025-02-03,2025-02-10,2025-02-03,2025-02-10,14,21.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0197,605,Treatment B,2,Muscle pain,Musculoskeletal and connective tissue disorders,MILD,N,POSSIBLE,2025-02-06,2025-02-23,2025-02-06,2025-02-23,21,38.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE02-0197,606,Treatment B,2,Fatigue,General disorders and administration site conditions,MODERATE,N,POSSIBLE,2025-01-31,2025-02-19,2025-01-31,2025-02-19,15,34.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE02-0197,607,Treatment B,2,Pruritus,Skin and subcutaneous tissue disorders,MODERATE,N,POSSIBLE,2025-01-18,,2025-01-18,,2,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE03-0198,608,Treatment B,2,Insomnia,Nervous system disorders,MILD,N,POSSIBLE,2025-06-02,2025-06-09,2025-06-02,2025-06-09,18,25.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE03-0198,609,Treatment B,2,Dizziness,Nervous system disorders,MODERATE,N,POSSIBLE,2025-06-10,2025-06-15,2025-06-10,2025-06-15,26,31.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE03-0198,610,Treatment B,2,Constipation,Gastrointestinal disorders,MILD,N,POSSIBLE,2025-06-11,2025-06-16,2025-06-11,2025-06-16,27,32.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE03-0198,611,Treatment B,2,Diarrhea,Gastrointestinal disorders,MODERATE,N,PROBABLE,2025-06-04,2025-06-10,2025-06-04,2025-06-10,20,26.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE03-0198,612,Treatment B,2,Dizziness,Nervous system disorders,MODERATE,N,POSSIBLE,2025-05-28,2025-06-06,2025-05-28,2025-06-06,13,22.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE04-0199,613,Treatment B,2,Fatigue,General disorders and administration site conditions,MILD,N,POSSIBLE,2025-03-31,2025-04-09,2025-03-31,2025-04-09,45,54.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0199,614,Treatment B,2,Insomnia,Nervous system disorders,MODERATE,N,POSSIBLE,2025-02-27,2025-03-06,2025-02-27,2025-03-06,13,20.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0200,615,Treatment B,2,Tachycardia,Cardiac disorders,MILD,N,POSSIBLE,2025-04-24,2025-05-06,2025-04-24,2025-05-06,8,20.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0200,616,Treatment B,2,Insomnia,Nervous system disorders,SEVERE,N,PROBABLE,2025-05-07,2025-05-08,2025-05-07,2025-05-08,21,22.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0202,617,Treatment B,2,Back pain,Musculoskeletal and connective tissue disorders,MILD,N,VERY LIKELY,2025-05-08,2025-05-09,2025-05-08,2025-05-09,10,11.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0202,618,Treatment B,2,Muscle pain,Musculoskeletal and connective tissue disorders,MILD,N,POSSIBLE,2025-05-08,2025-05-18,2025-05-08,2025-05-18,10,20.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0203,619,Treatment B,2,Dizziness,Nervous system disorders,MILD,Y,VERY LIKELY,2025-07-11,2025-07-15,2025-07-11,2025-07-15,15,19.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0204,620,Treatment A,1,Abdominal pain,Gastrointestinal disorders,MILD,Y,UNLIKELY,2025-02-25,2025-03-11,2025-02-25,2025-03-11,17,31.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0204,621,Treatment A,1,Back pain,Musculoskeletal and connective tissue disorders,MODERATE,N,PROBABLE,2025-02-10,,2025-02-10,,2,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0204,622,Treatment A,1,Abdominal pain,Gastrointestinal disorders,MODERATE,Y,UNLIKELY,2025-02-10,,2025-02-10,,2,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0204,623,Treatment A,1,Abdominal pain,Gastrointestinal disorders,MODERATE,N,UNLIKELY,2025-02-16,2025-02-22,2025-02-16,2025-02-22,8,14.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0204,624,Treatment A,1,Rash,Skin and subcutaneous tissue disorders,MILD,N,VERY LIKELY,2025-03-18,2025-03-23,2025-03-18,2025-03-23,38,43.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0204,625,Treatment A,1,Constipation,Gastrointestinal disorders,SEVERE,N,POSSIBLE,2025-03-20,2025-03-22,2025-03-20,2025-03-22,40,42.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0204,626,Treatment A,1,Back pain,Musculoskeletal and connective tissue disorders,MILD,N,PROBABLE,2025-03-04,,2025-03-04,,24,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0205,627,Treatment A,1,Vomiting,Gastrointestinal disorders,MILD,N,PROBABLE,2025-03-05,2025-03-18,2025-03-05,2025-03-18,49,62.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0205,628,Treatment A,1,Insomnia,Nervous system disorders,MODERATE,Y,POSSIBLE,2025-02-11,2025-02-17,2025-02-11,2025-02-17,27,33.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0205,629,Treatment A,1,Fatigue,General disorders and administration site conditions,MILD,N,UNLIKELY,2025-02-01,2025-02-03,2025-02-01,2025-02-03,17,19.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0205,630,Treatment A,1,Muscle pain,Musculoskeletal and connective tissue disorders,SEVERE,N,POSSIBLE,2025-02-07,2025-02-08,2025-02-07,2025-02-08,23,24.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0206,631,Treatment B,2,Nausea,Gastrointestinal disorders,MODERATE,N,PROBABLE,2025-05-25,2025-06-09,2025-05-25,2025-06-09,48,63.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE01-0206,632,Treatment B,2,Back pain,Musculoskeletal and connective tissue disorders,MODERATE,N,UNLIKELY,2025-04-24,,2025-04-24,,17,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE02-0207,633,Treatment A,1,Dizziness,Nervous system disorders,MILD,N,POSSIBLE,2025-07-30,2025-08-10,2025-07-30,2025-08-10,35,46.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0208,634,Treatment A,1,Diarrhea,Gastrointestinal disorders,MILD,N,PROBABLE,2025-02-03,2025-02-17,2025-02-03,2025-02-17,11,25.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0208,635,Treatment A,1,Rash,Skin and subcutaneous tissue disorders,MILD,N,POSSIBLE,2025-02-04,2025-02-23,2025-02-04,2025-02-23,12,31.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0208,636,Treatment A,1,Dizziness,Nervous system disorders,MODERATE,N,VERY LIKELY,2025-02-17,2025-03-03,2025-02-17,2025-03-03,25,39.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0208,637,Treatment A,1,Fever,General disorders and administration site conditions,MILD,N,POSSIBLE,2025-03-11,2025-03-28,2025-03-11,2025-03-28,47,64.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0208,638,Treatment A,1,Muscle pain,Musculoskeletal and connective tissue disorders,MODERATE,N,POSSIBLE,2025-02-17,2025-02-22,2025-02-17,2025-02-22,25,30.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0209,639,Treatment B,2,Pruritus,Skin and subcutaneous tissue disorders,MODERATE,N,UNLIKELY,2025-05-21,2025-05-27,2025-05-21,2025-05-27,23,29.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0209,640,Treatment B,2,Muscle pain,Musculoskeletal and connective tissue disorders,MODERATE,N,UNLIKELY,2025-05-29,2025-06-07,2025-05-29,2025-06-07,31,40.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0209,641,Treatment B,2,Back pain,Musculoskeletal and connective tissue disorders,MILD,N,POSSIBLE,2025-05-22,2025-05-23,2025-05-22,2025-05-23,24,25.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0209,642,Treatment B,2,Tachycardia,Cardiac disorders,MILD,N,UNLIKELY,2025-06-11,2025-06-14,2025-06-11,2025-06-14,44,47.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0209,643,Treatment B,2,Muscle pain,Musculoskeletal and connective tissue disorders,MODERATE,N,UNLIKELY,2025-05-25,,2025-05-25,,27,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0209,644,Treatment B,2,Cough,"Respiratory, thoracic and mediastinal disorders",MILD,N,POSSIBLE,2025-05-12,2025-05-28,2025-05-12,2025-05-28,14,30.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0210,645,Treatment A,1,Hypertension,Vascular disorders,MODERATE,N,PROBABLE,2025-05-09,,2025-05-09,,9,,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE05-0210,646,Treatment A,1,Tachycardia,Cardiac disorders,MODERATE,N,VERY LIKELY,2025-06-15,2025-06-22,2025-06-15,2025-06-22,46,53.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE05-0210,647,Treatment A,1,Fatigue,General disorders and administration site conditions,SEVERE,N,POSSIBLE,2025-06-17,2025-07-01,2025-06-17,2025-07-01,48,62.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE05-0210,648,Treatment A,1,Diarrhea,Gastrointestinal disorders,MODERATE,Y,PROBABLE,2025-05-15,2025-05-27,2025-05-15,2025-05-27,15,27.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE01-0211,649,Treatment B,2,Dyspnea,"Respiratory, thoracic and mediastinal disorders",SEVERE,N,POSSIBLE,2025-03-29,2025-04-13,2025-03-29,2025-04-13,19,34.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0211,650,Treatment B,2,Insomnia,Nervous system disorders,MILD,N,POSSIBLE,2025-04-15,2025-04-29,2025-04-15,2025-04-29,36,50.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0211,651,Treatment B,2,Nausea,Gastrointestinal disorders,MODERATE,N,UNLIKELY,2025-04-19,2025-04-20,2025-04-19,2025-04-20,40,41.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0211,652,Treatment B,2,Cough,"Respiratory, thoracic and mediastinal disorders",MODERATE,Y,UNLIKELY,2025-04-19,2025-04-28,2025-04-19,2025-04-28,40,49.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0211,653,Treatment B,2,Vomiting,Gastrointestinal disorders,MILD,N,UNLIKELY,2025-03-29,2025-04-12,2025-03-29,2025-04-12,19,33.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0212,654,Treatment B,2,Constipation,Gastrointestinal disorders,MILD,N,VERY LIKELY,2025-02-08,,2025-02-08,,6,,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0212,655,Treatment B,2,Hypertension,Vascular disorders,MILD,N,POSSIBLE,2025-03-14,2025-03-30,2025-03-14,2025-03-30,40,56.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0213,656,Treatment A,1,Vomiting,Gastrointestinal disorders,MILD,N,UNLIKELY,2025-07-30,2025-08-01,2025-07-30,2025-08-01,19,21.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0213,657,Treatment A,1,Constipation,Gastrointestinal disorders,MILD,Y,POSSIBLE,2025-08-03,2025-08-18,2025-08-03,2025-08-18,23,38.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0214,658,Treatment A,1,Abdominal pain,Gastrointestinal disorders,MILD,N,UNLIKELY,2025-03-01,2025-03-10,2025-03-01,2025-03-10,18,27.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0214,659,Treatment A,1,Back pain,Musculoskeletal and connective tissue disorders,MILD,N,VERY LIKELY,2025-03-02,,2025-03-02,,19,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0214,660,Treatment A,1,Tachycardia,Cardiac disorders,MILD,N,POSSIBLE,2025-03-07,2025-03-16,2025-03-07,2025-03-16,24,33.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0214,661,Treatment A,1,Constipation,Gastrointestinal disorders,MODERATE,N,PROBABLE,2025-02-23,2025-03-03,2025-02-23,2025-03-03,12,20.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0214,662,Treatment A,1,Vomiting,Gastrointestinal disorders,MODERATE,N,PROBABLE,2025-02-14,2025-03-04,2025-02-14,2025-03-04,3,21.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0215,663,Treatment B,2,Back pain,Musculoskeletal and connective tissue disorders,MILD,N,PROBABLE,2025-04-16,2025-04-21,2025-04-16,2025-04-21,9,14.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0215,664,Treatment B,2,Constipation,Gastrointestinal disorders,MODERATE,N,POSSIBLE,2025-05-05,2025-05-06,2025-05-05,2025-05-06,28,29.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0217,665,Placebo,3,Tachycardia,Cardiac disorders,MILD,N,PROBABLE,2025-07-10,2025-07-28,2025-07-10,2025-07-28,7,25.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0217,666,Placebo,3,Headache,Nervous system disorders,MILD,N,PROBABLE,2025-07-28,,2025-07-28,,25,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0217,667,Placebo,3,Muscle pain,Musculoskeletal and connective tissue disorders,MILD,N,PROBABLE,2025-07-15,,2025-07-15,,12,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0218,668,Treatment A,1,Rash,Skin and subcutaneous tissue disorders,MILD,N,PROBABLE,2025-05-24,2025-06-02,2025-05-24,2025-06-02,42,51.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE04-0219,669,Placebo,3,Fever,General disorders and administration site conditions,MODERATE,N,UNLIKELY,2025-03-20,2025-04-03,2025-03-20,2025-04-03,18,32.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0219,670,Placebo,3,Pruritus,Skin and subcutaneous tissue disorders,MILD,N,POSSIBLE,2025-04-03,2025-04-20,2025-04-03,2025-04-20,32,49.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0219,671,Placebo,3,Diarrhea,Gastrointestinal disorders,MODERATE,N,POSSIBLE,2025-03-10,2025-03-19,2025-03-10,2025-03-19,8,17.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0219,672,Placebo,3,Hypertension,Vascular disorders,MILD,N,VERY LIKELY,2025-04-16,,2025-04-16,,45,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0219,673,Placebo,3,Dyspnea,"Respiratory, thoracic and mediastinal disorders",MILD,N,UNLIKELY,2025-04-12,2025-04-29,2025-04-12,2025-04-29,41,58.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0220,674,Placebo,3,Headache,Nervous system disorders,MILD,N,PROBABLE,2025-05-15,2025-05-17,2025-05-15,2025-05-17,33,35.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0220,675,Placebo,3,Tachycardia,Cardiac disorders,MILD,N,POSSIBLE,2025-05-30,2025-06-08,2025-05-30,2025-06-08,48,57.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0220,676,Placebo,3,Dizziness,Nervous system disorders,MILD,N,UNLIKELY,2025-06-01,2025-06-02,2025-06-01,2025-06-02,50,51.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0220,677,Placebo,3,Muscle pain,Musculoskeletal and connective tissue disorders,MILD,N,PROBABLE,2025-05-23,2025-05-27,2025-05-23,2025-05-27,41,45.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0221,678,Treatment A,1,Fatigue,General disorders and administration site conditions,MILD,N,PROBABLE,2025-06-01,2025-06-02,2025-06-01,2025-06-02,41,42.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE01-0221,679,Treatment A,1,Diarrhea,Gastrointestinal disorders,MILD,N,POSSIBLE,2025-06-02,2025-06-21,2025-06-02,2025-06-21,42,61.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE02-0222,680,Treatment B,2,Abdominal pain,Gastrointestinal disorders,MILD,N,PROBABLE,2025-05-01,2025-05-11,2025-05-01,2025-05-11,33,43.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0222,681,Treatment B,2,Tachycardia,Cardiac disorders,MILD,N,VERY LIKELY,2025-05-10,2025-05-27,2025-05-10,2025-05-27,42,59.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0222,682,Treatment B,2,Nausea,Gastrointestinal disorders,MILD,N,PROBABLE,2025-04-10,2025-04-23,2025-04-10,2025-04-23,12,25.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0222,683,Treatment B,2,Back pain,Musculoskeletal and connective tissue disorders,MILD,N,POSSIBLE,2025-03-31,2025-04-04,2025-03-31,2025-04-04,2,6.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0222,684,Treatment B,2,Diarrhea,Gastrointestinal disorders,MILD,N,POSSIBLE,2025-05-04,,2025-05-04,,36,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0222,685,Treatment B,2,Pruritus,Skin and subcutaneous tissue disorders,MILD,N,VERY LIKELY,2025-05-08,2025-05-10,2025-05-08,2025-05-10,40,42.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0223,686,Treatment A,1,Cough,"Respiratory, thoracic and mediastinal disorders",MODERATE,N,POSSIBLE,2025-05-08,,2025-05-08,,39,,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0223,687,Treatment A,1,Fever,General disorders and administration site conditions,MILD,N,PROBABLE,2025-04-25,,2025-04-25,,26,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0223,688,Treatment A,1,Nausea,Gastrointestinal disorders,MILD,N,UNLIKELY,2025-05-16,2025-05-21,2025-05-16,2025-05-21,47,52.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0223,689,Treatment A,1,Insomnia,Nervous system disorders,SEVERE,N,UNLIKELY,2025-04-08,2025-04-23,2025-04-08,2025-04-23,9,24.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0224,690,Treatment B,2,Tachycardia,Cardiac disorders,SEVERE,N,PROBABLE,2025-05-23,2025-06-09,2025-05-23,2025-06-09,28,45.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0224,691,Treatment B,2,Pruritus,Skin and subcutaneous tissue disorders,SEVERE,N,UNLIKELY,2025-05-04,2025-05-20,2025-05-04,2025-05-20,9,25.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0224,692,Treatment B,2,Rash,Skin and subcutaneous tissue disorders,MODERATE,N,POSSIBLE,2025-04-29,2025-05-16,2025-04-29,2025-05-16,4,21.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0224,693,Treatment B,2,Dizziness,Nervous system disorders,MILD,N,POSSIBLE,2025-06-06,2025-06-23,2025-06-06,2025-06-23,42,59.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0224,694,Treatment B,2,Back pain,Musculoskeletal and connective tissue disorders,MODERATE,N,PROBABLE,2025-05-05,2025-05-13,2025-05-05,2025-05-13,10,18.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0225,695,Treatment B,2,Hypertension,Vascular disorders,MILD,Y,VERY LIKELY,2025-02-21,2025-03-01,2025-02-21,2025-03-01,36,44.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0225,696,Treatment B,2,Fever,General disorders and administration site conditions,MILD,N,POSSIBLE,2025-02-04,,2025-02-04,,19,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0225,697,Treatment B,2,Rash,Skin and subcutaneous tissue disorders,MODERATE,Y,PROBABLE,2025-02-24,2025-03-05,2025-02-24,2025-03-05,39,48.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0226,698,Treatment A,1,Muscle pain,Musculoskeletal and connective tissue disorders,MILD,N,POSSIBLE,2025-03-11,,2025-03-11,,20,,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0227,699,Placebo,3,Fatigue,General disorders and administration site conditions,MILD,N,VERY LIKELY,2025-06-02,2025-06-15,2025-06-02,2025-06-15,32,45.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0227,700,Placebo,3,Cough,"Respiratory, thoracic and mediastinal disorders",MODERATE,N,POSSIBLE,2025-06-03,,2025-06-03,,33,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0228,701,Treatment A,1,Vomiting,Gastrointestinal disorders,MILD,N,POSSIBLE,2025-02-12,2025-02-15,2025-02-12,2025-02-15,9,12.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0228,702,Treatment A,1,Fever,General disorders and administration site conditions,MILD,N,POSSIBLE,2025-03-15,,2025-03-15,,40,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0228,703,Treatment A,1,Dizziness,Nervous system disorders,MILD,N,POSSIBLE,2025-02-06,,2025-02-06,,3,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0228,704,Treatment A,1,Fever,General disorders and administration site conditions,MILD,N,VERY LIKELY,2025-03-08,,2025-03-08,,33,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0229,705,Treatment A,1,Hypertension,Vascular disorders,MILD,Y,PROBABLE,2025-04-01,,2025-04-01,,26,,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE04-0229,706,Treatment A,1,Dyspnea,"Respiratory, thoracic and mediastinal disorders",MILD,N,POSSIBLE,2025-03-29,2025-04-14,2025-03-29,2025-04-14,23,39.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE04-0229,707,Treatment A,1,Rash,Skin and subcutaneous tissue disorders,MILD,N,VERY LIKELY,2025-03-09,2025-03-20,2025-03-09,2025-03-20,3,14.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE05-0230,708,Treatment B,2,Hypertension,Vascular disorders,MODERATE,N,VERY LIKELY,2025-08-01,2025-08-11,2025-08-01,2025-08-11,23,33.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0230,709,Treatment B,2,Fever,General disorders and administration site conditions,MILD,N,POSSIBLE,2025-07-17,2025-07-31,2025-07-17,2025-07-31,8,22.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0230,710,Treatment B,2,Tremor,Nervous system disorders,MODERATE,N,POSSIBLE,2025-07-27,2025-08-05,2025-07-27,2025-08-05,18,27.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0230,711,Treatment B,2,Vomiting,Gastrointestinal disorders,MILD,N,UNLIKELY,2025-08-27,2025-09-15,2025-08-27,2025-09-15,49,68.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0231,712,Treatment B,2,Back pain,Musculoskeletal and connective tissue disorders,MILD,N,POSSIBLE,2025-05-07,2025-05-17,2025-05-07,2025-05-17,40,50.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0231,713,Treatment B,2,Nausea,Gastrointestinal disorders,MILD,N,PROBABLE,2025-03-31,2025-04-14,2025-03-31,2025-04-14,3,17.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0231,714,Treatment B,2,Dizziness,Nervous system disorders,MILD,Y,VERY LIKELY,2025-04-24,2025-05-01,2025-04-24,2025-05-01,27,34.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0231,715,Treatment B,2,Muscle pain,Musculoskeletal and connective tissue disorders,MODERATE,Y,POSSIBLE,2025-05-02,,2025-05-02,,35,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0232,716,Placebo,3,Muscle pain,Musculoskeletal and connective tissue disorders,MILD,Y,PROBABLE,2025-06-06,2025-06-16,2025-06-06,2025-06-16,26,36.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0232,717,Placebo,3,Tremor,Nervous system disorders,MILD,N,UNLIKELY,2025-06-05,2025-06-10,2025-06-05,2025-06-10,25,30.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0233,718,Treatment A,1,Pruritus,Skin and subcutaneous tissue disorders,MILD,N,UNLIKELY,2025-06-21,2025-06-29,2025-06-21,2025-06-29,18,26.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0233,719,Treatment A,1,Tachycardia,Cardiac disorders,MODERATE,N,POSSIBLE,2025-06-10,2025-06-20,2025-06-10,2025-06-20,7,17.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0233,720,Treatment A,1,Tremor,Nervous system disorders,MILD,N,UNLIKELY,2025-07-03,2025-07-20,2025-07-03,2025-07-20,30,47.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0233,721,Treatment A,1,Muscle pain,Musculoskeletal and connective tissue disorders,SEVERE,N,POSSIBLE,2025-07-14,2025-07-19,2025-07-14,2025-07-19,41,46.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0234,722,Treatment B,2,Rash,Skin and subcutaneous tissue disorders,MILD,N,PROBABLE,2025-04-10,2025-04-12,2025-04-10,2025-04-12,38,40.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0234,723,Treatment B,2,Fatigue,General disorders and administration site conditions,MODERATE,N,PROBABLE,2025-03-13,,2025-03-13,,10,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0234,724,Treatment B,2,Tremor,Nervous system disorders,MILD,N,PROBABLE,2025-03-26,2025-04-02,2025-03-26,2025-04-02,23,30.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0236,725,Placebo,3,Abdominal pain,Gastrointestinal disorders,MILD,N,PROBABLE,2025-08-07,2025-08-12,2025-08-07,2025-08-12,45,50.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0236,726,Placebo,3,Pruritus,Skin and subcutaneous tissue disorders,MODERATE,N,PROBABLE,2025-07-26,2025-08-04,2025-07-26,2025-08-04,33,42.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0236,727,Placebo,3,Cough,"Respiratory, thoracic and mediastinal disorders",MILD,Y,UNLIKELY,2025-07-20,,2025-07-20,,27,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0236,728,Placebo,3,Fever,General disorders and administration site conditions,SEVERE,N,POSSIBLE,2025-06-27,2025-07-05,2025-06-27,2025-07-05,4,12.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0236,729,Placebo,3,Nausea,Gastrointestinal disorders,MILD,N,POSSIBLE,2025-08-03,2025-08-10,2025-08-03,2025-08-10,41,48.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0236,730,Placebo,3,Hypertension,Vascular disorders,SEVERE,N,POSSIBLE,2025-06-26,2025-07-07,2025-06-26,2025-07-07,3,14.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0237,731,Treatment A,1,Tachycardia,Cardiac disorders,SEVERE,N,PROBABLE,2025-02-16,,2025-02-16,,23,,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0237,732,Treatment A,1,Hypertension,Vascular disorders,MODERATE,N,UNLIKELY,2025-02-12,2025-02-24,2025-02-12,2025-02-24,19,31.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0238,733,Treatment B,2,Muscle pain,Musculoskeletal and connective tissue disorders,MILD,N,POSSIBLE,2025-06-13,2025-06-25,2025-06-13,2025-06-25,5,17.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0238,734,Treatment B,2,Tachycardia,Cardiac disorders,MODERATE,N,UNLIKELY,2025-06-28,2025-07-17,2025-06-28,2025-07-17,20,39.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0238,735,Treatment B,2,Cough,"Respiratory, thoracic and mediastinal disorders",MILD,Y,UNLIKELY,2025-07-23,2025-08-01,2025-07-23,2025-08-01,45,54.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0238,736,Treatment B,2,Tremor,Nervous system disorders,MODERATE,N,POSSIBLE,2025-07-02,2025-07-07,2025-07-02,2025-07-07,24,29.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0239,737,Treatment A,1,Back pain,Musculoskeletal and connective tissue disorders,MODERATE,N,PROBABLE,2025-02-21,2025-03-11,2025-02-21,2025-03-11,15,33.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE05-0240,738,Treatment A,1,Cough,"Respiratory, thoracic and mediastinal disorders",MILD,N,PROBABLE,2025-05-04,2025-05-07,2025-05-04,2025-05-07,14,17.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0240,739,Treatment A,1,Constipation,Gastrointestinal disorders,MODERATE,N,VERY LIKELY,2025-05-31,2025-06-13,2025-05-31,2025-06-13,41,54.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0240,740,Treatment A,1,Tremor,Nervous system disorders,MILD,N,POSSIBLE,2025-06-06,2025-06-09,2025-06-06,2025-06-09,47,50.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0240,741,Treatment A,1,Fever,General disorders and administration site conditions,SEVERE,N,POSSIBLE,2025-06-03,2025-06-22,2025-06-03,2025-06-22,44,63.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0241,742,Treatment A,1,Tachycardia,Cardiac disorders,MILD,N,VERY LIKELY,2025-02-01,2025-02-18,2025-02-01,2025-02-18,6,23.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0241,743,Treatment A,1,Pruritus,Skin and subcutaneous tissue disorders,MILD,N,POSSIBLE,2025-02-15,2025-03-01,2025-02-15,2025-03-01,20,34.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0241,744,Treatment A,1,Dizziness,Nervous system disorders,MODERATE,N,POSSIBLE,2025-02-02,2025-02-06,2025-02-02,2025-02-06,7,11.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0241,745,Treatment A,1,Rash,Skin and subcutaneous tissue disorders,MODERATE,N,UNLIKELY,2025-02-02,,2025-02-02,,7,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0241,746,Treatment A,1,Constipation,Gastrointestinal disorders,MODERATE,N,POSSIBLE,2025-03-15,2025-03-26,2025-03-15,2025-03-26,48,59.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0242,747,Treatment B,2,Hypertension,Vascular disorders,MILD,N,UNLIKELY,2025-04-06,2025-04-24,2025-04-06,2025-04-24,16,34.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0242,748,Treatment B,2,Dizziness,Nervous system disorders,MILD,N,PROBABLE,2025-05-10,2025-05-17,2025-05-10,2025-05-17,50,57.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0242,749,Treatment B,2,Tachycardia,Cardiac disorders,MILD,Y,POSSIBLE,2025-05-05,2025-05-19,2025-05-05,2025-05-19,45,59.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0242,750,Treatment B,2,Abdominal pain,Gastrointestinal disorders,MILD,N,PROBABLE,2025-04-11,2025-04-13,2025-04-11,2025-04-13,21,23.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0242,751,Treatment B,2,Vomiting,Gastrointestinal disorders,MILD,N,UNLIKELY,2025-05-02,2025-05-20,2025-05-02,2025-05-20,42,60.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0242,752,Treatment B,2,Cough,"Respiratory, thoracic and mediastinal disorders",MILD,N,POSSIBLE,2025-04-01,2025-04-07,2025-04-01,2025-04-07,11,17.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0243,753,Placebo,3,Fever,General disorders and administration site conditions,MILD,N,POSSIBLE,2025-02-10,,2025-02-10,,26,,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0244,754,Placebo,3,Muscle pain,Musculoskeletal and connective tissue disorders,MILD,N,PROBABLE,2025-04-16,2025-04-19,2025-04-16,2025-04-19,16,19.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0245,755,Treatment B,2,Constipation,Gastrointestinal disorders,MILD,N,VERY LIKELY,2025-06-10,2025-06-24,2025-06-10,2025-06-24,4,18.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0245,756,Treatment B,2,Fever,General disorders and administration site conditions,MILD,N,PROBABLE,2025-06-10,2025-06-16,2025-06-10,2025-06-16,4,10.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0245,757,Treatment B,2,Diarrhea,Gastrointestinal disorders,MILD,N,UNLIKELY,2025-07-12,2025-07-22,2025-07-12,2025-07-22,36,46.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0245,758,Treatment B,2,Headache,Nervous system disorders,SEVERE,N,VERY LIKELY,2025-07-13,2025-07-26,2025-07-13,2025-07-26,37,50.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0246,759,Treatment A,1,Tachycardia,Cardiac disorders,MODERATE,N,POSSIBLE,2025-05-19,,2025-05-19,,22,,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0246,760,Treatment A,1,Nausea,Gastrointestinal disorders,MILD,N,POSSIBLE,2025-05-09,2025-05-19,2025-05-09,2025-05-19,12,22.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0246,761,Treatment A,1,Diarrhea,Gastrointestinal disorders,MILD,N,PROBABLE,2025-05-21,2025-06-09,2025-05-21,2025-06-09,24,43.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0247,762,Treatment B,2,Pruritus,Skin and subcutaneous tissue disorders,MILD,N,VERY LIKELY,2025-05-22,2025-06-08,2025-05-22,2025-06-08,45,62.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0247,763,Treatment B,2,Dizziness,Nervous system disorders,MILD,N,PROBABLE,2025-05-26,2025-06-12,2025-05-26,2025-06-12,49,66.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0248,764,Treatment A,1,Fever,General disorders and administration site conditions,MODERATE,N,POSSIBLE,2025-06-06,2025-06-17,2025-06-06,2025-06-17,2,13.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0248,765,Treatment A,1,Cough,"Respiratory, thoracic and mediastinal disorders",MILD,N,PROBABLE,2025-06-14,2025-06-22,2025-06-14,2025-06-22,10,18.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0249,766,Treatment A,1,Dizziness,Nervous system disorders,MODERATE,N,PROBABLE,2025-05-06,2025-05-24,2025-05-06,2025-05-24,38,56.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0249,767,Treatment A,1,Back pain,Musculoskeletal and connective tissue disorders,MODERATE,N,VERY LIKELY,2025-04-04,2025-04-20,2025-04-04,2025-04-20,6,22.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0249,768,Treatment A,1,Abdominal pain,Gastrointestinal disorders,MILD,N,POSSIBLE,2025-04-19,2025-04-27,2025-04-19,2025-04-27,21,29.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0249,769,Treatment A,1,Fatigue,General disorders and administration site conditions,MILD,N,POSSIBLE,2025-04-16,2025-05-05,2025-04-16,2025-05-05,18,37.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0249,770,Treatment A,1,Diarrhea,Gastrointestinal disorders,MODERATE,N,PROBABLE,2025-04-28,2025-05-01,2025-04-28,2025-05-01,30,33.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0249,771,Treatment A,1,Tachycardia,Cardiac disorders,MILD,N,PROBABLE,2025-05-16,2025-05-25,2025-05-16,2025-05-25,48,57.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0250,772,Treatment B,2,Diarrhea,Gastrointestinal disorders,SEVERE,N,VERY LIKELY,2025-05-23,2025-05-30,2025-05-23,2025-05-30,44,51.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0250,773,Treatment B,2,Vomiting,Gastrointestinal disorders,MILD,N,VERY LIKELY,2025-05-10,2025-05-27,2025-05-10,2025-05-27,31,48.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0251,774,Treatment B,2,Dizziness,Nervous system disorders,MODERATE,N,UNLIKELY,2025-08-19,2025-09-01,2025-08-19,2025-09-01,45,58.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0251,775,Treatment B,2,Fatigue,General disorders and administration site conditions,MILD,N,POSSIBLE,2025-07-21,,2025-07-21,,16,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0253,776,Placebo,3,Tachycardia,Cardiac disorders,SEVERE,N,PROBABLE,2025-02-15,2025-02-24,2025-02-15,2025-02-24,23,32.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0253,777,Placebo,3,Insomnia,Nervous system disorders,MILD,N,POSSIBLE,2025-03-14,2025-04-01,2025-03-14,2025-04-01,50,68.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0253,778,Placebo,3,Tachycardia,Cardiac disorders,MILD,N,PROBABLE,2025-02-07,2025-02-12,2025-02-07,2025-02-12,15,20.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0253,779,Placebo,3,Cough,"Respiratory, thoracic and mediastinal disorders",SEVERE,N,PROBABLE,2025-03-05,2025-03-22,2025-03-05,2025-03-22,41,58.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0254,780,Treatment B,2,Rash,Skin and subcutaneous tissue disorders,SEVERE,N,UNLIKELY,2025-08-12,2025-08-15,2025-08-12,2025-08-15,42,45.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0254,781,Treatment B,2,Headache,Nervous system disorders,MODERATE,N,POSSIBLE,2025-08-19,2025-09-06,2025-08-19,2025-09-06,49,67.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0255,782,Treatment A,1,Cough,"Respiratory, thoracic and mediastinal disorders",MODERATE,N,VERY LIKELY,2025-02-20,2025-02-25,2025-02-20,2025-02-25,13,18.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0255,783,Treatment A,1,Headache,Nervous system disorders,MILD,N,PROBABLE,2025-03-22,2025-03-29,2025-03-22,2025-03-29,43,50.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0255,784,Treatment A,1,Fever,General disorders and administration site conditions,MILD,N,UNLIKELY,2025-02-16,2025-02-19,2025-02-16,2025-02-19,9,12.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0256,785,Treatment B,2,Tremor,Nervous system disorders,MILD,N,UNLIKELY,2025-07-16,2025-08-03,2025-07-16,2025-08-03,38,56.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0256,786,Treatment B,2,Abdominal pain,Gastrointestinal disorders,MILD,N,UNLIKELY,2025-06-11,2025-06-15,2025-06-11,2025-06-15,3,7.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0256,787,Treatment B,2,Dizziness,Nervous system disorders,SEVERE,N,UNLIKELY,2025-07-10,2025-07-25,2025-07-10,2025-07-25,32,47.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0256,788,Treatment B,2,Fatigue,General disorders and administration site conditions,MILD,N,VERY LIKELY,2025-07-02,,2025-07-02,,24,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0256,789,Treatment B,2,Dizziness,Nervous system disorders,MILD,N,POSSIBLE,2025-06-24,2025-06-28,2025-06-24,2025-06-28,16,20.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0256,790,Treatment B,2,Diarrhea,Gastrointestinal disorders,MODERATE,N,POSSIBLE,2025-07-03,2025-07-15,2025-07-03,2025-07-15,25,37.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0257,791,Treatment A,1,Nausea,Gastrointestinal disorders,MILD,N,PROBABLE,2025-03-15,2025-03-24,2025-03-15,2025-03-24,30,39.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0257,792,Treatment A,1,Back pain,Musculoskeletal and connective tissue disorders,SEVERE,N,POSSIBLE,2025-03-04,2025-03-23,2025-03-04,2025-03-23,19,38.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0257,793,Treatment A,1,Rash,Skin and subcutaneous tissue disorders,SEVERE,N,VERY LIKELY,2025-03-20,2025-04-07,2025-03-20,2025-04-07,35,53.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0257,794,Treatment A,1,Tremor,Nervous system disorders,MILD,N,VERY LIKELY,2025-03-18,2025-04-01,2025-03-18,2025-04-01,33,47.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0258,795,Treatment B,2,Vomiting,Gastrointestinal disorders,MILD,N,PROBABLE,2025-05-05,2025-05-15,2025-05-05,2025-05-15,29,39.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0258,796,Treatment B,2,Cough,"Respiratory, thoracic and mediastinal disorders",MODERATE,Y,UNLIKELY,2025-04-13,2025-04-23,2025-04-13,2025-04-23,7,17.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0259,797,Treatment A,1,Dyspnea,"Respiratory, thoracic and mediastinal disorders",MILD,N,POSSIBLE,2025-04-19,2025-04-29,2025-04-19,2025-04-29,16,26.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0259,798,Treatment A,1,Back pain,Musculoskeletal and connective tissue disorders,MILD,N,POSSIBLE,2025-04-24,2025-05-06,2025-04-24,2025-05-06,21,33.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0259,799,Treatment A,1,Tachycardia,Cardiac disorders,MILD,N,POSSIBLE,2025-05-07,2025-05-11,2025-05-07,2025-05-11,34,38.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0260,800,Treatment A,1,Headache,Nervous system disorders,MILD,N,VERY LIKELY,2025-04-17,2025-05-01,2025-04-17,2025-05-01,42,56.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0260,801,Treatment A,1,Fatigue,General disorders and administration site conditions,MODERATE,N,VERY LIKELY,2025-04-15,2025-05-01,2025-04-15,2025-05-01,40,56.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0261,802,Placebo,3,Fever,General disorders and administration site conditions,MODERATE,N,UNLIKELY,2025-05-04,2025-05-23,2025-05-04,2025-05-23,49,68.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0261,803,Placebo,3,Tremor,Nervous system disorders,MODERATE,N,POSSIBLE,2025-03-21,2025-04-02,2025-03-21,2025-04-02,5,17.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0261,804,Placebo,3,Headache,Nervous system disorders,MILD,N,VERY LIKELY,2025-04-11,2025-04-24,2025-04-11,2025-04-24,26,39.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0261,805,Placebo,3,Muscle pain,Musculoskeletal and connective tissue disorders,MODERATE,N,POSSIBLE,2025-05-04,2025-05-13,2025-05-04,2025-05-13,49,58.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0262,806,Treatment A,1,Fatigue,General disorders and administration site conditions,MILD,N,PROBABLE,2025-05-25,2025-06-13,2025-05-25,2025-06-13,2,21.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0262,807,Treatment A,1,Vomiting,Gastrointestinal disorders,SEVERE,N,VERY LIKELY,2025-05-27,,2025-05-27,,4,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0262,808,Treatment A,1,Vomiting,Gastrointestinal disorders,MODERATE,N,POSSIBLE,2025-07-02,2025-07-10,2025-07-02,2025-07-10,40,48.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0262,809,Treatment A,1,Back pain,Musculoskeletal and connective tissue disorders,MILD,N,PROBABLE,2025-06-15,2025-06-30,2025-06-15,2025-06-30,23,38.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0263,810,Treatment B,2,Insomnia,Nervous system disorders,MILD,N,PROBABLE,2025-05-02,2025-05-05,2025-05-02,2025-05-05,44,47.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0263,811,Treatment B,2,Fatigue,General disorders and administration site conditions,MODERATE,N,POSSIBLE,2025-03-26,,2025-03-26,,7,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0264,812,Placebo,3,Headache,Nervous system disorders,MILD,Y,POSSIBLE,2025-06-05,2025-06-21,2025-06-05,2025-06-21,26,42.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0264,813,Placebo,3,Cough,"Respiratory, thoracic and mediastinal disorders",MILD,Y,PROBABLE,2025-05-29,,2025-05-29,,19,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0264,814,Placebo,3,Diarrhea,Gastrointestinal disorders,MILD,N,VERY LIKELY,2025-06-08,2025-06-18,2025-06-08,2025-06-18,29,39.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0265,815,Placebo,3,Tremor,Nervous system disorders,MILD,Y,PROBABLE,2025-08-01,2025-08-18,2025-08-01,2025-08-18,20,37.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0266,816,Treatment A,1,Back pain,Musculoskeletal and connective tissue disorders,MILD,N,PROBABLE,2025-05-17,2025-05-26,2025-05-17,2025-05-26,27,36.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0266,817,Treatment A,1,Headache,Nervous system disorders,MILD,N,PROBABLE,2025-05-08,2025-05-10,2025-05-08,2025-05-10,18,20.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0266,818,Treatment A,1,Nausea,Gastrointestinal disorders,MILD,N,VERY LIKELY,2025-05-17,2025-05-26,2025-05-17,2025-05-26,27,36.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0266,819,Treatment A,1,Vomiting,Gastrointestinal disorders,MODERATE,N,PROBABLE,2025-06-04,2025-06-11,2025-06-04,2025-06-11,45,52.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0266,820,Treatment A,1,Tachycardia,Cardiac disorders,MILD,N,UNLIKELY,2025-05-11,2025-05-26,2025-05-11,2025-05-26,21,36.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0266,821,Treatment A,1,Nausea,Gastrointestinal disorders,SEVERE,N,POSSIBLE,2025-05-04,2025-05-18,2025-05-04,2025-05-18,14,28.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0267,822,Placebo,3,Nausea,Gastrointestinal disorders,MILD,N,UNLIKELY,2025-03-23,2025-04-02,2025-03-23,2025-04-02,35,45.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0267,823,Placebo,3,Hypertension,Vascular disorders,MODERATE,N,PROBABLE,2025-03-16,2025-04-03,2025-03-16,2025-04-03,28,46.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0267,824,Placebo,3,Tachycardia,Cardiac disorders,MILD,N,PROBABLE,2025-02-21,2025-03-12,2025-02-21,2025-03-12,5,24.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0268,825,Treatment A,1,Fever,General disorders and administration site conditions,MILD,N,UNLIKELY,2025-08-01,2025-08-02,2025-08-01,2025-08-02,40,41.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0268,826,Treatment A,1,Vomiting,Gastrointestinal disorders,MILD,N,POSSIBLE,2025-07-02,2025-07-15,2025-07-02,2025-07-15,10,23.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0268,827,Treatment A,1,Pruritus,Skin and subcutaneous tissue disorders,MILD,N,PROBABLE,2025-07-01,,2025-07-01,,9,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0269,828,Treatment A,1,Fever,General disorders and administration site conditions,MILD,Y,VERY LIKELY,2025-03-08,2025-03-17,2025-03-08,2025-03-17,11,20.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0269,829,Treatment A,1,Dyspnea,"Respiratory, thoracic and mediastinal disorders",MODERATE,N,VERY LIKELY,2025-03-18,2025-03-30,2025-03-18,2025-03-30,21,33.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0269,830,Treatment A,1,Insomnia,Nervous system disorders,MODERATE,N,UNLIKELY,2025-04-12,,2025-04-12,,46,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0269,831,Treatment A,1,Fever,General disorders and administration site conditions,MILD,N,PROBABLE,2025-03-09,2025-03-23,2025-03-09,2025-03-23,12,26.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0270,832,Treatment B,2,Dizziness,Nervous system disorders,MILD,N,UNLIKELY,2025-03-18,2025-03-26,2025-03-18,2025-03-26,36,44.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0270,833,Treatment B,2,Cough,"Respiratory, thoracic and mediastinal disorders",MILD,N,POSSIBLE,2025-03-19,,2025-03-19,,37,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0270,834,Treatment B,2,Rash,Skin and subcutaneous tissue disorders,MILD,N,PROBABLE,2025-03-30,,2025-03-30,,48,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0270,835,Treatment B,2,Tremor,Nervous system disorders,MODERATE,N,PROBABLE,2025-03-22,2025-03-30,2025-03-22,2025-03-30,40,48.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0271,836,Treatment B,2,Tachycardia,Cardiac disorders,MILD,N,VERY LIKELY,2025-04-08,,2025-04-08,,21,,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0271,837,Treatment B,2,Back pain,Musculoskeletal and connective tissue disorders,MODERATE,N,PROBABLE,2025-04-03,2025-04-04,2025-04-03,2025-04-04,16,17.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0271,838,Treatment B,2,Nausea,Gastrointestinal disorders,SEVERE,N,UNLIKELY,2025-04-20,2025-05-06,2025-04-20,2025-05-06,33,49.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0271,839,Treatment B,2,Fatigue,General disorders and administration site conditions,MILD,N,POSSIBLE,2025-05-07,,2025-05-07,,50,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0272,840,Treatment A,1,Insomnia,Nervous system disorders,MILD,N,PROBABLE,2025-04-17,,2025-04-17,,45,,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0273,841,Treatment B,2,Insomnia,Nervous system disorders,MILD,N,VERY LIKELY,2025-05-25,2025-06-05,2025-05-25,2025-06-05,18,29.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0273,842,Treatment B,2,Tremor,Nervous system disorders,MODERATE,N,PROBABLE,2025-06-14,2025-06-19,2025-06-14,2025-06-19,38,43.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0273,843,Treatment B,2,Muscle pain,Musculoskeletal and connective tissue disorders,MODERATE,N,VERY LIKELY,2025-05-20,,2025-05-20,,13,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0273,844,Treatment B,2,Rash,Skin and subcutaneous tissue disorders,MILD,N,PROBABLE,2025-06-25,2025-07-08,2025-06-25,2025-07-08,49,62.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0274,845,Treatment B,2,Fever,General disorders and administration site conditions,MILD,N,POSSIBLE,2025-02-02,2025-02-18,2025-02-02,2025-02-18,9,25.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0275,846,Treatment A,1,Vomiting,Gastrointestinal disorders,MILD,N,UNLIKELY,2025-04-24,2025-05-05,2025-04-24,2025-05-05,42,53.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0275,847,Treatment A,1,Cough,"Respiratory, thoracic and mediastinal disorders",MODERATE,N,POSSIBLE,2025-04-29,2025-05-01,2025-04-29,2025-05-01,47,49.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0275,848,Treatment A,1,Abdominal pain,Gastrointestinal disorders,MILD,N,UNLIKELY,2025-04-10,2025-04-22,2025-04-10,2025-04-22,28,40.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0275,849,Treatment A,1,Cough,"Respiratory, thoracic and mediastinal disorders",MILD,N,PROBABLE,2025-04-07,2025-04-26,2025-04-07,2025-04-26,25,44.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0275,850,Treatment A,1,Pruritus,Skin and subcutaneous tissue disorders,MODERATE,N,PROBABLE,2025-03-31,2025-04-08,2025-03-31,2025-04-08,18,26.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0275,851,Treatment A,1,Constipation,Gastrointestinal disorders,MILD,N,UNLIKELY,2025-04-04,,2025-04-04,,22,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0276,852,Treatment A,1,Nausea,Gastrointestinal disorders,MILD,Y,VERY LIKELY,2025-07-20,2025-07-27,2025-07-20,2025-07-27,14,21.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0277,853,Placebo,3,Constipation,Gastrointestinal disorders,MILD,N,PROBABLE,2025-03-08,,2025-03-08,,42,,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0277,854,Placebo,3,Fever,General disorders and administration site conditions,MODERATE,N,POSSIBLE,2025-02-21,,2025-02-21,,27,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0278,855,Treatment B,2,Diarrhea,Gastrointestinal disorders,MODERATE,Y,PROBABLE,2025-06-17,,2025-06-17,,4,,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE03-0278,856,Treatment B,2,Headache,Nervous system disorders,MILD,N,POSSIBLE,2025-07-28,2025-07-30,2025-07-28,2025-07-30,45,47.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE03-0278,857,Treatment B,2,Vomiting,Gastrointestinal disorders,MODERATE,N,POSSIBLE,2025-07-18,2025-07-22,2025-07-18,2025-07-22,35,39.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE03-0278,858,Treatment B,2,Dyspnea,"Respiratory, thoracic and mediastinal disorders",MODERATE,N,POSSIBLE,2025-08-01,2025-08-15,2025-08-01,2025-08-15,49,63.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE03-0278,859,Treatment B,2,Muscle pain,Musculoskeletal and connective tissue disorders,MILD,N,POSSIBLE,2025-06-25,2025-06-27,2025-06-25,2025-06-27,12,14.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE04-0279,860,Treatment A,1,Dyspnea,"Respiratory, thoracic and mediastinal disorders",MODERATE,N,VERY LIKELY,2025-05-04,2025-05-11,2025-05-04,2025-05-11,19,26.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0280,861,Treatment B,2,Insomnia,Nervous system disorders,MODERATE,N,UNLIKELY,2025-04-25,2025-05-14,2025-04-25,2025-05-14,14,33.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0280,862,Treatment B,2,Headache,Nervous system disorders,MILD,N,POSSIBLE,2025-05-03,2025-05-06,2025-05-03,2025-05-06,22,25.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0280,863,Treatment B,2,Hypertension,Vascular disorders,MILD,N,PROBABLE,2025-05-01,2025-05-19,2025-05-01,2025-05-19,20,38.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0280,864,Treatment B,2,Headache,Nervous system disorders,MODERATE,N,POSSIBLE,2025-04-26,2025-05-06,2025-04-26,2025-05-06,15,25.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0281,865,Treatment B,2,Fever,General disorders and administration site conditions,MILD,N,POSSIBLE,2025-06-17,2025-06-27,2025-06-17,2025-06-27,37,47.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0282,866,Treatment A,1,Fatigue,General disorders and administration site conditions,SEVERE,N,PROBABLE,2025-07-20,2025-07-21,2025-07-20,2025-07-21,44,45.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0282,867,Treatment A,1,Diarrhea,Gastrointestinal disorders,MILD,Y,UNLIKELY,2025-07-20,2025-07-30,2025-07-20,2025-07-30,44,54.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0282,868,Treatment A,1,Abdominal pain,Gastrointestinal disorders,MODERATE,N,PROBABLE,2025-06-25,2025-07-12,2025-06-25,2025-07-12,19,36.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0282,869,Treatment A,1,Insomnia,Nervous system disorders,MODERATE,N,POSSIBLE,2025-07-09,2025-07-24,2025-07-09,2025-07-24,33,48.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0282,870,Treatment A,1,Hypertension,Vascular disorders,MILD,N,VERY LIKELY,2025-06-29,,2025-06-29,,23,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0282,871,Treatment A,1,Dizziness,Nervous system disorders,MILD,Y,POSSIBLE,2025-06-20,2025-07-06,2025-06-20,2025-07-06,14,30.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0283,872,Treatment A,1,Headache,Nervous system disorders,MILD,N,PROBABLE,2025-03-27,,2025-03-27,,9,,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0283,873,Treatment A,1,Headache,Nervous system disorders,MODERATE,N,POSSIBLE,2025-04-17,2025-05-04,2025-04-17,2025-05-04,30,47.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0283,874,Treatment A,1,Dyspnea,"Respiratory, thoracic and mediastinal disorders",MILD,N,UNLIKELY,2025-04-01,2025-04-09,2025-04-01,2025-04-09,14,22.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0284,875,Treatment B,2,Back pain,Musculoskeletal and connective tissue disorders,MILD,N,PROBABLE,2025-05-15,2025-06-03,2025-05-15,2025-06-03,10,29.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0284,876,Treatment B,2,Tachycardia,Cardiac disorders,MILD,N,PROBABLE,2025-05-15,2025-05-30,2025-05-15,2025-05-30,10,25.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0284,877,Treatment B,2,Diarrhea,Gastrointestinal disorders,MILD,N,POSSIBLE,2025-05-24,2025-06-10,2025-05-24,2025-06-10,19,36.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0284,878,Treatment B,2,Insomnia,Nervous system disorders,MILD,N,POSSIBLE,2025-05-18,,2025-05-18,,13,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0285,879,Placebo,3,Dizziness,Nervous system disorders,MODERATE,N,VERY LIKELY,2025-02-11,2025-02-18,2025-02-11,2025-02-18,17,24.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0285,880,Placebo,3,Headache,Nervous system disorders,MODERATE,N,PROBABLE,2025-03-07,2025-03-23,2025-03-07,2025-03-23,41,57.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0285,881,Placebo,3,Muscle pain,Musculoskeletal and connective tissue disorders,MILD,N,PROBABLE,2025-01-30,2025-02-11,2025-01-30,2025-02-11,5,17.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0285,882,Placebo,3,Headache,Nervous system disorders,MILD,N,UNLIKELY,2025-01-27,2025-02-07,2025-01-27,2025-02-07,2,13.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0286,883,Placebo,3,Cough,"Respiratory, thoracic and mediastinal disorders",SEVERE,N,POSSIBLE,2025-03-27,2025-04-10,2025-03-27,2025-04-10,3,17.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0286,884,Placebo,3,Fatigue,General disorders and administration site conditions,MILD,N,VERY LIKELY,2025-05-13,,2025-05-13,,50,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0286,885,Placebo,3,Fever,General disorders and administration site conditions,MILD,N,POSSIBLE,2025-04-11,2025-04-26,2025-04-11,2025-04-26,18,33.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0287,886,Treatment B,2,Dizziness,Nervous system disorders,MODERATE,N,VERY LIKELY,2025-02-12,2025-02-28,2025-02-12,2025-02-28,6,22.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0287,887,Treatment B,2,Fever,General disorders and administration site conditions,MILD,N,VERY LIKELY,2025-02-12,,2025-02-12,,6,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0287,888,Treatment B,2,Nausea,Gastrointestinal disorders,MILD,N,POSSIBLE,2025-03-01,2025-03-02,2025-03-01,2025-03-02,23,24.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0287,889,Treatment B,2,Fever,General disorders and administration site conditions,MILD,N,UNLIKELY,2025-02-25,2025-03-04,2025-02-25,2025-03-04,19,26.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0288,890,Placebo,3,Hypertension,Vascular disorders,MILD,N,UNLIKELY,2025-03-02,,2025-03-02,,34,,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0288,891,Placebo,3,Tachycardia,Cardiac disorders,SEVERE,N,PROBABLE,2025-03-11,2025-03-19,2025-03-11,2025-03-19,43,51.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0288,892,Placebo,3,Pruritus,Skin and subcutaneous tissue disorders,MILD,N,PROBABLE,2025-03-10,,2025-03-10,,42,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0288,893,Placebo,3,Insomnia,Nervous system disorders,MILD,N,PROBABLE,2025-03-10,2025-03-26,2025-03-10,2025-03-26,42,58.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0288,894,Placebo,3,Cough,"Respiratory, thoracic and mediastinal disorders",MODERATE,N,PROBABLE,2025-02-28,2025-03-15,2025-02-28,2025-03-15,32,47.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0289,895,Treatment B,2,Headache,Nervous system disorders,MILD,N,PROBABLE,2025-02-08,2025-02-20,2025-02-08,2025-02-20,2,14.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0289,896,Treatment B,2,Insomnia,Nervous system disorders,MILD,N,UNLIKELY,2025-02-14,2025-03-03,2025-02-14,2025-03-03,8,25.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0290,897,Treatment A,1,Tachycardia,Cardiac disorders,MILD,N,UNLIKELY,2025-07-27,2025-08-08,2025-07-27,2025-08-08,43,55.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0290,898,Treatment A,1,Hypertension,Vascular disorders,MILD,N,PROBABLE,2025-08-03,,2025-08-03,,50,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0290,899,Treatment A,1,Back pain,Musculoskeletal and connective tissue disorders,MILD,N,POSSIBLE,2025-06-20,2025-07-01,2025-06-20,2025-07-01,6,17.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0290,900,Treatment A,1,Vomiting,Gastrointestinal disorders,MODERATE,N,VERY LIKELY,2025-07-06,2025-07-24,2025-07-06,2025-07-24,22,40.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0291,901,Placebo,3,Dizziness,Nervous system disorders,MILD,N,UNLIKELY,2025-02-25,,2025-02-25,,24,,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0291,902,Placebo,3,Hypertension,Vascular disorders,MODERATE,N,PROBABLE,2025-02-22,2025-02-23,2025-02-22,2025-02-23,21,22.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0292,903,Treatment A,1,Rash,Skin and subcutaneous tissue disorders,MODERATE,N,POSSIBLE,2025-04-02,2025-04-20,2025-04-02,2025-04-20,32,50.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0292,904,Treatment A,1,Insomnia,Nervous system disorders,MILD,N,POSSIBLE,2025-03-21,2025-04-08,2025-03-21,2025-04-08,20,38.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0292,905,Treatment A,1,Vomiting,Gastrointestinal disorders,MILD,Y,PROBABLE,2025-03-24,2025-03-27,2025-03-24,2025-03-27,23,26.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0293,906,Treatment B,2,Hypertension,Vascular disorders,MODERATE,N,POSSIBLE,2025-07-06,2025-07-18,2025-07-06,2025-07-18,26,38.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0293,907,Treatment B,2,Cough,"Respiratory, thoracic and mediastinal disorders",MODERATE,N,VERY LIKELY,2025-06-16,,2025-06-16,,6,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0293,908,Treatment B,2,Tachycardia,Cardiac disorders,MILD,N,POSSIBLE,2025-07-11,,2025-07-11,,31,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0293,909,Treatment B,2,Dizziness,Nervous system disorders,MILD,N,VERY LIKELY,2025-07-14,,2025-07-14,,34,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0293,910,Treatment B,2,Abdominal pain,Gastrointestinal disorders,SEVERE,N,UNLIKELY,2025-07-12,2025-07-28,2025-07-12,2025-07-28,32,48.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0294,911,Treatment B,2,Constipation,Gastrointestinal disorders,MILD,Y,POSSIBLE,2025-07-16,2025-07-21,2025-07-16,2025-07-21,46,51.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0294,912,Treatment B,2,Back pain,Musculoskeletal and connective tissue disorders,MILD,N,PROBABLE,2025-06-30,2025-07-15,2025-06-30,2025-07-15,30,45.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0295,913,Treatment B,2,Tachycardia,Cardiac disorders,MILD,N,VERY LIKELY,2025-05-09,2025-05-14,2025-05-09,2025-05-14,35,40.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0295,914,Treatment B,2,Dyspnea,"Respiratory, thoracic and mediastinal disorders",MILD,N,PROBABLE,2025-04-20,2025-04-29,2025-04-20,2025-04-29,16,25.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0295,915,Treatment B,2,Pruritus,Skin and subcutaneous tissue disorders,MILD,N,UNLIKELY,2025-05-20,,2025-05-20,,46,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0295,916,Treatment B,2,Fatigue,General disorders and administration site conditions,MODERATE,N,VERY LIKELY,2025-05-07,,2025-05-07,,33,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0296,917,Treatment B,2,Vomiting,Gastrointestinal disorders,MILD,N,PROBABLE,2025-03-08,2025-03-12,2025-03-08,2025-03-12,49,53.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0296,918,Treatment B,2,Dizziness,Nervous system disorders,MODERATE,N,POSSIBLE,2025-01-23,2025-02-03,2025-01-23,2025-02-03,5,16.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0296,919,Treatment B,2,Fatigue,General disorders and administration site conditions,MILD,N,VERY LIKELY,2025-02-12,2025-02-19,2025-02-12,2025-02-19,25,32.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0297,920,Treatment B,2,Insomnia,Nervous system disorders,SEVERE,N,POSSIBLE,2025-06-14,2025-06-18,2025-06-14,2025-06-18,23,27.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0297,921,Treatment B,2,Pruritus,Skin and subcutaneous tissue disorders,MILD,N,PROBABLE,2025-07-06,2025-07-16,2025-07-06,2025-07-16,45,55.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0297,922,Treatment B,2,Tremor,Nervous system disorders,MILD,N,POSSIBLE,2025-05-25,2025-06-07,2025-05-25,2025-06-07,3,16.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0297,923,Treatment B,2,Constipation,Gastrointestinal disorders,MILD,N,POSSIBLE,2025-06-18,2025-07-07,2025-06-18,2025-07-07,27,46.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0297,924,Treatment B,2,Back pain,Musculoskeletal and connective tissue disorders,MILD,N,PROBABLE,2025-06-23,2025-07-04,2025-06-23,2025-07-04,32,43.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0297,925,Treatment B,2,Diarrhea,Gastrointestinal disorders,MODERATE,N,POSSIBLE,2025-07-05,2025-07-10,2025-07-05,2025-07-10,44,49.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0298,926,Treatment B,2,Muscle pain,Musculoskeletal and connective tissue disorders,MODERATE,N,POSSIBLE,2025-03-26,,2025-03-26,,36,,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0298,927,Treatment B,2,Muscle pain,Musculoskeletal and connective tissue disorders,MILD,N,VERY LIKELY,2025-03-06,2025-03-10,2025-03-06,2025-03-10,16,20.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0298,928,Treatment B,2,Insomnia,Nervous system disorders,MILD,N,POSSIBLE,2025-03-06,2025-03-16,2025-03-06,2025-03-16,16,26.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0298,929,Treatment B,2,Constipation,Gastrointestinal disorders,MODERATE,N,UNLIKELY,2025-03-24,2025-04-07,2025-03-24,2025-04-07,34,48.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0298,930,Treatment B,2,Diarrhea,Gastrointestinal disorders,MILD,N,UNLIKELY,2025-04-07,2025-04-24,2025-04-07,2025-04-24,48,65.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0299,931,Treatment A,1,Abdominal pain,Gastrointestinal disorders,MODERATE,N,VERY LIKELY,2025-02-22,,2025-02-22,,26,,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0300,932,Treatment B,2,Fatigue,General disorders and administration site conditions,MODERATE,N,VERY LIKELY,2025-05-24,2025-05-27,2025-05-24,2025-05-27,24,27.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0300,933,Treatment B,2,Rash,Skin and subcutaneous tissue disorders,MILD,Y,PROBABLE,2025-06-13,2025-06-21,2025-06-13,2025-06-21,44,52.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0300,934,Treatment B,2,Constipation,Gastrointestinal disorders,MILD,Y,UNLIKELY,2025-06-16,2025-06-21,2025-06-16,2025-06-21,47,52.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0300,935,Treatment B,2,Dizziness,Nervous system disorders,MODERATE,N,POSSIBLE,2025-05-18,2025-06-06,2025-05-18,2025-06-06,18,37.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0301,936,Treatment A,1,Tachycardia,Cardiac disorders,MILD,N,PROBABLE,2025-02-02,2025-02-08,2025-02-02,2025-02-08,13,19.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0301,937,Treatment A,1,Pruritus,Skin and subcutaneous tissue disorders,MILD,N,PROBABLE,2025-02-19,2025-03-06,2025-02-19,2025-03-06,30,45.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0301,938,Treatment A,1,Dizziness,Nervous system disorders,MILD,N,PROBABLE,2025-02-11,2025-02-13,2025-02-11,2025-02-13,22,24.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0302,939,Treatment B,2,Rash,Skin and subcutaneous tissue disorders,MILD,N,POSSIBLE,2025-05-29,2025-05-30,2025-05-29,2025-05-30,8,9.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0302,940,Treatment B,2,Constipation,Gastrointestinal disorders,MODERATE,Y,POSSIBLE,2025-06-08,2025-06-14,2025-06-08,2025-06-14,18,24.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0303,941,Treatment B,2,Dizziness,Nervous system disorders,MILD,N,VERY LIKELY,2025-07-15,2025-07-25,2025-07-15,2025-07-25,18,28.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0303,942,Treatment B,2,Cough,"Respiratory, thoracic and mediastinal disorders",MILD,N,POSSIBLE,2025-07-15,2025-07-19,2025-07-15,2025-07-19,18,22.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0304,943,Treatment A,1,Back pain,Musculoskeletal and connective tissue disorders,MILD,N,POSSIBLE,2025-06-09,2025-06-28,2025-06-09,2025-06-28,20,39.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0305,944,Placebo,3,Constipation,Gastrointestinal disorders,SEVERE,N,POSSIBLE,2025-05-04,,2025-05-04,,50,,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0305,945,Placebo,3,Vomiting,Gastrointestinal disorders,MILD,N,UNLIKELY,2025-04-13,,2025-04-13,,29,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0305,946,Placebo,3,Tachycardia,Cardiac disorders,MILD,N,PROBABLE,2025-04-12,,2025-04-12,,28,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0305,947,Placebo,3,Muscle pain,Musculoskeletal and connective tissue disorders,MODERATE,N,VERY LIKELY,2025-04-12,2025-04-24,2025-04-12,2025-04-24,28,40.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0305,948,Placebo,3,Dyspnea,"Respiratory, thoracic and mediastinal disorders",MILD,N,VERY LIKELY,2025-03-31,,2025-03-31,,16,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0306,949,Treatment A,1,Insomnia,Nervous system disorders,MODERATE,N,PROBABLE,2025-05-23,2025-05-29,2025-05-23,2025-05-29,32,38.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0307,950,Treatment A,1,Tremor,Nervous system disorders,MODERATE,N,PROBABLE,2025-04-19,2025-04-29,2025-04-19,2025-04-29,22,32.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0307,951,Treatment A,1,Constipation,Gastrointestinal disorders,MILD,N,VERY LIKELY,2025-04-20,,2025-04-20,,23,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0307,952,Treatment A,1,Fatigue,General disorders and administration site conditions,MILD,N,VERY LIKELY,2025-04-25,2025-04-27,2025-04-25,2025-04-27,28,30.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0307,953,Treatment A,1,Abdominal pain,Gastrointestinal disorders,MILD,N,POSSIBLE,2025-05-14,,2025-05-14,,47,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0308,954,Treatment A,1,Rash,Skin and subcutaneous tissue disorders,MILD,N,PROBABLE,2025-04-27,2025-05-09,2025-04-27,2025-05-09,45,57.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0308,955,Treatment A,1,Fever,General disorders and administration site conditions,MILD,N,POSSIBLE,2025-04-27,2025-05-03,2025-04-27,2025-05-03,45,51.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0309,956,Treatment A,1,Dyspnea,"Respiratory, thoracic and mediastinal disorders",MILD,N,UNLIKELY,2025-03-18,2025-04-01,2025-03-18,2025-04-01,43,57.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0309,957,Treatment A,1,Nausea,Gastrointestinal disorders,MILD,N,VERY LIKELY,2025-02-27,2025-03-13,2025-02-27,2025-03-13,24,38.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0309,958,Treatment A,1,Cough,"Respiratory, thoracic and mediastinal disorders",MODERATE,N,PROBABLE,2025-03-04,2025-03-06,2025-03-04,2025-03-06,29,31.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0309,959,Treatment A,1,Tachycardia,Cardiac disorders,MILD,N,UNLIKELY,2025-02-24,,2025-02-24,,21,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0310,960,Treatment B,2,Fatigue,General disorders and administration site conditions,MILD,N,VERY LIKELY,2025-05-20,2025-05-30,2025-05-20,2025-05-30,11,21.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0311,961,Treatment B,2,Vomiting,Gastrointestinal disorders,MILD,N,UNLIKELY,2025-04-06,,2025-04-06,,17,,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE01-0311,962,Treatment B,2,Fatigue,General disorders and administration site conditions,MODERATE,N,POSSIBLE,2025-04-01,2025-04-14,2025-04-01,2025-04-14,12,25.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE03-0313,963,Treatment B,2,Rash,Skin and subcutaneous tissue disorders,MODERATE,N,POSSIBLE,2025-07-16,2025-07-18,2025-07-16,2025-07-18,32,34.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0313,964,Treatment B,2,Headache,Nervous system disorders,MILD,N,POSSIBLE,2025-06-25,2025-06-30,2025-06-25,2025-06-30,11,16.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0313,965,Treatment B,2,Hypertension,Vascular disorders,MILD,N,VERY LIKELY,2025-07-18,2025-07-19,2025-07-18,2025-07-19,34,35.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0313,966,Treatment B,2,Fever,General disorders and administration site conditions,MILD,N,VERY LIKELY,2025-07-10,,2025-07-10,,26,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0314,967,Treatment B,2,Abdominal pain,Gastrointestinal disorders,MILD,Y,POSSIBLE,2025-04-10,2025-04-23,2025-04-10,2025-04-23,45,58.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0315,968,Treatment A,1,Fever,General disorders and administration site conditions,MILD,N,POSSIBLE,2025-02-16,,2025-02-16,,7,,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0315,969,Treatment A,1,Hypertension,Vascular disorders,MILD,N,PROBABLE,2025-03-18,,2025-03-18,,37,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0315,970,Treatment A,1,Abdominal pain,Gastrointestinal disorders,MODERATE,N,UNLIKELY,2025-03-01,,2025-03-01,,20,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0316,971,Treatment B,2,Back pain,Musculoskeletal and connective tissue disorders,MILD,N,UNLIKELY,2025-08-05,2025-08-08,2025-08-05,2025-08-08,28,31.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0316,972,Treatment B,2,Back pain,Musculoskeletal and connective tissue disorders,MILD,N,PROBABLE,2025-07-13,2025-07-19,2025-07-13,2025-07-19,5,11.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0316,973,Treatment B,2,Fatigue,General disorders and administration site conditions,SEVERE,Y,POSSIBLE,2025-07-16,2025-07-26,2025-07-16,2025-07-26,8,18.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0317,974,Placebo,3,Vomiting,Gastrointestinal disorders,MODERATE,N,POSSIBLE,2025-07-12,,2025-07-12,,43,,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0317,975,Placebo,3,Abdominal pain,Gastrointestinal disorders,MODERATE,N,POSSIBLE,2025-06-23,,2025-06-23,,24,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0317,976,Placebo,3,Diarrhea,Gastrointestinal disorders,MILD,N,POSSIBLE,2025-06-23,2025-07-09,2025-06-23,2025-07-09,24,40.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0317,977,Placebo,3,Fever,General disorders and administration site conditions,SEVERE,N,VERY LIKELY,2025-07-04,2025-07-21,2025-07-04,2025-07-21,35,52.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0318,978,Placebo,3,Tremor,Nervous system disorders,MILD,N,PROBABLE,2025-03-20,2025-04-08,2025-03-20,2025-04-08,7,26.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0318,979,Placebo,3,Dyspnea,"Respiratory, thoracic and mediastinal disorders",MILD,N,POSSIBLE,2025-04-28,2025-05-09,2025-04-28,2025-05-09,46,57.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0319,980,Placebo,3,Back pain,Musculoskeletal and connective tissue disorders,MILD,Y,UNLIKELY,2025-05-25,2025-06-11,2025-05-25,2025-06-11,6,23.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0319,981,Placebo,3,Fatigue,General disorders and administration site conditions,SEVERE,N,POSSIBLE,2025-06-17,2025-06-23,2025-06-17,2025-06-23,29,35.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0319,982,Placebo,3,Headache,Nervous system disorders,MILD,N,POSSIBLE,2025-06-14,2025-07-01,2025-06-14,2025-07-01,26,43.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0319,983,Placebo,3,Diarrhea,Gastrointestinal disorders,MILD,N,PROBABLE,2025-05-21,2025-06-03,2025-05-21,2025-06-03,2,15.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0319,984,Placebo,3,Insomnia,Nervous system disorders,MODERATE,Y,POSSIBLE,2025-06-30,2025-07-02,2025-06-30,2025-07-02,42,44.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0320,985,Treatment B,2,Hypertension,Vascular disorders,MILD,N,POSSIBLE,2025-05-25,2025-05-31,2025-05-25,2025-05-31,11,17.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0320,986,Treatment B,2,Nausea,Gastrointestinal disorders,MODERATE,Y,POSSIBLE,2025-06-26,2025-06-30,2025-06-26,2025-06-30,43,47.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0320,987,Treatment B,2,Hypertension,Vascular disorders,SEVERE,N,UNLIKELY,2025-05-27,2025-06-01,2025-05-27,2025-06-01,13,18.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0321,988,Treatment A,1,Dyspnea,"Respiratory, thoracic and mediastinal disorders",MILD,N,POSSIBLE,2025-06-21,2025-06-27,2025-06-21,2025-06-27,28,34.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0321,989,Treatment A,1,Hypertension,Vascular disorders,MILD,N,UNLIKELY,2025-06-25,2025-07-01,2025-06-25,2025-07-01,32,38.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0322,990,Treatment A,1,Tremor,Nervous system disorders,SEVERE,N,POSSIBLE,2025-07-25,2025-07-28,2025-07-25,2025-07-28,13,16.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0323,991,Treatment B,2,Back pain,Musculoskeletal and connective tissue disorders,MILD,N,VERY LIKELY,2025-08-04,2025-08-23,2025-08-04,2025-08-23,27,46.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0323,992,Treatment B,2,Headache,Nervous system disorders,MILD,N,POSSIBLE,2025-07-31,2025-08-08,2025-07-31,2025-08-08,23,31.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0323,993,Treatment B,2,Dyspnea,"Respiratory, thoracic and mediastinal disorders",MILD,N,POSSIBLE,2025-07-25,,2025-07-25,,17,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0323,994,Treatment B,2,Fever,General disorders and administration site conditions,MODERATE,N,VERY LIKELY,2025-08-24,2025-09-09,2025-08-24,2025-09-09,47,63.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0324,995,Treatment B,2,Tachycardia,Cardiac disorders,MILD,N,POSSIBLE,2025-03-23,2025-03-27,2025-03-23,2025-03-27,3,7.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0325,996,Placebo,3,Fatigue,General disorders and administration site conditions,SEVERE,N,POSSIBLE,2025-06-27,2025-07-10,2025-06-27,2025-07-10,41,54.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE05-0325,997,Placebo,3,Cough,"Respiratory, thoracic and mediastinal disorders",SEVERE,N,PROBABLE,2025-06-16,2025-06-24,2025-06-16,2025-06-24,30,38.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE01-0326,998,Treatment A,1,Dizziness,Nervous system disorders,MODERATE,N,VERY LIKELY,2025-02-22,2025-02-27,2025-02-22,2025-02-27,19,24.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0326,999,Treatment A,1,Vomiting,Gastrointestinal disorders,MODERATE,N,POSSIBLE,2025-02-22,,2025-02-22,,19,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0326,1000,Treatment A,1,Dizziness,Nervous system disorders,MODERATE,N,PROBABLE,2025-02-17,,2025-02-17,,14,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0326,1001,Treatment A,1,Dizziness,Nervous system disorders,MILD,N,POSSIBLE,2025-02-06,,2025-02-06,,3,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0327,1002,Placebo,3,Hypertension,Vascular disorders,MILD,N,POSSIBLE,2025-07-20,2025-07-22,2025-07-20,2025-07-22,43,45.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0327,1003,Placebo,3,Nausea,Gastrointestinal disorders,MILD,N,VERY LIKELY,2025-07-09,2025-07-26,2025-07-09,2025-07-26,32,49.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0328,1004,Treatment A,1,Tremor,Nervous system disorders,SEVERE,N,PROBABLE,2025-03-13,2025-03-15,2025-03-13,2025-03-15,13,15.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0329,1005,Treatment B,2,Muscle pain,Musculoskeletal and connective tissue disorders,MILD,N,POSSIBLE,2025-05-08,,2025-05-08,,37,,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0329,1006,Treatment B,2,Insomnia,Nervous system disorders,MILD,N,PROBABLE,2025-05-19,2025-06-01,2025-05-19,2025-06-01,48,61.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0329,1007,Treatment B,2,Abdominal pain,Gastrointestinal disorders,MILD,N,UNLIKELY,2025-04-04,2025-04-18,2025-04-04,2025-04-18,3,17.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0329,1008,Treatment B,2,Headache,Nervous system disorders,MILD,N,POSSIBLE,2025-05-17,2025-05-23,2025-05-17,2025-05-23,46,52.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0331,1009,Placebo,3,Vomiting,Gastrointestinal disorders,MILD,N,UNLIKELY,2025-04-30,2025-05-19,2025-04-30,2025-05-19,44,63.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0331,1010,Placebo,3,Fatigue,General disorders and administration site conditions,MILD,N,PROBABLE,2025-03-23,2025-04-08,2025-03-23,2025-04-08,6,22.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0331,1011,Placebo,3,Dizziness,Nervous system disorders,MILD,N,POSSIBLE,2025-04-12,2025-04-13,2025-04-12,2025-04-13,26,27.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0331,1012,Placebo,3,Dizziness,Nervous system disorders,MILD,N,PROBABLE,2025-04-05,2025-04-17,2025-04-05,2025-04-17,19,31.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0331,1013,Placebo,3,Muscle pain,Musculoskeletal and connective tissue disorders,MILD,N,PROBABLE,2025-04-06,,2025-04-06,,20,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0331,1014,Placebo,3,Dizziness,Nervous system disorders,MILD,N,VERY LIKELY,2025-04-12,2025-04-21,2025-04-12,2025-04-21,26,35.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0332,1015,Treatment B,2,Nausea,Gastrointestinal disorders,SEVERE,N,PROBABLE,2025-05-01,2025-05-05,2025-05-01,2025-05-05,47,51.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0333,1016,Treatment B,2,Nausea,Gastrointestinal disorders,SEVERE,N,POSSIBLE,2025-04-21,2025-05-01,2025-04-21,2025-05-01,9,19.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0333,1017,Treatment B,2,Back pain,Musculoskeletal and connective tissue disorders,MODERATE,N,POSSIBLE,2025-04-22,2025-05-05,2025-04-22,2025-05-05,10,23.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0333,1018,Treatment B,2,Dizziness,Nervous system disorders,MILD,N,VERY LIKELY,2025-05-08,2025-05-15,2025-05-08,2025-05-15,26,33.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0334,1019,Placebo,3,Headache,Nervous system disorders,MODERATE,N,VERY LIKELY,2025-02-21,2025-03-10,2025-02-21,2025-03-10,31,48.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE04-0334,1020,Placebo,3,Hypertension,Vascular disorders,MILD,N,UNLIKELY,2025-02-24,2025-03-06,2025-02-24,2025-03-06,34,44.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE04-0334,1021,Placebo,3,Muscle pain,Musculoskeletal and connective tissue disorders,MILD,N,POSSIBLE,2025-02-13,,2025-02-13,,23,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE05-0335,1022,Treatment A,1,Tachycardia,Cardiac disorders,MODERATE,N,POSSIBLE,2025-02-10,,2025-02-10,,12,,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE05-0335,1023,Treatment A,1,Cough,"Respiratory, thoracic and mediastinal disorders",MODERATE,N,PROBABLE,2025-02-23,2025-02-25,2025-02-23,2025-02-25,25,27.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE01-0336,1024,Treatment B,2,Diarrhea,Gastrointestinal disorders,MODERATE,N,POSSIBLE,2025-04-16,2025-04-20,2025-04-16,2025-04-20,45,49.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0336,1025,Treatment B,2,Tremor,Nervous system disorders,MILD,N,VERY LIKELY,2025-04-01,2025-04-14,2025-04-01,2025-04-14,30,43.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0337,1026,Treatment B,2,Cough,"Respiratory, thoracic and mediastinal disorders",MODERATE,N,POSSIBLE,2025-07-15,2025-08-01,2025-07-15,2025-08-01,46,63.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0337,1027,Treatment B,2,Vomiting,Gastrointestinal disorders,MILD,N,PROBABLE,2025-07-11,2025-07-19,2025-07-11,2025-07-19,42,50.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0337,1028,Treatment B,2,Cough,"Respiratory, thoracic and mediastinal disorders",SEVERE,N,UNLIKELY,2025-06-12,,2025-06-12,,13,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0338,1029,Treatment A,1,Pruritus,Skin and subcutaneous tissue disorders,MILD,N,POSSIBLE,2025-03-05,2025-03-17,2025-03-05,2025-03-17,30,42.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0338,1030,Treatment A,1,Cough,"Respiratory, thoracic and mediastinal disorders",MILD,N,UNLIKELY,2025-02-23,2025-03-11,2025-02-23,2025-03-11,20,36.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0338,1031,Treatment A,1,Insomnia,Nervous system disorders,SEVERE,N,POSSIBLE,2025-02-28,,2025-02-28,,25,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0338,1032,Treatment A,1,Vomiting,Gastrointestinal disorders,MILD,Y,POSSIBLE,2025-03-25,2025-04-03,2025-03-25,2025-04-03,50,59.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0339,1033,Treatment B,2,Fatigue,General disorders and administration site conditions,MILD,N,POSSIBLE,2025-04-30,2025-05-02,2025-04-30,2025-05-02,15,17.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0339,1034,Treatment B,2,Pruritus,Skin and subcutaneous tissue disorders,MODERATE,N,POSSIBLE,2025-05-03,2025-05-19,2025-05-03,2025-05-19,18,34.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0339,1035,Treatment B,2,Fever,General disorders and administration site conditions,MODERATE,N,POSSIBLE,2025-04-24,2025-04-26,2025-04-24,2025-04-26,9,11.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0340,1036,Treatment B,2,Rash,Skin and subcutaneous tissue disorders,MODERATE,Y,PROBABLE,2025-01-30,2025-02-01,2025-01-30,2025-02-01,16,18.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0340,1037,Treatment B,2,Fever,General disorders and administration site conditions,SEVERE,N,UNLIKELY,2025-02-07,2025-02-08,2025-02-07,2025-02-08,24,25.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0341,1038,Treatment A,1,Hypertension,Vascular disorders,MILD,N,POSSIBLE,2025-02-22,,2025-02-22,,28,,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0341,1039,Treatment A,1,Muscle pain,Musculoskeletal and connective tissue disorders,SEVERE,N,POSSIBLE,2025-02-27,,2025-02-27,,33,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0342,1040,Treatment B,2,Nausea,Gastrointestinal disorders,MILD,Y,PROBABLE,2025-08-13,2025-08-19,2025-08-13,2025-08-19,44,50.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0342,1041,Treatment B,2,Abdominal pain,Gastrointestinal disorders,MODERATE,N,POSSIBLE,2025-07-14,2025-07-25,2025-07-14,2025-07-25,14,25.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0342,1042,Treatment B,2,Hypertension,Vascular disorders,MILD,N,UNLIKELY,2025-08-12,,2025-08-12,,43,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0342,1043,Treatment B,2,Headache,Nervous system disorders,SEVERE,N,PROBABLE,2025-07-24,2025-08-01,2025-07-24,2025-08-01,24,32.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0342,1044,Treatment B,2,Rash,Skin and subcutaneous tissue disorders,MILD,N,VERY LIKELY,2025-07-13,2025-07-24,2025-07-13,2025-07-24,13,24.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0343,1045,Treatment B,2,Hypertension,Vascular disorders,MILD,N,UNLIKELY,2025-04-19,2025-04-29,2025-04-19,2025-04-29,47,57.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0343,1046,Treatment B,2,Abdominal pain,Gastrointestinal disorders,MODERATE,N,UNLIKELY,2025-03-29,2025-04-16,2025-03-29,2025-04-16,26,44.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0343,1047,Treatment B,2,Nausea,Gastrointestinal disorders,MODERATE,Y,PROBABLE,2025-04-07,2025-04-23,2025-04-07,2025-04-23,35,51.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0343,1048,Treatment B,2,Pruritus,Skin and subcutaneous tissue disorders,MILD,N,POSSIBLE,2025-04-11,,2025-04-11,,39,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0343,1049,Treatment B,2,Dizziness,Nervous system disorders,MILD,N,POSSIBLE,2025-03-14,2025-03-29,2025-03-14,2025-03-29,11,26.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0343,1050,Treatment B,2,Nausea,Gastrointestinal disorders,MILD,N,POSSIBLE,2025-04-19,2025-05-06,2025-04-19,2025-05-06,47,64.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0344,1051,Treatment B,2,Tachycardia,Cardiac disorders,MODERATE,N,VERY LIKELY,2025-04-10,2025-04-17,2025-04-10,2025-04-17,25,32.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE04-0344,1052,Treatment B,2,Rash,Skin and subcutaneous tissue disorders,MILD,N,VERY LIKELY,2025-04-26,2025-05-05,2025-04-26,2025-05-05,41,50.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE05-0345,1053,Treatment A,1,Tachycardia,Cardiac disorders,MODERATE,N,VERY LIKELY,2025-04-08,2025-04-13,2025-04-08,2025-04-13,44,49.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0345,1054,Treatment A,1,Abdominal pain,Gastrointestinal disorders,MODERATE,N,PROBABLE,2025-03-09,2025-03-10,2025-03-09,2025-03-10,14,15.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0345,1055,Treatment A,1,Pruritus,Skin and subcutaneous tissue disorders,MODERATE,N,UNLIKELY,2025-04-08,2025-04-16,2025-04-08,2025-04-16,44,52.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0346,1056,Treatment B,2,Tremor,Nervous system disorders,MODERATE,N,PROBABLE,2025-06-30,,2025-06-30,,21,,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0346,1057,Treatment B,2,Cough,"Respiratory, thoracic and mediastinal disorders",MILD,N,VERY LIKELY,2025-07-13,2025-07-31,2025-07-13,2025-07-31,34,52.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0346,1058,Treatment B,2,Rash,Skin and subcutaneous tissue disorders,MODERATE,N,VERY LIKELY,2025-07-04,,2025-07-04,,25,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0347,1059,Treatment B,2,Dyspnea,"Respiratory, thoracic and mediastinal disorders",MILD,N,PROBABLE,2025-05-05,2025-05-21,2025-05-05,2025-05-21,36,52.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0347,1060,Treatment B,2,Pruritus,Skin and subcutaneous tissue disorders,MILD,N,POSSIBLE,2025-05-04,2025-05-16,2025-05-04,2025-05-16,35,47.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0348,1061,Placebo,3,Diarrhea,Gastrointestinal disorders,MODERATE,N,PROBABLE,2025-03-04,,2025-03-04,,42,,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE03-0348,1062,Placebo,3,Back pain,Musculoskeletal and connective tissue disorders,MILD,Y,PROBABLE,2025-02-28,2025-03-07,2025-02-28,2025-03-07,38,45.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE03-0348,1063,Placebo,3,Constipation,Gastrointestinal disorders,MILD,N,UNLIKELY,2025-01-29,2025-02-06,2025-01-29,2025-02-06,8,16.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE03-0348,1064,Placebo,3,Headache,Nervous system disorders,MODERATE,N,POSSIBLE,2025-03-04,2025-03-12,2025-03-04,2025-03-12,42,50.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE04-0349,1065,Treatment B,2,Diarrhea,Gastrointestinal disorders,MODERATE,Y,POSSIBLE,2025-05-03,,2025-05-03,,28,,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE04-0349,1066,Treatment B,2,Insomnia,Nervous system disorders,MILD,N,UNLIKELY,2025-05-02,2025-05-18,2025-05-02,2025-05-18,27,43.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE04-0349,1067,Treatment B,2,Constipation,Gastrointestinal disorders,MILD,N,PROBABLE,2025-05-08,2025-05-21,2025-05-08,2025-05-21,33,46.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE05-0350,1068,Treatment B,2,Tachycardia,Cardiac disorders,MILD,N,VERY LIKELY,2025-04-23,2025-05-05,2025-04-23,2025-05-05,16,28.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0351,1069,Placebo,3,Headache,Nervous system disorders,MILD,N,POSSIBLE,2025-02-26,,2025-02-26,,15,,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0351,1070,Placebo,3,Fever,General disorders and administration site conditions,MILD,N,UNLIKELY,2025-03-26,2025-03-28,2025-03-26,2025-03-28,43,45.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0351,1071,Placebo,3,Muscle pain,Musculoskeletal and connective tissue disorders,MILD,N,POSSIBLE,2025-03-22,2025-04-05,2025-03-22,2025-04-05,39,53.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0351,1072,Placebo,3,Dyspnea,"Respiratory, thoracic and mediastinal disorders",MILD,Y,POSSIBLE,2025-03-14,2025-03-30,2025-03-14,2025-03-30,31,47.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0352,1073,Treatment A,1,Nausea,Gastrointestinal disorders,MILD,N,PROBABLE,2025-03-31,2025-04-15,2025-03-31,2025-04-15,38,53.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0352,1074,Treatment A,1,Dizziness,Nervous system disorders,MILD,N,UNLIKELY,2025-04-08,2025-04-21,2025-04-08,2025-04-21,46,59.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0352,1075,Treatment A,1,Headache,Nervous system disorders,MILD,Y,PROBABLE,2025-03-27,,2025-03-27,,34,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0353,1076,Treatment A,1,Headache,Nervous system disorders,MILD,N,PROBABLE,2025-07-09,,2025-07-09,,33,,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0353,1077,Treatment A,1,Insomnia,Nervous system disorders,MILD,N,PROBABLE,2025-07-12,2025-07-22,2025-07-12,2025-07-22,36,46.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0353,1078,Treatment A,1,Abdominal pain,Gastrointestinal disorders,MODERATE,N,UNLIKELY,2025-07-15,,2025-07-15,,39,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0353,1079,Treatment A,1,Dyspnea,"Respiratory, thoracic and mediastinal disorders",SEVERE,N,POSSIBLE,2025-07-16,,2025-07-16,,40,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0353,1080,Treatment A,1,Insomnia,Nervous system disorders,MILD,N,POSSIBLE,2025-07-05,2025-07-11,2025-07-05,2025-07-11,29,35.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0353,1081,Treatment A,1,Rash,Skin and subcutaneous tissue disorders,MODERATE,N,PROBABLE,2025-06-10,2025-06-16,2025-06-10,2025-06-16,4,10.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0353,1082,Treatment A,1,Dyspnea,"Respiratory, thoracic and mediastinal disorders",MILD,N,POSSIBLE,2025-06-29,2025-07-15,2025-06-29,2025-07-15,23,39.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0354,1083,Treatment A,1,Dizziness,Nervous system disorders,MILD,N,POSSIBLE,2025-06-04,2025-06-18,2025-06-04,2025-06-18,41,55.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0354,1084,Treatment A,1,Muscle pain,Musculoskeletal and connective tissue disorders,MILD,N,VERY LIKELY,2025-05-12,2025-05-17,2025-05-12,2025-05-17,18,23.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0355,1085,Treatment A,1,Insomnia,Nervous system disorders,MILD,N,UNLIKELY,2025-03-07,,2025-03-07,,32,,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0355,1086,Treatment A,1,Tachycardia,Cardiac disorders,MODERATE,N,PROBABLE,2025-02-19,2025-03-10,2025-02-19,2025-03-10,16,35.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0355,1087,Treatment A,1,Dyspnea,"Respiratory, thoracic and mediastinal disorders",MILD,N,UNLIKELY,2025-02-22,2025-03-06,2025-02-22,2025-03-06,19,31.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0355,1088,Treatment A,1,Dizziness,Nervous system disorders,MODERATE,N,POSSIBLE,2025-03-07,2025-03-14,2025-03-07,2025-03-14,32,39.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0356,1089,Treatment B,2,Pruritus,Skin and subcutaneous tissue disorders,MODERATE,N,POSSIBLE,2025-06-01,2025-06-18,2025-06-01,2025-06-18,41,58.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0358,1090,Treatment B,2,Fatigue,General disorders and administration site conditions,MILD,N,PROBABLE,2025-08-01,2025-08-18,2025-08-01,2025-08-18,44,61.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0358,1091,Treatment B,2,Abdominal pain,Gastrointestinal disorders,MODERATE,N,POSSIBLE,2025-07-11,2025-07-24,2025-07-11,2025-07-24,23,36.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0360,1092,Treatment A,1,Diarrhea,Gastrointestinal disorders,MODERATE,N,UNLIKELY,2025-04-03,2025-04-14,2025-04-03,2025-04-14,42,53.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0361,1093,Treatment B,2,Tachycardia,Cardiac disorders,MODERATE,N,POSSIBLE,2025-02-17,2025-03-04,2025-02-17,2025-03-04,4,19.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0361,1094,Treatment B,2,Insomnia,Nervous system disorders,MILD,N,POSSIBLE,2025-03-05,,2025-03-05,,20,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0361,1095,Treatment B,2,Fever,General disorders and administration site conditions,MODERATE,N,UNLIKELY,2025-02-26,2025-03-05,2025-02-26,2025-03-05,13,20.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0361,1096,Treatment B,2,Tremor,Nervous system disorders,MILD,N,POSSIBLE,2025-03-11,,2025-03-11,,26,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0361,1097,Treatment B,2,Constipation,Gastrointestinal disorders,MILD,N,PROBABLE,2025-02-26,2025-03-14,2025-02-26,2025-03-14,13,29.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0362,1098,Treatment A,1,Tachycardia,Cardiac disorders,MILD,N,UNLIKELY,2025-05-18,2025-06-01,2025-05-18,2025-06-01,18,32.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0362,1099,Treatment A,1,Fever,General disorders and administration site conditions,MODERATE,N,VERY LIKELY,2025-06-13,2025-06-15,2025-06-13,2025-06-15,44,46.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0362,1100,Treatment A,1,Nausea,Gastrointestinal disorders,MILD,N,PROBABLE,2025-05-25,2025-06-09,2025-05-25,2025-06-09,25,40.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0362,1101,Treatment A,1,Vomiting,Gastrointestinal disorders,MILD,N,POSSIBLE,2025-05-24,2025-06-11,2025-05-24,2025-06-11,24,42.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0362,1102,Treatment A,1,Tachycardia,Cardiac disorders,MILD,N,PROBABLE,2025-05-23,2025-06-02,2025-05-23,2025-06-02,23,33.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0363,1103,Treatment B,2,Tachycardia,Cardiac disorders,MODERATE,Y,UNLIKELY,2025-08-08,2025-08-12,2025-08-08,2025-08-12,37,41.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0363,1104,Treatment B,2,Vomiting,Gastrointestinal disorders,MODERATE,N,UNLIKELY,2025-08-02,2025-08-03,2025-08-02,2025-08-03,31,32.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0363,1105,Treatment B,2,Fever,General disorders and administration site conditions,SEVERE,N,UNLIKELY,2025-07-06,,2025-07-06,,4,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0363,1106,Treatment B,2,Cough,"Respiratory, thoracic and mediastinal disorders",SEVERE,N,PROBABLE,2025-07-23,2025-07-27,2025-07-23,2025-07-27,21,25.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0363,1107,Treatment B,2,Fever,General disorders and administration site conditions,MODERATE,N,UNLIKELY,2025-08-08,2025-08-26,2025-08-08,2025-08-26,37,55.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0363,1108,Treatment B,2,Abdominal pain,Gastrointestinal disorders,MODERATE,N,PROBABLE,2025-07-15,,2025-07-15,,13,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0364,1109,Placebo,3,Fatigue,General disorders and administration site conditions,SEVERE,N,PROBABLE,2025-06-07,2025-06-20,2025-06-07,2025-06-20,32,45.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0365,1110,Placebo,3,Dyspnea,"Respiratory, thoracic and mediastinal disorders",MILD,N,PROBABLE,2025-02-24,,2025-02-24,,20,,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0365,1111,Placebo,3,Dyspnea,"Respiratory, thoracic and mediastinal disorders",MILD,N,PROBABLE,2025-03-07,2025-03-20,2025-03-07,2025-03-20,31,44.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0365,1112,Placebo,3,Fatigue,General disorders and administration site conditions,SEVERE,Y,PROBABLE,2025-03-21,,2025-03-21,,45,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0366,1113,Placebo,3,Pruritus,Skin and subcutaneous tissue disorders,MILD,Y,UNLIKELY,2025-06-12,2025-07-01,2025-06-12,2025-07-01,19,38.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0366,1114,Placebo,3,Cough,"Respiratory, thoracic and mediastinal disorders",MILD,N,UNLIKELY,2025-07-05,2025-07-18,2025-07-05,2025-07-18,42,55.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0367,1115,Treatment B,2,Tachycardia,Cardiac disorders,MILD,Y,VERY LIKELY,2025-06-28,,2025-06-28,,39,,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0367,1116,Treatment B,2,Insomnia,Nervous system disorders,MODERATE,N,POSSIBLE,2025-07-03,,2025-07-03,,44,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0367,1117,Treatment B,2,Dizziness,Nervous system disorders,MILD,N,POSSIBLE,2025-07-02,,2025-07-02,,43,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0368,1118,Placebo,3,Nausea,Gastrointestinal disorders,MILD,N,VERY LIKELY,2025-06-09,2025-06-27,2025-06-09,2025-06-27,6,24.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0368,1119,Placebo,3,Cough,"Respiratory, thoracic and mediastinal disorders",MODERATE,N,POSSIBLE,2025-06-25,,2025-06-25,,22,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0368,1120,Placebo,3,Fatigue,General disorders and administration site conditions,MILD,N,PROBABLE,2025-06-28,,2025-06-28,,25,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0368,1121,Placebo,3,Rash,Skin and subcutaneous tissue disorders,MILD,N,POSSIBLE,2025-06-19,2025-06-22,2025-06-19,2025-06-22,16,19.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0369,1122,Treatment B,2,Muscle pain,Musculoskeletal and connective tissue disorders,MILD,N,PROBABLE,2025-05-24,2025-05-28,2025-05-24,2025-05-28,49,53.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0369,1123,Treatment B,2,Cough,"Respiratory, thoracic and mediastinal disorders",MILD,N,UNLIKELY,2025-05-24,2025-06-01,2025-05-24,2025-06-01,49,57.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0369,1124,Treatment B,2,Headache,Nervous system disorders,MILD,N,POSSIBLE,2025-04-13,2025-05-01,2025-04-13,2025-05-01,8,26.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0369,1125,Treatment B,2,Nausea,Gastrointestinal disorders,MILD,N,VERY LIKELY,2025-04-10,2025-04-15,2025-04-10,2025-04-15,5,10.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0370,1126,Placebo,3,Fatigue,General disorders and administration site conditions,MILD,N,POSSIBLE,2025-05-08,2025-05-09,2025-05-08,2025-05-09,14,15.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0370,1127,Placebo,3,Pruritus,Skin and subcutaneous tissue disorders,MILD,N,POSSIBLE,2025-05-08,2025-05-15,2025-05-08,2025-05-15,14,21.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0370,1128,Placebo,3,Muscle pain,Musculoskeletal and connective tissue disorders,MODERATE,N,POSSIBLE,2025-06-12,2025-06-15,2025-06-12,2025-06-15,49,52.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0371,1129,Treatment B,2,Back pain,Musculoskeletal and connective tissue disorders,MODERATE,N,POSSIBLE,2025-03-18,2025-03-28,2025-03-18,2025-03-28,10,20.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE02-0372,1130,Treatment A,1,Hypertension,Vascular disorders,MODERATE,N,POSSIBLE,2025-04-06,,2025-04-06,,13,,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0372,1131,Treatment A,1,Dizziness,Nervous system disorders,MODERATE,N,UNLIKELY,2025-04-23,2025-05-07,2025-04-23,2025-05-07,30,44.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0372,1132,Treatment A,1,Pruritus,Skin and subcutaneous tissue disorders,MILD,N,UNLIKELY,2025-05-03,,2025-05-03,,40,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0373,1133,Treatment B,2,Fever,General disorders and administration site conditions,MILD,N,POSSIBLE,2025-04-02,2025-04-18,2025-04-02,2025-04-18,9,25.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0373,1134,Treatment B,2,Insomnia,Nervous system disorders,MILD,N,PROBABLE,2025-04-25,2025-05-08,2025-04-25,2025-05-08,32,45.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0373,1135,Treatment B,2,Fever,General disorders and administration site conditions,SEVERE,Y,VERY LIKELY,2025-04-21,2025-05-03,2025-04-21,2025-05-03,28,40.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0373,1136,Treatment B,2,Tachycardia,Cardiac disorders,MILD,N,UNLIKELY,2025-03-27,2025-04-02,2025-03-27,2025-04-02,3,9.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0373,1137,Treatment B,2,Fever,General disorders and administration site conditions,MILD,N,UNLIKELY,2025-04-17,2025-04-28,2025-04-17,2025-04-28,24,35.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0374,1138,Treatment B,2,Nausea,Gastrointestinal disorders,MODERATE,N,VERY LIKELY,2025-08-29,,2025-08-29,,49,,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0374,1139,Treatment B,2,Rash,Skin and subcutaneous tissue disorders,SEVERE,N,POSSIBLE,2025-08-13,2025-08-25,2025-08-13,2025-08-25,33,45.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0375,1140,Treatment B,2,Diarrhea,Gastrointestinal disorders,MILD,N,PROBABLE,2025-07-10,2025-07-14,2025-07-10,2025-07-14,43,47.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0375,1141,Treatment B,2,Headache,Nervous system disorders,MILD,Y,POSSIBLE,2025-07-15,2025-07-26,2025-07-15,2025-07-26,48,59.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0375,1142,Treatment B,2,Tremor,Nervous system disorders,MILD,N,UNLIKELY,2025-05-30,2025-06-06,2025-05-30,2025-06-06,2,9.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0375,1143,Treatment B,2,Tachycardia,Cardiac disorders,MILD,N,PROBABLE,2025-07-14,2025-07-18,2025-07-14,2025-07-18,47,51.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0376,1144,Treatment A,1,Muscle pain,Musculoskeletal and connective tissue disorders,MILD,N,POSSIBLE,2025-07-17,2025-07-29,2025-07-17,2025-07-29,10,22.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0376,1145,Treatment A,1,Fatigue,General disorders and administration site conditions,MILD,Y,POSSIBLE,2025-07-14,,2025-07-14,,7,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0376,1146,Treatment A,1,Cough,"Respiratory, thoracic and mediastinal disorders",MODERATE,N,PROBABLE,2025-07-25,2025-08-10,2025-07-25,2025-08-10,18,34.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0376,1147,Treatment A,1,Rash,Skin and subcutaneous tissue disorders,MODERATE,N,UNLIKELY,2025-07-16,2025-07-18,2025-07-16,2025-07-18,9,11.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0377,1148,Placebo,3,Nausea,Gastrointestinal disorders,MILD,N,UNLIKELY,2025-08-12,2025-08-28,2025-08-12,2025-08-28,40,56.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0378,1149,Treatment A,1,Constipation,Gastrointestinal disorders,MILD,N,POSSIBLE,2025-04-01,,2025-04-01,,48,,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0378,1150,Treatment A,1,Fever,General disorders and administration site conditions,MODERATE,N,PROBABLE,2025-02-17,2025-02-22,2025-02-17,2025-02-22,5,10.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0379,1151,Treatment A,1,Rash,Skin and subcutaneous tissue disorders,SEVERE,N,PROBABLE,2025-02-27,2025-03-16,2025-02-27,2025-03-16,15,32.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0379,1152,Treatment A,1,Dizziness,Nervous system disorders,MODERATE,N,POSSIBLE,2025-02-26,2025-03-10,2025-02-26,2025-03-10,14,26.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0379,1153,Treatment A,1,Back pain,Musculoskeletal and connective tissue disorders,MILD,N,POSSIBLE,2025-02-23,2025-03-06,2025-02-23,2025-03-06,11,22.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0379,1154,Treatment A,1,Dizziness,Nervous system disorders,MILD,N,PROBABLE,2025-03-06,,2025-03-06,,22,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0379,1155,Treatment A,1,Headache,Nervous system disorders,MILD,N,POSSIBLE,2025-04-02,2025-04-18,2025-04-02,2025-04-18,49,65.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0380,1156,Placebo,3,Nausea,Gastrointestinal disorders,MILD,N,UNLIKELY,2025-07-01,2025-07-13,2025-07-01,2025-07-13,41,53.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0380,1157,Placebo,3,Cough,"Respiratory, thoracic and mediastinal disorders",MILD,N,VERY LIKELY,2025-07-10,,2025-07-10,,50,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0381,1158,Treatment A,1,Pruritus,Skin and subcutaneous tissue disorders,MODERATE,N,POSSIBLE,2025-02-23,2025-03-11,2025-02-23,2025-03-11,32,48.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0381,1159,Treatment A,1,Rash,Skin and subcutaneous tissue disorders,MODERATE,N,POSSIBLE,2025-02-26,2025-03-17,2025-02-26,2025-03-17,35,54.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0381,1160,Treatment A,1,Hypertension,Vascular disorders,MILD,N,POSSIBLE,2025-02-13,2025-03-02,2025-02-13,2025-03-02,22,39.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0382,1161,Treatment A,1,Tremor,Nervous system disorders,MILD,N,POSSIBLE,2025-07-24,2025-08-01,2025-07-24,2025-08-01,19,27.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0382,1162,Treatment A,1,Dyspnea,"Respiratory, thoracic and mediastinal disorders",MILD,N,UNLIKELY,2025-07-27,2025-08-06,2025-07-27,2025-08-06,22,32.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0383,1163,Treatment B,2,Dizziness,Nervous system disorders,MILD,N,POSSIBLE,2025-06-12,,2025-06-12,,5,,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE04-0384,1164,Treatment A,1,Headache,Nervous system disorders,MILD,Y,POSSIBLE,2025-03-21,,2025-03-21,,33,,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0384,1165,Treatment A,1,Abdominal pain,Gastrointestinal disorders,MILD,N,POSSIBLE,2025-03-18,2025-04-01,2025-03-18,2025-04-01,30,44.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0384,1166,Treatment A,1,Fever,General disorders and administration site conditions,MODERATE,N,PROBABLE,2025-02-24,2025-03-09,2025-02-24,2025-03-09,8,21.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0385,1167,Treatment A,1,Muscle pain,Musculoskeletal and connective tissue disorders,MILD,N,POSSIBLE,2025-05-16,2025-05-30,2025-05-16,2025-05-30,5,19.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0385,1168,Treatment A,1,Muscle pain,Musculoskeletal and connective tissue disorders,SEVERE,N,PROBABLE,2025-05-14,2025-05-18,2025-05-14,2025-05-18,3,7.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0385,1169,Treatment A,1,Tachycardia,Cardiac disorders,SEVERE,N,VERY LIKELY,2025-05-27,2025-06-03,2025-05-27,2025-06-03,16,23.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0386,1170,Treatment A,1,Diarrhea,Gastrointestinal disorders,MILD,N,POSSIBLE,2025-04-05,2025-04-20,2025-04-05,2025-04-20,25,40.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0386,1171,Treatment A,1,Tachycardia,Cardiac disorders,MODERATE,N,POSSIBLE,2025-04-09,2025-04-10,2025-04-09,2025-04-10,29,30.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0387,1172,Placebo,3,Fever,General disorders and administration site conditions,MILD,N,POSSIBLE,2025-04-01,2025-04-12,2025-04-01,2025-04-12,24,35.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0387,1173,Placebo,3,Rash,Skin and subcutaneous tissue disorders,MODERATE,N,POSSIBLE,2025-04-02,2025-04-03,2025-04-02,2025-04-03,25,26.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0387,1174,Placebo,3,Diarrhea,Gastrointestinal disorders,MILD,Y,PROBABLE,2025-04-05,2025-04-18,2025-04-05,2025-04-18,28,41.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0387,1175,Placebo,3,Cough,"Respiratory, thoracic and mediastinal disorders",SEVERE,N,POSSIBLE,2025-03-22,,2025-03-22,,14,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0387,1176,Placebo,3,Dyspnea,"Respiratory, thoracic and mediastinal disorders",MODERATE,N,UNLIKELY,2025-04-11,2025-04-28,2025-04-11,2025-04-28,34,51.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0387,1177,Placebo,3,Pruritus,Skin and subcutaneous tissue disorders,MILD,N,UNLIKELY,2025-04-27,2025-05-05,2025-04-27,2025-05-05,50,58.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0387,1178,Placebo,3,Headache,Nervous system disorders,MILD,N,POSSIBLE,2025-04-25,,2025-04-25,,48,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0389,1179,Treatment B,2,Nausea,Gastrointestinal disorders,MODERATE,Y,PROBABLE,2025-02-28,2025-03-01,2025-02-28,2025-03-01,12,13.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE04-0389,1180,Treatment B,2,Vomiting,Gastrointestinal disorders,MODERATE,N,PROBABLE,2025-03-09,,2025-03-09,,21,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE04-0389,1181,Treatment B,2,Dizziness,Nervous system disorders,MODERATE,N,VERY LIKELY,2025-02-25,2025-03-03,2025-02-25,2025-03-03,9,15.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE04-0389,1182,Treatment B,2,Tachycardia,Cardiac disorders,MILD,N,PROBABLE,2025-02-24,2025-03-05,2025-02-24,2025-03-05,8,17.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE04-0389,1183,Treatment B,2,Dyspnea,"Respiratory, thoracic and mediastinal disorders",SEVERE,N,PROBABLE,2025-03-22,,2025-03-22,,34,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE04-0389,1184,Treatment B,2,Muscle pain,Musculoskeletal and connective tissue disorders,MILD,N,POSSIBLE,2025-03-28,2025-04-13,2025-03-28,2025-04-13,40,56.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE05-0390,1185,Treatment A,1,Fatigue,General disorders and administration site conditions,MILD,N,UNLIKELY,2025-05-05,2025-05-20,2025-05-05,2025-05-20,19,34.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0390,1186,Treatment A,1,Abdominal pain,Gastrointestinal disorders,MODERATE,Y,VERY LIKELY,2025-04-22,2025-05-05,2025-04-22,2025-05-05,6,19.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0390,1187,Treatment A,1,Fatigue,General disorders and administration site conditions,MILD,N,POSSIBLE,2025-05-16,2025-06-02,2025-05-16,2025-06-02,30,47.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0391,1188,Placebo,3,Rash,Skin and subcutaneous tissue disorders,MILD,N,POSSIBLE,2025-07-12,2025-07-26,2025-07-12,2025-07-26,11,25.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0392,1189,Treatment A,1,Vomiting,Gastrointestinal disorders,MODERATE,N,VERY LIKELY,2025-07-27,2025-08-06,2025-07-27,2025-08-06,40,50.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0392,1190,Treatment A,1,Vomiting,Gastrointestinal disorders,MODERATE,N,POSSIBLE,2025-07-01,2025-07-13,2025-07-01,2025-07-13,14,26.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0392,1191,Treatment A,1,Fever,General disorders and administration site conditions,SEVERE,Y,PROBABLE,2025-07-05,,2025-07-05,,18,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0393,1192,Treatment B,2,Abdominal pain,Gastrointestinal disorders,MODERATE,N,POSSIBLE,2025-08-20,2025-08-28,2025-08-20,2025-08-28,42,50.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0393,1193,Treatment B,2,Back pain,Musculoskeletal and connective tissue disorders,MILD,N,PROBABLE,2025-07-26,,2025-07-26,,17,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0393,1194,Treatment B,2,Diarrhea,Gastrointestinal disorders,MILD,N,PROBABLE,2025-08-10,2025-08-25,2025-08-10,2025-08-25,32,47.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0393,1195,Treatment B,2,Dizziness,Nervous system disorders,MILD,N,POSSIBLE,2025-08-11,2025-08-27,2025-08-11,2025-08-27,33,49.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0394,1196,Treatment B,2,Fatigue,General disorders and administration site conditions,MILD,N,PROBABLE,2025-06-22,2025-07-05,2025-06-22,2025-07-05,22,35.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0394,1197,Treatment B,2,Dizziness,Nervous system disorders,MILD,N,UNLIKELY,2025-06-24,2025-06-28,2025-06-24,2025-06-28,24,28.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0395,1198,Placebo,3,Abdominal pain,Gastrointestinal disorders,SEVERE,N,UNLIKELY,2025-05-31,2025-06-10,2025-05-31,2025-06-10,30,40.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0395,1199,Placebo,3,Dizziness,Nervous system disorders,MILD,N,VERY LIKELY,2025-05-12,2025-05-26,2025-05-12,2025-05-26,11,25.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0395,1200,Placebo,3,Cough,"Respiratory, thoracic and mediastinal disorders",MILD,N,PROBABLE,2025-05-31,2025-06-08,2025-05-31,2025-06-08,30,38.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0396,1201,Treatment B,2,Rash,Skin and subcutaneous tissue disorders,MILD,N,VERY LIKELY,2025-04-11,2025-04-27,2025-04-11,2025-04-27,46,62.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0396,1202,Treatment B,2,Dyspnea,"Respiratory, thoracic and mediastinal disorders",MILD,Y,UNLIKELY,2025-04-09,2025-04-11,2025-04-09,2025-04-11,44,46.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0396,1203,Treatment B,2,Nausea,Gastrointestinal disorders,MILD,N,PROBABLE,2025-03-24,,2025-03-24,,28,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0397,1204,Treatment B,2,Pruritus,Skin and subcutaneous tissue disorders,MODERATE,N,PROBABLE,2025-03-30,2025-04-05,2025-03-30,2025-04-05,29,35.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0397,1205,Treatment B,2,Dyspnea,"Respiratory, thoracic and mediastinal disorders",MILD,N,VERY LIKELY,2025-03-30,,2025-03-30,,29,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0397,1206,Treatment B,2,Pruritus,Skin and subcutaneous tissue disorders,MILD,N,PROBABLE,2025-04-14,2025-04-23,2025-04-14,2025-04-23,44,53.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0397,1207,Treatment B,2,Headache,Nervous system disorders,MODERATE,N,PROBABLE,2025-03-23,2025-04-06,2025-03-23,2025-04-06,22,36.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0398,1208,Treatment B,2,Rash,Skin and subcutaneous tissue disorders,MODERATE,N,UNLIKELY,2025-07-10,2025-07-25,2025-07-10,2025-07-25,37,52.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0398,1209,Treatment B,2,Pruritus,Skin and subcutaneous tissue disorders,MILD,N,UNLIKELY,2025-07-16,2025-07-23,2025-07-16,2025-07-23,43,50.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0398,1210,Treatment B,2,Dyspnea,"Respiratory, thoracic and mediastinal disorders",MILD,N,POSSIBLE,2025-07-10,2025-07-22,2025-07-10,2025-07-22,37,49.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0398,1211,Treatment B,2,Insomnia,Nervous system disorders,MODERATE,N,POSSIBLE,2025-07-08,2025-07-24,2025-07-08,2025-07-24,35,51.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0398,1212,Treatment B,2,Fever,General disorders and administration site conditions,MILD,N,POSSIBLE,2025-07-03,2025-07-18,2025-07-03,2025-07-18,30,45.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0398,1213,Treatment B,2,Vomiting,Gastrointestinal disorders,MILD,N,POSSIBLE,2025-06-11,2025-06-21,2025-06-11,2025-06-21,8,18.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0399,1214,Treatment B,2,Dizziness,Nervous system disorders,MODERATE,Y,PROBABLE,2025-04-25,2025-05-03,2025-04-25,2025-05-03,2,10.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0399,1215,Treatment B,2,Fatigue,General disorders and administration site conditions,MODERATE,N,UNLIKELY,2025-05-12,,2025-05-12,,19,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0399,1216,Treatment B,2,Rash,Skin and subcutaneous tissue disorders,MILD,N,POSSIBLE,2025-04-27,,2025-04-27,,4,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0399,1217,Treatment B,2,Pruritus,Skin and subcutaneous tissue disorders,MODERATE,N,UNLIKELY,2025-04-30,2025-05-17,2025-04-30,2025-05-17,7,24.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0399,1218,Treatment B,2,Constipation,Gastrointestinal disorders,MILD,N,POSSIBLE,2025-05-04,2025-05-07,2025-05-04,2025-05-07,11,14.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0399,1219,Treatment B,2,Headache,Nervous system disorders,MODERATE,N,POSSIBLE,2025-04-26,2025-05-02,2025-04-26,2025-05-02,3,9.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0400,1220,Treatment B,2,Constipation,Gastrointestinal disorders,MODERATE,N,POSSIBLE,2025-04-18,2025-04-24,2025-04-18,2025-04-24,25,31.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0400,1221,Treatment B,2,Tachycardia,Cardiac disorders,MILD,N,PROBABLE,2025-05-13,2025-05-17,2025-05-13,2025-05-17,50,54.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0400,1222,Treatment B,2,Dizziness,Nervous system disorders,MILD,Y,PROBABLE,2025-05-12,2025-05-28,2025-05-12,2025-05-28,49,65.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0400,1223,Treatment B,2,Tachycardia,Cardiac disorders,MILD,N,PROBABLE,2025-04-10,2025-04-12,2025-04-10,2025-04-12,17,19.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0401,1224,Treatment B,2,Tremor,Nervous system disorders,SEVERE,N,VERY LIKELY,2025-03-16,2025-03-20,2025-03-16,2025-03-20,41,45.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0401,1225,Treatment B,2,Constipation,Gastrointestinal disorders,MILD,N,PROBABLE,2025-02-05,,2025-02-05,,2,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0401,1226,Treatment B,2,Hypertension,Vascular disorders,MODERATE,N,POSSIBLE,2025-02-05,2025-02-15,2025-02-05,2025-02-15,2,12.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0402,1227,Treatment A,1,Diarrhea,Gastrointestinal disorders,MILD,N,PROBABLE,2025-03-07,2025-03-09,2025-03-07,2025-03-09,29,31.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0404,1228,Treatment B,2,Constipation,Gastrointestinal disorders,MILD,N,PROBABLE,2025-03-23,2025-04-07,2025-03-23,2025-04-07,4,19.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0404,1229,Treatment B,2,Back pain,Musculoskeletal and connective tissue disorders,MODERATE,N,UNLIKELY,2025-05-04,,2025-05-04,,46,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0405,1230,Treatment A,1,Pruritus,Skin and subcutaneous tissue disorders,MODERATE,N,PROBABLE,2025-02-19,2025-02-27,2025-02-19,2025-02-27,10,18.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0405,1231,Treatment A,1,Tremor,Nervous system disorders,MODERATE,N,UNLIKELY,2025-03-07,2025-03-25,2025-03-07,2025-03-25,26,44.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0405,1232,Treatment A,1,Muscle pain,Musculoskeletal and connective tissue disorders,MODERATE,N,PROBABLE,2025-03-17,2025-04-01,2025-03-17,2025-04-01,36,51.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0406,1233,Treatment A,1,Cough,"Respiratory, thoracic and mediastinal disorders",MILD,N,POSSIBLE,2025-03-24,2025-03-27,2025-03-24,2025-03-27,37,40.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0406,1234,Treatment A,1,Headache,Nervous system disorders,SEVERE,N,POSSIBLE,2025-03-17,2025-03-18,2025-03-17,2025-03-18,30,31.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0406,1235,Treatment A,1,Tachycardia,Cardiac disorders,MILD,N,POSSIBLE,2025-03-03,2025-03-10,2025-03-03,2025-03-10,16,23.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0406,1236,Treatment A,1,Abdominal pain,Gastrointestinal disorders,MILD,N,UNLIKELY,2025-03-01,2025-03-11,2025-03-01,2025-03-11,14,24.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0407,1237,Treatment A,1,Diarrhea,Gastrointestinal disorders,MILD,N,UNLIKELY,2025-06-30,2025-07-08,2025-06-30,2025-07-08,33,41.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0407,1238,Treatment A,1,Tachycardia,Cardiac disorders,MILD,N,VERY LIKELY,2025-06-07,2025-06-20,2025-06-07,2025-06-20,10,23.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0408,1239,Treatment A,1,Nausea,Gastrointestinal disorders,MILD,Y,UNLIKELY,2025-07-26,2025-08-04,2025-07-26,2025-08-04,37,46.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0409,1240,Treatment A,1,Abdominal pain,Gastrointestinal disorders,MODERATE,N,POSSIBLE,2025-07-30,2025-08-15,2025-07-30,2025-08-15,26,42.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0410,1241,Treatment A,1,Hypertension,Vascular disorders,MODERATE,N,POSSIBLE,2025-04-14,2025-04-23,2025-04-14,2025-04-23,32,41.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0410,1242,Treatment A,1,Diarrhea,Gastrointestinal disorders,MILD,N,POSSIBLE,2025-04-01,2025-04-05,2025-04-01,2025-04-05,19,23.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0411,1243,Treatment A,1,Tachycardia,Cardiac disorders,MILD,N,POSSIBLE,2025-05-05,2025-05-19,2025-05-05,2025-05-19,29,43.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0411,1244,Treatment A,1,Dizziness,Nervous system disorders,MILD,N,POSSIBLE,2025-05-21,2025-06-07,2025-05-21,2025-06-07,45,62.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0411,1245,Treatment A,1,Fever,General disorders and administration site conditions,MODERATE,N,UNLIKELY,2025-05-16,2025-05-24,2025-05-16,2025-05-24,40,48.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0411,1246,Treatment A,1,Vomiting,Gastrointestinal disorders,MILD,N,POSSIBLE,2025-05-24,2025-06-06,2025-05-24,2025-06-06,48,61.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0411,1247,Treatment A,1,Headache,Nervous system disorders,MILD,N,PROBABLE,2025-04-10,2025-04-12,2025-04-10,2025-04-12,4,6.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0412,1248,Placebo,3,Dyspnea,"Respiratory, thoracic and mediastinal disorders",SEVERE,N,POSSIBLE,2025-07-17,,2025-07-17,,10,,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0412,1249,Placebo,3,Cough,"Respiratory, thoracic and mediastinal disorders",MILD,Y,VERY LIKELY,2025-07-24,2025-07-27,2025-07-24,2025-07-27,17,20.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0412,1250,Placebo,3,Diarrhea,Gastrointestinal disorders,MODERATE,N,POSSIBLE,2025-07-25,,2025-07-25,,18,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0412,1251,Placebo,3,Insomnia,Nervous system disorders,MILD,N,VERY LIKELY,2025-07-29,,2025-07-29,,22,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0413,1252,Treatment A,1,Pruritus,Skin and subcutaneous tissue disorders,MILD,N,PROBABLE,2025-07-15,2025-08-01,2025-07-15,2025-08-01,9,26.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0413,1253,Treatment A,1,Nausea,Gastrointestinal disorders,MILD,N,PROBABLE,2025-07-27,,2025-07-27,,21,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0414,1254,Treatment B,2,Dizziness,Nervous system disorders,MILD,N,POSSIBLE,2025-07-25,2025-08-07,2025-07-25,2025-08-07,27,40.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0414,1255,Treatment B,2,Hypertension,Vascular disorders,SEVERE,N,POSSIBLE,2025-07-30,2025-08-08,2025-07-30,2025-08-08,32,41.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0414,1256,Treatment B,2,Fatigue,General disorders and administration site conditions,MILD,N,PROBABLE,2025-07-14,,2025-07-14,,16,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0414,1257,Treatment B,2,Insomnia,Nervous system disorders,SEVERE,N,UNLIKELY,2025-07-02,2025-07-12,2025-07-02,2025-07-12,4,14.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0414,1258,Treatment B,2,Dyspnea,"Respiratory, thoracic and mediastinal disorders",MODERATE,N,PROBABLE,2025-08-16,2025-08-31,2025-08-16,2025-08-31,49,64.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0416,1259,Treatment B,2,Dizziness,Nervous system disorders,MILD,N,UNLIKELY,2025-06-19,2025-07-04,2025-06-19,2025-07-04,49,64.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0416,1260,Treatment B,2,Insomnia,Nervous system disorders,MODERATE,N,VERY LIKELY,2025-05-09,2025-05-12,2025-05-09,2025-05-12,8,11.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0416,1261,Treatment B,2,Constipation,Gastrointestinal disorders,MODERATE,N,PROBABLE,2025-05-04,,2025-05-04,,3,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0417,1262,Treatment A,1,Abdominal pain,Gastrointestinal disorders,MODERATE,N,POSSIBLE,2025-04-06,2025-04-22,2025-04-06,2025-04-22,13,29.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0417,1263,Treatment A,1,Dizziness,Nervous system disorders,MILD,N,POSSIBLE,2025-04-06,2025-04-22,2025-04-06,2025-04-22,13,29.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0418,1264,Treatment A,1,Rash,Skin and subcutaneous tissue disorders,MILD,N,PROBABLE,2025-06-25,2025-06-29,2025-06-25,2025-06-29,45,49.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0418,1265,Treatment A,1,Tremor,Nervous system disorders,MILD,N,POSSIBLE,2025-05-13,2025-05-26,2025-05-13,2025-05-26,2,15.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0419,1266,Placebo,3,Back pain,Musculoskeletal and connective tissue disorders,MILD,Y,UNLIKELY,2025-06-05,2025-06-18,2025-06-05,2025-06-18,45,58.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0419,1267,Placebo,3,Muscle pain,Musculoskeletal and connective tissue disorders,MODERATE,N,UNLIKELY,2025-05-25,2025-06-07,2025-05-25,2025-06-07,34,47.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0421,1268,Treatment A,1,Tremor,Nervous system disorders,MILD,N,UNLIKELY,2025-05-26,2025-05-31,2025-05-26,2025-05-31,45,50.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0422,1269,Placebo,3,Abdominal pain,Gastrointestinal disorders,MODERATE,N,UNLIKELY,2025-07-30,2025-08-16,2025-07-30,2025-08-16,28,45.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0422,1270,Placebo,3,Tachycardia,Cardiac disorders,MILD,N,PROBABLE,2025-07-20,2025-08-03,2025-07-20,2025-08-03,18,32.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0422,1271,Placebo,3,Headache,Nervous system disorders,MILD,N,PROBABLE,2025-08-01,2025-08-10,2025-08-01,2025-08-10,30,39.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0423,1272,Treatment B,2,Dyspnea,"Respiratory, thoracic and mediastinal disorders",MILD,N,VERY LIKELY,2025-08-26,2025-08-30,2025-08-26,2025-08-30,49,53.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0423,1273,Treatment B,2,Diarrhea,Gastrointestinal disorders,MILD,N,PROBABLE,2025-08-06,2025-08-25,2025-08-06,2025-08-25,29,48.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0423,1274,Treatment B,2,Dizziness,Nervous system disorders,MILD,Y,POSSIBLE,2025-08-02,2025-08-15,2025-08-02,2025-08-15,25,38.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0425,1275,Treatment A,1,Insomnia,Nervous system disorders,MILD,N,POSSIBLE,2025-07-10,2025-07-13,2025-07-10,2025-07-13,30,33.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE05-0425,1276,Treatment A,1,Cough,"Respiratory, thoracic and mediastinal disorders",MILD,N,POSSIBLE,2025-07-02,2025-07-15,2025-07-02,2025-07-15,22,35.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE01-0426,1277,Treatment A,1,Headache,Nervous system disorders,MILD,N,UNLIKELY,2025-05-13,,2025-05-13,,29,,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE01-0426,1278,Treatment A,1,Back pain,Musculoskeletal and connective tissue disorders,MILD,N,PROBABLE,2025-06-01,2025-06-03,2025-06-01,2025-06-03,48,50.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE01-0426,1279,Treatment A,1,Cough,"Respiratory, thoracic and mediastinal disorders",MODERATE,Y,POSSIBLE,2025-05-07,2025-05-12,2025-05-07,2025-05-12,23,28.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE02-0427,1280,Placebo,3,Diarrhea,Gastrointestinal disorders,MODERATE,N,PROBABLE,2025-05-27,2025-06-03,2025-05-27,2025-06-03,18,25.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0427,1281,Placebo,3,Diarrhea,Gastrointestinal disorders,MILD,Y,VERY LIKELY,2025-05-24,,2025-05-24,,15,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0429,1282,Treatment B,2,Dizziness,Nervous system disorders,MODERATE,N,UNLIKELY,2025-03-12,2025-03-22,2025-03-12,2025-03-22,32,42.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0429,1283,Treatment B,2,Headache,Nervous system disorders,MILD,N,POSSIBLE,2025-02-28,2025-03-09,2025-02-28,2025-03-09,20,29.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0429,1284,Treatment B,2,Dyspnea,"Respiratory, thoracic and mediastinal disorders",SEVERE,N,PROBABLE,2025-02-23,2025-02-26,2025-02-23,2025-02-26,15,18.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0429,1285,Treatment B,2,Hypertension,Vascular disorders,MILD,N,POSSIBLE,2025-03-19,2025-04-04,2025-03-19,2025-04-04,39,55.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0430,1286,Treatment B,2,Nausea,Gastrointestinal disorders,MILD,N,POSSIBLE,2025-07-06,,2025-07-06,,42,,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0430,1287,Treatment B,2,Pruritus,Skin and subcutaneous tissue disorders,MODERATE,N,POSSIBLE,2025-06-15,2025-06-16,2025-06-15,2025-06-16,21,22.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0430,1288,Treatment B,2,Headache,Nervous system disorders,MILD,N,POSSIBLE,2025-06-16,2025-06-24,2025-06-16,2025-06-24,22,30.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0430,1289,Treatment B,2,Tremor,Nervous system disorders,MILD,Y,PROBABLE,2025-06-21,2025-07-03,2025-06-21,2025-07-03,27,39.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0431,1290,Treatment A,1,Tachycardia,Cardiac disorders,SEVERE,N,POSSIBLE,2025-05-18,2025-05-29,2025-05-18,2025-05-29,13,24.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0432,1291,Placebo,3,Muscle pain,Musculoskeletal and connective tissue disorders,SEVERE,N,UNLIKELY,2025-05-28,2025-06-15,2025-05-28,2025-06-15,6,24.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0432,1292,Placebo,3,Tremor,Nervous system disorders,MILD,N,POSSIBLE,2025-07-09,2025-07-12,2025-07-09,2025-07-12,48,51.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0433,1293,Treatment B,2,Constipation,Gastrointestinal disorders,MILD,N,UNLIKELY,2025-03-28,2025-03-31,2025-03-28,2025-03-31,50,53.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE03-0433,1294,Treatment B,2,Dizziness,Nervous system disorders,SEVERE,N,POSSIBLE,2025-03-27,2025-04-12,2025-03-27,2025-04-12,49,65.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE04-0434,1295,Placebo,3,Fatigue,General disorders and administration site conditions,MILD,N,VERY LIKELY,2025-04-23,2025-05-12,2025-04-23,2025-05-12,5,24.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0434,1296,Placebo,3,Dyspnea,"Respiratory, thoracic and mediastinal disorders",SEVERE,N,POSSIBLE,2025-05-13,2025-05-14,2025-05-13,2025-05-14,25,26.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0435,1297,Treatment A,1,Fatigue,General disorders and administration site conditions,MILD,N,UNLIKELY,2025-06-16,,2025-06-16,,16,,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0435,1298,Treatment A,1,Hypertension,Vascular disorders,MILD,N,POSSIBLE,2025-06-20,2025-06-26,2025-06-20,2025-06-26,20,26.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0436,1299,Treatment B,2,Abdominal pain,Gastrointestinal disorders,MILD,N,POSSIBLE,2025-04-15,2025-04-23,2025-04-15,2025-04-23,16,24.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0436,1300,Treatment B,2,Constipation,Gastrointestinal disorders,MILD,N,POSSIBLE,2025-04-01,2025-04-18,2025-04-01,2025-04-18,2,19.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0436,1301,Treatment B,2,Insomnia,Nervous system disorders,MODERATE,N,PROBABLE,2025-04-12,2025-04-15,2025-04-12,2025-04-15,13,16.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0436,1302,Treatment B,2,Nausea,Gastrointestinal disorders,MILD,N,POSSIBLE,2025-04-08,,2025-04-08,,9,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0437,1303,Treatment B,2,Headache,Nervous system disorders,MODERATE,N,POSSIBLE,2025-04-28,,2025-04-28,,47,,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0437,1304,Treatment B,2,Constipation,Gastrointestinal disorders,MILD,N,POSSIBLE,2025-04-24,2025-05-05,2025-04-24,2025-05-05,43,54.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0437,1305,Treatment B,2,Constipation,Gastrointestinal disorders,MILD,N,POSSIBLE,2025-04-26,2025-05-02,2025-04-26,2025-05-02,45,51.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0437,1306,Treatment B,2,Dyspnea,"Respiratory, thoracic and mediastinal disorders",MILD,N,VERY LIKELY,2025-03-30,,2025-03-30,,18,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0438,1307,Treatment A,1,Vomiting,Gastrointestinal disorders,MODERATE,N,POSSIBLE,2025-03-06,,2025-03-06,,5,,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0438,1308,Treatment A,1,Rash,Skin and subcutaneous tissue disorders,MODERATE,Y,POSSIBLE,2025-03-12,2025-03-27,2025-03-12,2025-03-27,11,26.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0439,1309,Treatment B,2,Tremor,Nervous system disorders,MILD,Y,POSSIBLE,2025-02-16,2025-03-07,2025-02-16,2025-03-07,18,37.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0439,1310,Treatment B,2,Insomnia,Nervous system disorders,MODERATE,N,PROBABLE,2025-02-22,2025-03-13,2025-02-22,2025-03-13,24,43.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0440,1311,Treatment A,1,Diarrhea,Gastrointestinal disorders,MILD,N,VERY LIKELY,2025-03-10,2025-03-25,2025-03-10,2025-03-25,39,54.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0440,1312,Treatment A,1,Abdominal pain,Gastrointestinal disorders,MODERATE,N,PROBABLE,2025-03-07,,2025-03-07,,36,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0440,1313,Treatment A,1,Pruritus,Skin and subcutaneous tissue disorders,MODERATE,N,UNLIKELY,2025-03-08,,2025-03-08,,37,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0440,1314,Treatment A,1,Back pain,Musculoskeletal and connective tissue disorders,MILD,N,PROBABLE,2025-03-04,2025-03-22,2025-03-04,2025-03-22,33,51.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0440,1315,Treatment A,1,Vomiting,Gastrointestinal disorders,MILD,N,UNLIKELY,2025-02-23,2025-03-02,2025-02-23,2025-03-02,24,31.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0441,1316,Treatment B,2,Dyspnea,"Respiratory, thoracic and mediastinal disorders",MILD,N,UNLIKELY,2025-05-07,2025-05-11,2025-05-07,2025-05-11,49,53.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE02-0442,1317,Treatment B,2,Constipation,Gastrointestinal disorders,MILD,N,UNLIKELY,2025-07-02,,2025-07-02,,3,,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0442,1318,Treatment B,2,Nausea,Gastrointestinal disorders,MODERATE,N,PROBABLE,2025-07-26,,2025-07-26,,27,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0443,1319,Treatment A,1,Pruritus,Skin and subcutaneous tissue disorders,MODERATE,N,POSSIBLE,2025-04-09,2025-04-19,2025-04-09,2025-04-19,2,12.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0443,1320,Treatment A,1,Headache,Nervous system disorders,MODERATE,N,VERY LIKELY,2025-04-10,,2025-04-10,,3,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0444,1321,Treatment B,2,Hypertension,Vascular disorders,MILD,N,POSSIBLE,2025-05-13,,2025-05-13,,39,,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0445,1322,Placebo,3,Headache,Nervous system disorders,MILD,N,POSSIBLE,2025-05-28,2025-05-29,2025-05-28,2025-05-29,22,23.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0445,1323,Placebo,3,Pruritus,Skin and subcutaneous tissue disorders,MILD,N,UNLIKELY,2025-06-17,2025-06-27,2025-06-17,2025-06-27,42,52.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0445,1324,Placebo,3,Nausea,Gastrointestinal disorders,MILD,N,PROBABLE,2025-05-11,2025-05-17,2025-05-11,2025-05-17,5,11.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0446,1325,Treatment A,1,Dizziness,Nervous system disorders,MODERATE,Y,POSSIBLE,2025-04-05,,2025-04-05,,23,,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0446,1326,Treatment A,1,Constipation,Gastrointestinal disorders,MILD,N,POSSIBLE,2025-03-27,2025-04-07,2025-03-27,2025-04-07,14,25.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0447,1327,Treatment B,2,Fever,General disorders and administration site conditions,SEVERE,N,PROBABLE,2025-03-13,2025-03-16,2025-03-13,2025-03-16,32,35.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0447,1328,Treatment B,2,Headache,Nervous system disorders,MILD,N,POSSIBLE,2025-03-09,,2025-03-09,,28,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0447,1329,Treatment B,2,Back pain,Musculoskeletal and connective tissue disorders,MILD,N,PROBABLE,2025-03-06,2025-03-16,2025-03-06,2025-03-16,25,35.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0447,1330,Treatment B,2,Tremor,Nervous system disorders,MODERATE,Y,UNLIKELY,2025-03-08,2025-03-27,2025-03-08,2025-03-27,27,46.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0447,1331,Treatment B,2,Pruritus,Skin and subcutaneous tissue disorders,MILD,N,PROBABLE,2025-03-20,,2025-03-20,,39,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0448,1332,Treatment A,1,Tachycardia,Cardiac disorders,MODERATE,N,POSSIBLE,2025-05-20,2025-06-01,2025-05-20,2025-06-01,38,50.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0448,1333,Treatment A,1,Fever,General disorders and administration site conditions,MODERATE,N,POSSIBLE,2025-05-02,2025-05-05,2025-05-02,2025-05-05,20,23.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0449,1334,Placebo,3,Tremor,Nervous system disorders,MODERATE,N,POSSIBLE,2025-04-07,2025-04-15,2025-04-07,2025-04-15,27,35.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0449,1335,Placebo,3,Vomiting,Gastrointestinal disorders,MILD,N,POSSIBLE,2025-03-21,2025-04-04,2025-03-21,2025-04-04,10,24.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0449,1336,Placebo,3,Vomiting,Gastrointestinal disorders,MILD,N,POSSIBLE,2025-03-28,,2025-03-28,,17,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0449,1337,Placebo,3,Pruritus,Skin and subcutaneous tissue disorders,MILD,N,POSSIBLE,2025-03-13,2025-03-16,2025-03-13,2025-03-16,2,5.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0449,1338,Placebo,3,Vomiting,Gastrointestinal disorders,MILD,N,UNLIKELY,2025-04-19,2025-04-30,2025-04-19,2025-04-30,39,50.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0449,1339,Placebo,3,Dizziness,Nervous system disorders,MILD,N,POSSIBLE,2025-03-19,,2025-03-19,,8,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0450,1340,Treatment B,2,Tremor,Nervous system disorders,MILD,Y,PROBABLE,2025-04-13,2025-04-20,2025-04-13,2025-04-20,18,25.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0450,1341,Treatment B,2,Tremor,Nervous system disorders,MILD,N,UNLIKELY,2025-04-26,2025-05-12,2025-04-26,2025-05-12,31,47.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0450,1342,Treatment B,2,Vomiting,Gastrointestinal disorders,MILD,N,PROBABLE,2025-04-23,2025-05-04,2025-04-23,2025-05-04,28,39.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0451,1343,Treatment A,1,Pruritus,Skin and subcutaneous tissue disorders,MILD,N,VERY LIKELY,2025-07-10,2025-07-13,2025-07-10,2025-07-13,33,36.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0451,1344,Treatment A,1,Muscle pain,Musculoskeletal and connective tissue disorders,SEVERE,N,VERY LIKELY,2025-06-10,2025-06-12,2025-06-10,2025-06-12,3,5.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0452,1345,Treatment A,1,Muscle pain,Musculoskeletal and connective tissue disorders,MODERATE,N,POSSIBLE,2025-06-23,2025-07-07,2025-06-23,2025-07-07,49,63.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0452,1346,Treatment A,1,Dizziness,Nervous system disorders,MILD,Y,PROBABLE,2025-06-02,,2025-06-02,,28,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0453,1347,Treatment A,1,Headache,Nervous system disorders,MILD,N,POSSIBLE,2025-03-11,2025-03-18,2025-03-11,2025-03-18,24,31.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0453,1348,Treatment A,1,Back pain,Musculoskeletal and connective tissue disorders,MILD,N,POSSIBLE,2025-03-16,2025-04-01,2025-03-16,2025-04-01,29,45.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0453,1349,Treatment A,1,Back pain,Musculoskeletal and connective tissue disorders,MILD,Y,POSSIBLE,2025-03-16,2025-03-19,2025-03-16,2025-03-19,29,32.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0453,1350,Treatment A,1,Abdominal pain,Gastrointestinal disorders,MILD,N,VERY LIKELY,2025-03-28,2025-03-30,2025-03-28,2025-03-30,41,43.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0453,1351,Treatment A,1,Dyspnea,"Respiratory, thoracic and mediastinal disorders",MILD,Y,POSSIBLE,2025-03-18,2025-04-02,2025-03-18,2025-04-02,31,46.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0453,1352,Treatment A,1,Tremor,Nervous system disorders,MILD,N,POSSIBLE,2025-03-13,2025-03-30,2025-03-13,2025-03-30,26,43.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0456,1353,Treatment B,2,Insomnia,Nervous system disorders,MILD,N,PROBABLE,2025-08-15,2025-08-17,2025-08-15,2025-08-17,37,39.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0456,1354,Treatment B,2,Nausea,Gastrointestinal disorders,MODERATE,N,POSSIBLE,2025-07-12,,2025-07-12,,3,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0456,1355,Treatment B,2,Fever,General disorders and administration site conditions,MODERATE,N,POSSIBLE,2025-07-22,2025-07-23,2025-07-22,2025-07-23,13,14.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0456,1356,Treatment B,2,Dizziness,Nervous system disorders,SEVERE,N,POSSIBLE,2025-08-22,2025-09-02,2025-08-22,2025-09-02,44,55.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0456,1357,Treatment B,2,Fever,General disorders and administration site conditions,MILD,N,PROBABLE,2025-08-25,2025-08-27,2025-08-25,2025-08-27,47,49.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0457,1358,Treatment B,2,Dizziness,Nervous system disorders,MILD,N,UNLIKELY,2025-02-26,,2025-02-26,,42,,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0457,1359,Treatment B,2,Nausea,Gastrointestinal disorders,MILD,N,POSSIBLE,2025-02-01,,2025-02-01,,17,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0457,1360,Treatment B,2,Hypertension,Vascular disorders,MILD,N,PROBABLE,2025-02-04,2025-02-09,2025-02-04,2025-02-09,20,25.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0458,1361,Treatment A,1,Abdominal pain,Gastrointestinal disorders,MILD,N,VERY LIKELY,2025-03-25,2025-04-09,2025-03-25,2025-04-09,30,45.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0458,1362,Treatment A,1,Fever,General disorders and administration site conditions,MILD,N,PROBABLE,2025-03-14,2025-03-25,2025-03-14,2025-03-25,19,30.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0458,1363,Treatment A,1,Hypertension,Vascular disorders,MILD,N,UNLIKELY,2025-04-13,2025-04-24,2025-04-13,2025-04-24,49,60.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0458,1364,Treatment A,1,Tremor,Nervous system disorders,MODERATE,N,VERY LIKELY,2025-03-19,2025-04-03,2025-03-19,2025-04-03,24,39.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0458,1365,Treatment A,1,Diarrhea,Gastrointestinal disorders,MODERATE,N,POSSIBLE,2025-04-05,2025-04-06,2025-04-05,2025-04-06,41,42.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0459,1366,Treatment A,1,Pruritus,Skin and subcutaneous tissue disorders,MILD,N,PROBABLE,2025-02-20,2025-02-24,2025-02-20,2025-02-24,4,8.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0459,1367,Treatment A,1,Pruritus,Skin and subcutaneous tissue disorders,MILD,Y,POSSIBLE,2025-02-20,2025-03-01,2025-02-20,2025-03-01,4,13.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0460,1368,Treatment B,2,Tremor,Nervous system disorders,MILD,N,POSSIBLE,2025-04-13,2025-04-14,2025-04-13,2025-04-14,31,32.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0460,1369,Treatment B,2,Dyspnea,"Respiratory, thoracic and mediastinal disorders",MODERATE,N,PROBABLE,2025-04-19,2025-04-27,2025-04-19,2025-04-27,37,45.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0460,1370,Treatment B,2,Hypertension,Vascular disorders,MODERATE,N,POSSIBLE,2025-03-20,2025-04-06,2025-03-20,2025-04-06,7,24.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0460,1371,Treatment B,2,Cough,"Respiratory, thoracic and mediastinal disorders",MILD,N,PROBABLE,2025-04-27,,2025-04-27,,45,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0461,1372,Treatment A,1,Cough,"Respiratory, thoracic and mediastinal disorders",MILD,N,VERY LIKELY,2025-04-13,,2025-04-13,,11,,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0462,1373,Treatment B,2,Fever,General disorders and administration site conditions,MODERATE,N,VERY LIKELY,2025-05-16,2025-05-30,2025-05-16,2025-05-30,10,24.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0462,1374,Treatment B,2,Back pain,Musculoskeletal and connective tissue disorders,MILD,N,POSSIBLE,2025-05-23,2025-06-08,2025-05-23,2025-06-08,17,33.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0463,1375,Placebo,3,Tremor,Nervous system disorders,MILD,N,POSSIBLE,2025-07-03,2025-07-10,2025-07-03,2025-07-10,7,14.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0463,1376,Placebo,3,Tachycardia,Cardiac disorders,MODERATE,N,POSSIBLE,2025-08-05,,2025-08-05,,40,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0463,1377,Placebo,3,Fever,General disorders and administration site conditions,MODERATE,N,PROBABLE,2025-07-13,2025-07-18,2025-07-13,2025-07-18,17,22.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0463,1378,Placebo,3,Nausea,Gastrointestinal disorders,MILD,N,POSSIBLE,2025-07-20,,2025-07-20,,24,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0464,1379,Treatment A,1,Diarrhea,Gastrointestinal disorders,MILD,N,POSSIBLE,2025-04-06,2025-04-19,2025-04-06,2025-04-19,29,42.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0464,1380,Treatment A,1,Fatigue,General disorders and administration site conditions,MODERATE,Y,UNLIKELY,2025-04-07,2025-04-18,2025-04-07,2025-04-18,30,41.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0464,1381,Treatment A,1,Muscle pain,Musculoskeletal and connective tissue disorders,MODERATE,N,PROBABLE,2025-03-27,2025-03-29,2025-03-27,2025-03-29,19,21.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0464,1382,Treatment A,1,Cough,"Respiratory, thoracic and mediastinal disorders",MILD,N,VERY LIKELY,2025-03-26,2025-04-01,2025-03-26,2025-04-01,18,24.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0465,1383,Treatment B,2,Nausea,Gastrointestinal disorders,MILD,N,POSSIBLE,2025-02-22,2025-02-26,2025-02-22,2025-02-26,25,29.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE05-0465,1384,Treatment B,2,Muscle pain,Musculoskeletal and connective tissue disorders,SEVERE,N,UNLIKELY,2025-03-04,,2025-03-04,,35,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE01-0466,1385,Treatment B,2,Fever,General disorders and administration site conditions,MODERATE,N,VERY LIKELY,2025-07-08,2025-07-15,2025-07-08,2025-07-15,8,15.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0467,1386,Treatment A,1,Rash,Skin and subcutaneous tissue disorders,MODERATE,N,PROBABLE,2025-04-17,2025-04-29,2025-04-17,2025-04-29,31,43.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,N
CLIN-2025-042,CLIN-2025-042-SITE03-0468,1387,Treatment B,2,Insomnia,Nervous system disorders,MILD,N,PROBABLE,2025-03-26,2025-03-28,2025-03-26,2025-03-28,14,16.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0468,1388,Treatment B,2,Cough,"Respiratory, thoracic and mediastinal disorders",MODERATE,N,VERY LIKELY,2025-03-27,2025-03-30,2025-03-27,2025-03-30,15,18.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0468,1389,Treatment B,2,Hypertension,Vascular disorders,MILD,N,PROBABLE,2025-04-21,2025-05-09,2025-04-21,2025-05-09,40,58.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0468,1390,Treatment B,2,Fever,General disorders and administration site conditions,MODERATE,N,VERY LIKELY,2025-04-25,2025-05-04,2025-04-25,2025-05-04,44,53.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0468,1391,Treatment B,2,Tremor,Nervous system disorders,SEVERE,N,VERY LIKELY,2025-03-24,2025-04-08,2025-03-24,2025-04-08,12,27.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0468,1392,Treatment B,2,Cough,"Respiratory, thoracic and mediastinal disorders",MILD,N,POSSIBLE,2025-04-20,2025-04-26,2025-04-20,2025-04-26,39,45.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0469,1393,Placebo,3,Vomiting,Gastrointestinal disorders,MILD,N,POSSIBLE,2025-03-05,2025-03-13,2025-03-05,2025-03-13,13,21.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0469,1394,Placebo,3,Diarrhea,Gastrointestinal disorders,MODERATE,N,POSSIBLE,2025-03-04,2025-03-08,2025-03-04,2025-03-08,12,16.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0469,1395,Placebo,3,Tachycardia,Cardiac disorders,MILD,N,POSSIBLE,2025-04-07,2025-04-21,2025-04-07,2025-04-21,46,60.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0469,1396,Placebo,3,Insomnia,Nervous system disorders,MILD,N,VERY LIKELY,2025-03-25,2025-04-06,2025-03-25,2025-04-06,33,45.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0469,1397,Placebo,3,Dyspnea,"Respiratory, thoracic and mediastinal disorders",MILD,N,POSSIBLE,2025-04-06,2025-04-19,2025-04-06,2025-04-19,45,58.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0470,1398,Treatment A,1,Abdominal pain,Gastrointestinal disorders,MODERATE,N,VERY LIKELY,2025-04-20,2025-04-30,2025-04-20,2025-04-30,6,16.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0470,1399,Treatment A,1,Back pain,Musculoskeletal and connective tissue disorders,MILD,N,UNLIKELY,2025-06-02,,2025-06-02,,49,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0470,1400,Treatment A,1,Fatigue,General disorders and administration site conditions,MODERATE,N,POSSIBLE,2025-05-22,2025-05-31,2025-05-22,2025-05-31,38,47.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0471,1401,Treatment A,1,Dyspnea,"Respiratory, thoracic and mediastinal disorders",MODERATE,N,PROBABLE,2025-06-15,2025-07-01,2025-06-15,2025-07-01,46,62.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0471,1402,Treatment A,1,Nausea,Gastrointestinal disorders,MILD,Y,POSSIBLE,2025-05-15,2025-05-25,2025-05-15,2025-05-25,15,25.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0472,1403,Treatment B,2,Fatigue,General disorders and administration site conditions,MILD,N,PROBABLE,2025-03-16,2025-03-23,2025-03-16,2025-03-23,4,11.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0473,1404,Treatment B,2,Vomiting,Gastrointestinal disorders,SEVERE,N,POSSIBLE,2025-06-18,,2025-06-18,,49,,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0473,1405,Treatment B,2,Diarrhea,Gastrointestinal disorders,MILD,N,PROBABLE,2025-06-05,2025-06-11,2025-06-05,2025-06-11,36,42.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0473,1406,Treatment B,2,Diarrhea,Gastrointestinal disorders,MILD,N,PROBABLE,2025-05-31,2025-06-15,2025-05-31,2025-06-15,31,46.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0473,1407,Treatment B,2,Abdominal pain,Gastrointestinal disorders,MILD,Y,PROBABLE,2025-06-17,,2025-06-17,,48,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0474,1408,Treatment A,1,Vomiting,Gastrointestinal disorders,MILD,N,POSSIBLE,2025-06-04,2025-06-10,2025-06-04,2025-06-10,7,13.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0474,1409,Treatment A,1,Nausea,Gastrointestinal disorders,MODERATE,N,POSSIBLE,2025-06-24,,2025-06-24,,27,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0474,1410,Treatment A,1,Dyspnea,"Respiratory, thoracic and mediastinal disorders",MILD,Y,POSSIBLE,2025-06-22,2025-06-28,2025-06-22,2025-06-28,25,31.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0474,1411,Treatment A,1,Muscle pain,Musculoskeletal and connective tissue disorders,MODERATE,N,PROBABLE,2025-05-31,2025-06-03,2025-05-31,2025-06-03,3,6.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0474,1412,Treatment A,1,Vomiting,Gastrointestinal disorders,MILD,N,POSSIBLE,2025-05-30,2025-06-16,2025-05-30,2025-06-16,2,19.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0474,1413,Treatment A,1,Abdominal pain,Gastrointestinal disorders,MODERATE,N,UNLIKELY,2025-06-05,2025-06-17,2025-06-05,2025-06-17,8,20.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0474,1414,Treatment A,1,Abdominal pain,Gastrointestinal disorders,MILD,N,UNLIKELY,2025-06-15,2025-06-30,2025-06-15,2025-06-30,18,33.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0475,1415,Treatment B,2,Cough,"Respiratory, thoracic and mediastinal disorders",MILD,N,POSSIBLE,2025-07-12,2025-07-26,2025-07-12,2025-07-26,14,28.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0475,1416,Treatment B,2,Vomiting,Gastrointestinal disorders,MODERATE,N,POSSIBLE,2025-07-09,2025-07-15,2025-07-09,2025-07-15,11,17.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0475,1417,Treatment B,2,Muscle pain,Musculoskeletal and connective tissue disorders,MILD,N,UNLIKELY,2025-08-07,,2025-08-07,,40,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0475,1418,Treatment B,2,Hypertension,Vascular disorders,MODERATE,N,POSSIBLE,2025-06-30,2025-07-07,2025-06-30,2025-07-07,2,9.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0475,1419,Treatment B,2,Vomiting,Gastrointestinal disorders,MILD,N,PROBABLE,2025-07-16,2025-07-30,2025-07-16,2025-07-30,18,32.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0476,1420,Treatment B,2,Insomnia,Nervous system disorders,MILD,N,POSSIBLE,2025-04-12,2025-04-19,2025-04-12,2025-04-19,42,49.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0476,1421,Treatment B,2,Constipation,Gastrointestinal disorders,MILD,N,POSSIBLE,2025-04-11,2025-04-16,2025-04-11,2025-04-16,41,46.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0476,1422,Treatment B,2,Tremor,Nervous system disorders,MILD,N,POSSIBLE,2025-03-19,2025-03-29,2025-03-19,2025-03-29,18,28.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0477,1423,Placebo,3,Tremor,Nervous system disorders,MODERATE,N,POSSIBLE,2025-02-21,2025-02-22,2025-02-21,2025-02-22,12,13.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0478,1424,Treatment A,1,Pruritus,Skin and subcutaneous tissue disorders,MILD,N,POSSIBLE,2025-02-20,2025-03-02,2025-02-20,2025-03-02,6,16.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0478,1425,Treatment A,1,Abdominal pain,Gastrointestinal disorders,MILD,N,POSSIBLE,2025-03-10,2025-03-29,2025-03-10,2025-03-29,24,43.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0478,1426,Treatment A,1,Tremor,Nervous system disorders,MILD,N,PROBABLE,2025-03-12,2025-03-17,2025-03-12,2025-03-17,26,31.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0478,1427,Treatment A,1,Insomnia,Nervous system disorders,MILD,N,PROBABLE,2025-03-31,2025-04-16,2025-03-31,2025-04-16,45,61.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0478,1428,Treatment A,1,Fatigue,General disorders and administration site conditions,MILD,N,POSSIBLE,2025-03-04,2025-03-10,2025-03-04,2025-03-10,18,24.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0479,1429,Placebo,3,Fatigue,General disorders and administration site conditions,MODERATE,N,PROBABLE,2025-05-20,2025-05-24,2025-05-20,2025-05-24,30,34.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0479,1430,Placebo,3,Vomiting,Gastrointestinal disorders,MILD,N,UNLIKELY,2025-05-05,2025-05-11,2025-05-05,2025-05-11,15,21.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0479,1431,Placebo,3,Tremor,Nervous system disorders,MILD,N,PROBABLE,2025-04-23,2025-05-05,2025-04-23,2025-05-05,3,15.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0480,1432,Placebo,3,Diarrhea,Gastrointestinal disorders,MODERATE,N,PROBABLE,2025-07-15,2025-07-18,2025-07-15,2025-07-18,13,16.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0480,1433,Placebo,3,Abdominal pain,Gastrointestinal disorders,MODERATE,N,UNLIKELY,2025-07-29,2025-08-04,2025-07-29,2025-08-04,27,33.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0480,1434,Placebo,3,Tachycardia,Cardiac disorders,MILD,N,VERY LIKELY,2025-08-20,2025-09-08,2025-08-20,2025-09-08,49,68.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0480,1435,Placebo,3,Constipation,Gastrointestinal disorders,MILD,N,UNLIKELY,2025-08-05,2025-08-12,2025-08-05,2025-08-12,34,41.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0480,1436,Placebo,3,Vomiting,Gastrointestinal disorders,MILD,N,UNLIKELY,2025-08-14,2025-09-02,2025-08-14,2025-09-02,43,62.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0480,1437,Placebo,3,Tachycardia,Cardiac disorders,MILD,N,POSSIBLE,2025-07-27,2025-08-12,2025-07-27,2025-08-12,25,41.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0480,1438,Placebo,3,Cough,"Respiratory, thoracic and mediastinal disorders",MILD,N,UNLIKELY,2025-08-08,2025-08-16,2025-08-08,2025-08-16,37,45.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0481,1439,Treatment A,1,Muscle pain,Musculoskeletal and connective tissue disorders,MILD,N,UNLIKELY,2025-02-22,2025-03-05,2025-02-22,2025-03-05,11,22.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0481,1440,Treatment A,1,Diarrhea,Gastrointestinal disorders,SEVERE,N,UNLIKELY,2025-03-31,,2025-03-31,,48,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0481,1441,Treatment A,1,Pruritus,Skin and subcutaneous tissue disorders,MILD,N,POSSIBLE,2025-03-19,2025-03-22,2025-03-19,2025-03-22,36,39.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0482,1442,Treatment A,1,Dizziness,Nervous system disorders,MILD,N,UNLIKELY,2025-05-14,2025-05-18,2025-05-14,2025-05-18,17,21.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0482,1443,Treatment A,1,Fatigue,General disorders and administration site conditions,MILD,N,PROBABLE,2025-05-13,,2025-05-13,,16,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0482,1444,Treatment A,1,Dyspnea,"Respiratory, thoracic and mediastinal disorders",MILD,N,POSSIBLE,2025-05-30,2025-06-08,2025-05-30,2025-06-08,33,42.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0482,1445,Treatment A,1,Nausea,Gastrointestinal disorders,SEVERE,N,POSSIBLE,2025-06-13,,2025-06-13,,47,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0483,1446,Treatment B,2,Nausea,Gastrointestinal disorders,MILD,N,PROBABLE,2025-06-28,,2025-06-28,,8,,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0483,1447,Treatment B,2,Dizziness,Nervous system disorders,MILD,N,PROBABLE,2025-08-01,2025-08-16,2025-08-01,2025-08-16,42,57.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0483,1448,Treatment B,2,Headache,Nervous system disorders,SEVERE,N,PROBABLE,2025-07-10,,2025-07-10,,20,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0483,1449,Treatment B,2,Back pain,Musculoskeletal and connective tissue disorders,MODERATE,N,POSSIBLE,2025-07-29,2025-08-14,2025-07-29,2025-08-14,39,55.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0483,1450,Treatment B,2,Hypertension,Vascular disorders,MILD,N,UNLIKELY,2025-07-22,2025-07-30,2025-07-22,2025-07-30,32,40.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0483,1451,Treatment B,2,Tachycardia,Cardiac disorders,MODERATE,N,VERY LIKELY,2025-07-11,2025-07-26,2025-07-11,2025-07-26,21,36.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0485,1452,Treatment A,1,Headache,Nervous system disorders,MILD,N,UNLIKELY,2025-06-25,2025-07-03,2025-06-25,2025-07-03,36,44.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0485,1453,Treatment A,1,Fatigue,General disorders and administration site conditions,MILD,N,POSSIBLE,2025-06-08,2025-06-24,2025-06-08,2025-06-24,19,35.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0485,1454,Treatment A,1,Back pain,Musculoskeletal and connective tissue disorders,MODERATE,N,POSSIBLE,2025-06-07,2025-06-11,2025-06-07,2025-06-11,18,22.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0485,1455,Treatment A,1,Cough,"Respiratory, thoracic and mediastinal disorders",MODERATE,N,PROBABLE,2025-06-27,2025-07-09,2025-06-27,2025-07-09,38,50.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0486,1456,Treatment B,2,Fatigue,General disorders and administration site conditions,MILD,Y,PROBABLE,2025-03-23,2025-04-08,2025-03-23,2025-04-08,50,66.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0486,1457,Treatment B,2,Hypertension,Vascular disorders,MODERATE,N,POSSIBLE,2025-02-15,2025-02-27,2025-02-15,2025-02-27,14,26.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0486,1458,Treatment B,2,Rash,Skin and subcutaneous tissue disorders,MODERATE,N,PROBABLE,2025-02-18,2025-03-02,2025-02-18,2025-03-02,17,29.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0486,1459,Treatment B,2,Nausea,Gastrointestinal disorders,MILD,N,POSSIBLE,2025-02-12,2025-02-14,2025-02-12,2025-02-14,11,13.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0486,1460,Treatment B,2,Nausea,Gastrointestinal disorders,MILD,N,POSSIBLE,2025-03-18,2025-04-03,2025-03-18,2025-04-03,45,61.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0487,1461,Treatment B,2,Muscle pain,Musculoskeletal and connective tissue disorders,SEVERE,Y,UNLIKELY,2025-07-12,2025-07-13,2025-07-12,2025-07-13,39,40.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0487,1462,Treatment B,2,Hypertension,Vascular disorders,MODERATE,N,POSSIBLE,2025-06-19,2025-06-29,2025-06-19,2025-06-29,16,26.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0488,1463,Treatment A,1,Fatigue,General disorders and administration site conditions,MODERATE,N,POSSIBLE,2025-06-25,2025-07-10,2025-06-25,2025-07-10,35,50.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0488,1464,Treatment A,1,Hypertension,Vascular disorders,SEVERE,N,PROBABLE,2025-07-08,2025-07-18,2025-07-08,2025-07-18,48,58.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0488,1465,Treatment A,1,Muscle pain,Musculoskeletal and connective tissue disorders,MILD,N,PROBABLE,2025-06-29,2025-07-03,2025-06-29,2025-07-03,39,43.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0489,1466,Treatment A,1,Headache,Nervous system disorders,MILD,N,PROBABLE,2025-04-18,2025-04-22,2025-04-18,2025-04-22,46,50.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0489,1467,Treatment A,1,Fatigue,General disorders and administration site conditions,MILD,N,UNLIKELY,2025-03-09,2025-03-27,2025-03-09,2025-03-27,6,24.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0489,1468,Treatment A,1,Vomiting,Gastrointestinal disorders,MODERATE,N,VERY LIKELY,2025-04-10,2025-04-22,2025-04-10,2025-04-22,38,50.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0489,1469,Treatment A,1,Headache,Nervous system disorders,MILD,N,PROBABLE,2025-04-20,2025-04-28,2025-04-20,2025-04-28,48,56.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0489,1470,Treatment A,1,Dizziness,Nervous system disorders,MILD,N,PROBABLE,2025-03-24,2025-04-02,2025-03-24,2025-04-02,21,30.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0491,1471,Placebo,3,Cough,"Respiratory, thoracic and mediastinal disorders",MODERATE,N,POSSIBLE,2025-05-24,2025-06-02,2025-05-24,2025-06-02,45,54.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0491,1472,Placebo,3,Back pain,Musculoskeletal and connective tissue disorders,MILD,N,PROBABLE,2025-04-19,2025-05-08,2025-04-19,2025-05-08,10,29.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0492,1473,Placebo,3,Rash,Skin and subcutaneous tissue disorders,MILD,N,VERY LIKELY,2025-07-11,,2025-07-11,,10,,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0492,1474,Placebo,3,Fatigue,General disorders and administration site conditions,MODERATE,Y,POSSIBLE,2025-08-08,2025-08-20,2025-08-08,2025-08-20,38,50.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0492,1475,Placebo,3,Constipation,Gastrointestinal disorders,MODERATE,N,POSSIBLE,2025-08-11,2025-08-15,2025-08-11,2025-08-15,41,45.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0492,1476,Placebo,3,Constipation,Gastrointestinal disorders,MILD,N,VERY LIKELY,2025-07-21,2025-07-31,2025-07-21,2025-07-31,20,30.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0493,1477,Treatment B,2,Dyspnea,"Respiratory, thoracic and mediastinal disorders",MILD,N,POSSIBLE,2025-07-19,,2025-07-19,,41,,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0493,1478,Treatment B,2,Dyspnea,"Respiratory, thoracic and mediastinal disorders",SEVERE,N,POSSIBLE,2025-07-03,,2025-07-03,,25,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0494,1479,Treatment B,2,Cough,"Respiratory, thoracic and mediastinal disorders",MILD,N,UNLIKELY,2025-04-09,,2025-04-09,,37,,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE04-0494,1480,Treatment B,2,Abdominal pain,Gastrointestinal disorders,MILD,N,UNLIKELY,2025-03-09,2025-03-15,2025-03-09,2025-03-15,6,12.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0495,1481,Treatment A,1,Cough,"Respiratory, thoracic and mediastinal disorders",MILD,N,VERY LIKELY,2025-05-30,2025-06-10,2025-05-30,2025-06-10,14,25.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0495,1482,Treatment A,1,Abdominal pain,Gastrointestinal disorders,MILD,N,POSSIBLE,2025-06-18,,2025-06-18,,33,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0496,1483,Treatment A,1,Muscle pain,Musculoskeletal and connective tissue disorders,MILD,N,POSSIBLE,2025-04-06,2025-04-08,2025-04-06,2025-04-08,23,25.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0496,1484,Treatment A,1,Fatigue,General disorders and administration site conditions,MILD,Y,POSSIBLE,2025-04-26,2025-04-29,2025-04-26,2025-04-29,43,46.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE01-0496,1485,Treatment A,1,Tremor,Nervous system disorders,MILD,N,UNLIKELY,2025-03-24,2025-04-04,2025-03-24,2025-04-04,10,21.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0497,1486,Treatment A,1,Nausea,Gastrointestinal disorders,MILD,N,POSSIBLE,2025-06-15,2025-06-26,2025-06-15,2025-06-26,23,34.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0497,1487,Treatment A,1,Nausea,Gastrointestinal disorders,SEVERE,N,POSSIBLE,2025-06-14,2025-06-21,2025-06-14,2025-06-21,22,29.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0497,1488,Treatment A,1,Back pain,Musculoskeletal and connective tissue disorders,MILD,Y,POSSIBLE,2025-07-08,,2025-07-08,,46,,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0497,1489,Treatment A,1,Pruritus,Skin and subcutaneous tissue disorders,MILD,N,PROBABLE,2025-06-17,2025-07-04,2025-06-17,2025-07-04,25,42.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0497,1490,Treatment A,1,Hypertension,Vascular disorders,MILD,N,PROBABLE,2025-06-16,2025-07-05,2025-06-16,2025-07-05,24,43.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE02-0497,1491,Treatment A,1,Muscle pain,Musculoskeletal and connective tissue disorders,MILD,N,VERY LIKELY,2025-06-01,2025-06-11,2025-06-01,2025-06-11,9,19.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0498,1492,Treatment B,2,Dyspnea,"Respiratory, thoracic and mediastinal disorders",MILD,N,VERY LIKELY,2025-04-05,,2025-04-05,,24,,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0498,1493,Treatment B,2,Dizziness,Nervous system disorders,MILD,N,POSSIBLE,2025-03-29,2025-04-13,2025-03-29,2025-04-13,17,32.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE03-0498,1494,Treatment B,2,Vomiting,Gastrointestinal disorders,MILD,N,POSSIBLE,2025-04-18,2025-04-28,2025-04-18,2025-04-28,37,47.0,N,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
CLIN-2025-042,CLIN-2025-042-SITE05-0500,1495,Treatment A,1,Vomiting,Gastrointestinal disorders,MILD,N,UNLIKELY,2025-07-13,2025-07-31,2025-07-13,2025-07-31,36,54.0,Y,Y,Y,ASYMPTOMATIC LABORATORY VALUE ABNORMALITIES,Y
